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ABSTRACT
THE CELLULAR AND MOLECULAR DYNAMICS OF THE 
QUEUOSINE MODIFICATION IN TRANSFER RNA:
DEFINITION, MODULATION, DEFICIENCIES,
AND EFFECT OF THE QUEUOSINE MODIFICATION SYSTEM
Rana C. Morris 
Old DominioQ University and Eastern Virginia Medical School, 1997 
Director Dr. Mark S. Elliott
The presence o f the queuosine modification in the wobble position of tRNA“ , tRNA*5*, tRNAhIS, 
and tRNA151* is associated with a decrease in cellular growth rate, an increase in the ability to withstand 
environmental stress, and differentiation of pleuripotent cells into mature phenotypes. The loss of this 
normal modification is strongly correlated with neoplastic transformation and tumor progression of a wide 
variety of cancers.
The “normal” system for formation of the queuosine modification in tRNA was studied in human 
fibroblast cell cultures and in mouse, rat and human liver tissues. The queuosine modification system is 
shown to be made up of three distinct mechanisms: uptake of the queuine base across the plasma 
membrane; incorporation of this base into cytoplasmic tRNA; and salvage of the base from products of 
normal tRNA degradation. The queuine membrane transporter and incorporation enzyme are activated via 
phosphorylation by protein kinase C and inactivated by the action of a phosphatase. This regulation by 
phosphorylation integrates the queuosine modification system into a very sensitive eukaryotic cellular 
switching mechanism already known to produce phenotypic alterations with strong correlations to changes 
in queuosine levels.
A comparative study of two “abnormal” human adenocarcinoma cell-lines (colon and breast) was 
performed to assess their queuosine levels and determine the malfunctioning system step(s) for the cause of 
the observed deficiencies. The 100% queuosine-deficient colon tumor cell-line possessed a null mutation 
for the queuosine incorporation enzyme, while the 50-60% queuosine-deficient breast tumor cell-line 
exhibited a strong deficiency in the queuine salvage mechanism. These results demonstrate the potential 
for determination of even multiple sites of lesions in the modification sytem that would yield queuosine- 
deficient tRNA characteristic of tumors.
Computational modeling was utilized to determine the biological function for the queuosine 
modification. Steric, electrostatic, and structural differences were observed for queuosine, queuosine- 
analogues and guanosine, the nucleosides incorporated into tRNA“p anticodon stem/loop structures, and in 
triad complexes of tRNA*sp with mRNA and tRNA1*®. The results of this research identify 
indistinguishable energetic parameters for complexes of queuosine-modified anticodon loops when paired 
with an mRNA containing cytosine- or a uridine-ending codon. However, guanosine-containing anticodon 
loops demonstrate much stronger energetic stability with cytosine-ending codons. The difference in codon
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bias is shown to be due to the restriction of anticodon loop flexibility by a queuosine-induced extended 
intraloop hydrogen bonding network and only minimally due to a shift in hydrogen bonding pattern 
produced by an intraresidue hydrogen bond.
A key difference in the physiology of normal and neoplastic cells is in the increased expression of 
oncodevelopmental genes with respect to those housekeeping genes needed for survival. Sequence 
analysis of several oncodevelopmental and housekeeping transcripts suggests the presence of a contrasting 
bias in the usage of queuosine*related codons which end in cytosine or either cytosine or uridine, 
respectively. In combination with the mechanism proposed for tRNA19 decoding preferences, this codon 
usage bias suggests a potentially influential role for the queuosine modification system in the translational 
control of oncodevelopmental gene expression.
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‘Turns out not where but who you’re with that really matters.
‘Turns out not where but what you think that really matters.
Whatever tears at us, whatever holds us down, 
if nothing can be done we’U make the best of what’s around.
paraphrased from “The Best of What’s Around” by the Dave Matthews Band 
from their Album Under the Table and Dreaming (1994, The RCA Records Label)
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CHAPTER ONE 
MUCH ADO ABOUT Q
Introduction
In 1953 the world of science changed because of James D. Watson and Francis H. C. Crick’s 
publication on the structure of deoxyribonucleic acid (1). This treatise was not the first to describe the 
three-dimensional structure of a macromolecule, however it was the first attempt to describe the possible 
mechanism for a macromolecule’s biological function based on the proposed conformation. Since this 
time, molecular biologists, biochemists, physiological chemists, and structural biologists have studied the 
impact that the structure of a compound would have on its function. In fact, the quote “structure is 
function” has often been regarded as the credo for modem biomolecular research.
For nucleic acids, the three-dimensional structure of each molecule is largely based on its primary 
structure, the nucleotide sequence. In the late 1950s, a primitive mechanism for determining the sequence 
of nucleic acids was developed. This procedure was comprised o f a difficult and complicated series of 
nuclease digestions and analysis of overlapping fragment lengths. It was not until 1965, after seven years 
of work, that the first nucleic acid, yeast alanyl-transfer ribonucleic acid (tRNA11*), was sequenced (2). In 
addition to the traditional nucleotide bases o f RNA molecules [adenosine (A), cytosine (C), guanosine (G), 
and uridine (U)], the same group discovered that there exist, in tRNA approximately 80 modified forms of 
these nucleotides (3). These modified nucleotides comprise up to 25 % of all bases in a given tRNA. Most 
of these involve simple methylations of the four basic RNA bases, with a small number of other types of 
minor nucleotide alterations such as the reduction of uridine’s C5-C6 double bond to form dihydrouridine 
and the deamination o f adenosine to form inosine. There are a few large modifications that have been 
identified solely in tRNA, and these have been shown to exist only in the anticodon region-one of the two 
major functional centers of the molecule (4).
The development of a gas chromatography/mass spectrometry-based method allowed for the 
identification of the nucleotide composition o f purified tRNAs (5). However, in 1968 a peak arose in the 
profile o f an Escherichia coli tRNAlyr hydrolysate that could not be matched with previously established 
standards (6-8). Because this was a new and unknown base, it was given the designation “Q”. In the 
vocabulary of biochemistry, the Q base needed to be assigned a  name that could more definitively identify 
its nucleotidyl form. Since the free form of G was called guanine, for example, the free form of Q was to 
be called queuine. Thus, the written name for the presence of Q in a polynucleotide form was to be 
queuosine, again based on the example of guanosine for G. This development o f a naming scheme was 
important for the validation of the existence of the Q nucleotide, as Q was eventually found to exist in the 
tRNA of every organism yet studied, with the notable exception of yeast (9-11).
The journal model for this dissertation is Nucleic Acids Research.
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In 1972, the Q modified nucleotide was localized to position 34 of tRNAs specific for aspartate, 
asparagine, histidine, and tyrosine (HXFigure 1-1). The structure of queuosine was later determined by gas 
chromatography/mass spectroscopy (S) and elucidated by X-ray crystallography (13) (Figure 1-2). 
Queuosine was identified as a strangely modified guanosine analogue. The N-7 position of the purine ring 
is a C-7 in queuosine, which is the site of attachment for an ammomethyl tether to a 
dihydroxycyclopentenediol ring. This structure is known to be further modified with the addition of 
mannose and galactose residues to the cydopentenediol ring hydroxyl groups of tRNA*9  and tRNA15'1, 
respectively (14). By chemical naming convention, the basic queuosine molecule was defined as 7-(3,4- 
rranr-4,5-cfr-dihydroxy-l-cyclopenten-3-ylaminomethyI)-7-deazaguanosine. Since the early 1970s, focus 
on Q research has shied away from structural studies to branch into two main directions: sub-cellular 
biochemical research and physiological clinical research.
Biochemical Research
Basic biochemical research has characterized and localized the queuosine modification in the tRNA 
of intracellular organelles (mitochondriaand chIoroplast)and organisms as diverse as monerans (such as 
Escherichiacoli, Zymomonasmobilis, Bacillus stearothermophilus, and Salmonella typhimurium), protistans 
(Chlamydomonasreinhardtii, Chlorellapyrenoidosa, Acanthamoebacastellaniiand Dictyostelium 
discoideum), and plants (Lupinus leuteus, tobacco, and wheat), as well as many animals [from marine life 
(lingula, starfish, topminnow, flounder, and hagfish), insects (Bombyx mori, and Drosophila melanogaster), 
amphibians (Xenopus laevus), to mammals (mice, rats, opossum, rabbits, cows, and humans)]. Thus far, only 
one genus from the kingdom Fungi has been tested. However, several species of yeast have been identified as 
the only organisms currently known that do not contain the queuosine modification in their tRNA (10).
In biological systems, the Q base is known to exist in three forms: free queuine base, free nucleotide 
or nucleoside, and nucleoside incorporated in tRNA. The free base form, present in all cells and cell-types, 
has only recently been suggested to play a physiological role within a cell—modulationof receptor tyrosine 
kinases such as epidermal growth factor receptor and platelet-derivedgrowth factor receptor( 15). The free 
nucleoside or nucleotide exists in the cell due to the normal turnover of tRNA and appears to have no direct 
physiological role, although queuosine-S’-phosphatehas been reported to serve as a source of salvaged 
queuine base in mammalian cells (16,17). The incorporated form of Q has been demonstrated in aspartyl-, 
asparaginy 1-, histidy 1-, and tyrosyl-tRNA isoaccepting families of many organisms (11X These modified 
tRNA populations are further separated into queuosine-containingtRNA“p and tRNA1**, and the glycosylated 
forms of these queuosine-containingtRNAs; mannosy!atedqueuosine-containingtRNA<sp and galactosylated 
queuosine-containingtRNAIyr(14,18,19> The purpose ofthese incorporated modification forms is notyet 
known.
Originally, it was thought that queuosine modifications in prokaryotic and eukaryotic tRNA were 
evolutionary conserved. Thus, the enzyme that catalyzed the formation of this modification was assigned the

















Figure l - l .  Molecular Skeleton, Ribbon Diagram, and Electron Density Surface o f  Aminoacylated i'east Aspartyl l/tN/I.The main structure of the tRNA is 
shown in dark blue with the second and third anticodon bases in orange (light color, near the bottom) and the wobble base in red (medium color, at the bottom). 
The site for aminoacylation, the ribose o f  the adenosine at position 76, is shown in green on top. The Molecular Skeleton (representation on the left) is shown in 
ball and stick rendering with the hydrogen bonding sites o f  the anticodon and the 2 ’ and 3 ' hydroxyl groups, for covalent attachment to aspartate, as space filling 
models. The Ribbon Diagram (center) shows the backbone structure o f the tRNA with the anticodon and aminoacylated residues as ball and stick rendering. The 
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Figure 1-2. Structures o f Guanine and Queuine Bases. A two dimensional representation of the 
nucleotidyl bases are drawn with an R representing the attachment site for an H for the base form (often 
abbreviated as G and Q) or a ribose for the nucleoside form (known as Guanosine and Queuosine). The 
classical nucleic acid numbering scheme is shown. Queuine is a modified guanine with the IUPAC 
designation 7-(3”,4”-tra/»-4”,5”-cir-dihydroxy-1 ”-cyclopenten-3”-ylaminomethyl)-7-deazaguanine.
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name tRNA-guaninetransgIycosylase(TGTase; E.C. 2.4.2.29) regardless of the taxonomic classificationof 
the host organism. This enzyme was named based on it’s originally measured ability to transfer a guanine 
base into the wobble position of these tRNA families (20-22X More recently the Enzyme Commission has 
renamed this protein tRNA-guanineribosyitransferase(TGRase), although the original designation is still in 
wide use. With the furtherpurificationand identificationof components o f the prokaryoticand eukaryotic 
systems, this assumptionof conserved evolution is now in doubt.
The localization,structure, and metabolism of Q have been well studied in prokaryotes, and are now 
under scrutiny in eukaryotes with the developmentof new methods to study the presence or absence of the 
queuosine modification in mammalian tRNA.
Prokaryotes synthesize this nucleotide through a series of post-transcriptionalsteps catalyzed by 
enzymes encoded in the "queuine operon" (23). First, tRNA-guaninetransglycosylase(TGTase—thegene 
product of tgt) inserts preQi (7-aminomethyl-7-deazaguanine)into the cognate tRNAs (24) via a base- 
exchange reaction without disruptingthe phosphoribosy (backbone (22). Then, a second enzyme, s- 
adenosylmethionine^RNAribosyItransferase-isomerase(gene product of queA), adds the ribosyl group from 
an s-adenosylmethionineto the transcriptat the end of the 7-aminomethylside chain of the inserted preQi and 
isomerizes it to form the epoxycyclopentanediolmoiety of what is called oQ (25,26X Finally, the epoxy 
group of the oQ is reduced to form queuosine in an as-yet-unknown vitamin B,2-dependent reaction (27).
This completes the prokaryoticqueuosmesynthesis.
It has been suggested that most eukaryotes, including humans, salvage the fully-formedqueuine base 
from their diet or through absorption of metabolic turnover products from symbiotic bacteria living in the 
intestines of the host (16,17,28,29). Once inside the circulatory system of the organism, queuine is efficiently 
taken up by a specific cellular transport mechanism (30). Then, a cytosolic enzyme often referred to as either 
TGTase or TGRase inserts the pre-formed queuine base into the four queuosine-specifictRNA isoacceptors 
(21,31 > Finally, in the case of eukaryotic tRNA*5’’ and tRNA*1", glycosylatedqueuosine-modifiedtRNA 
isotypes have been documented (14X In 1977, a rat liver mannosyltransferasewas identified which places 
mannose residues on the hydroxyl groups of the cyclopentenediolring of tRNA*9  (18> It is presumed that 
there is a similar galactosyltransferasewhich exists that catalyzes the observed tRNAlyrgIycosylations(19).
Many methods have been developed to detect queuosine-containing tRNAs. Early techniques to 
study the nucleotide composition o f tRNAs included the use of infrared analysis and ramen spectroscopy. 
However, the most successful method to identify specific nucleotides, including Q, in tRNA samples was 
traditional gas chromatography/mass spectrometry (5). Three different methods of analysis have since 
been developed that have become the accepted procedures to measure the levels of queuosine-modified 
tRNAs. These include high performance liquid chromatography strategies (HPLC), an in vitro enzymatic 
radiolabeling assay, and, most recently, in vivo cell culture radiolabeling assays.
(n the early days of “Q” research, several chromatographic matrices were utilized for the 
separation of queuosine-containing tRNAs including dihydroxyboryl-substitutued cellulose, acetylated-
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dihydroxyborophenyl-succino-aminoethyl cellulose and concavalin A-sepharose affinity chromatography 
(3,32,33). Eventually, with the development of HPLC technology, reversed phase HPLC matrices were 
demonstrated to quickly and efficiently separate queuosine-containing from queuosine-deficient tRNAs 
based on hydrophobic criteria (3435). Studies on the chromatographic mobility of the queuosine-modified 
tRNA (3) and x-ray crystal structure of queuosine (13) have suggested that the physiological state of the 
molecule includes a positively-charged quaternary amine in the aminomethyl linker between the base and 
the cyclopentenediol ring. Due to the presence of charged amine group and the two hydroxyl groups on 
the cyclopentenediol moiety, the queuosine-containing tRNAs can be separated from other non-queuosine- 
containing isoforms of tRNAs using RPC-5 HPLC (34). Thus, the total level o f queuosine-containing 
tRNAs can be determined with this method. Recently, a W-Porex C4 HPLC column was shown to resolve 
not only queuosine-containing from non-queuosine-containing tRNA isoforms, but also to separate the four 
isoaccepting families as well (36,37). Using the W-Porex C4 HPLC method, it is now possible to measure 
the queuosine-modification levels for all four families of queuosine-containing tRNAs at once, as is shown 
in the Appendix of this document. These HPLC methods require a large amount (1 to 2 mg) of tRNA and 
are, therefore, only suitable for very large cell culture preparations or tissue analysis of substantial organ 
biopsies.
A somewhat faster and more sensitive method for measuring queuosine levels was developed 
utilizing the cloned Escherichiacoli queuosine-incorporationenzyme, TGTase, in an in vitro assay (38,39} 
The modificationof tRNA with queuosine is an irreversibleone, thus enzymatic incorporationof a 
radiolabeledqueuine or guanine will “tag” the tRNAs that did not previously contain this modified base. The 
amount o f queuosine-containingtRNA will, therefore, be inverselyproportionalto the signal obtained. This 
method requires extensive purification of the tRNA fraction from samples, but has been widely used to 
measure the levels o f queuosine in biopsy tissues (40-43} organ tissue lysates (40,43,44) and cell culture 
lysates (17,30,45)
Cell culture methods were more recently developed to measure cellular activities pertaining to the 
queuosine modification system in vivo. In order to measure the permeabilityof or active transport (“uptake”) 
mechanism in cells for the queuine base, a culture of cells is exposed to radiolabeledqueuine for a period of 
time and the amount o f radioactivity taken up by the cells is assessed (30). A modificationof this strategy was 
made to measure the amount of radiolabeledqueuine incorporated into cytoplasmic tRNA (46). The treatment 
of cells with radiolabeledqueuine is the same in this method as with the uptake assay, however the cytosolic 
fraction is filtered to retain any radiolabeledqueuine that has been incorporated into large macromolecules 
such as tRNA. A method to measure the salvage of queuosine base from tRNA turnover products is similar to 
that of the incorporation assay but involves a pulse-chasetype of experimental design (16). Cell cultures are 
pre-treated with queuine-free media for varying lengths of time to produce a queuosine-free population of 
tRNAs and to induce any cellular salvage mechanisms for the maintenanceof cytosolic queuine levels. Then, 
a 24 hour exposure of the cells to radiolabeled-queuineis performed to fully saturate the tRNAs with the
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radiolabeled-base. Two sets of cultures are assayed for the ability of the ceils to retain the label in 
macromolecularform: one is monitored for the rate of tRNA turnover (total levels of radiolabeled-tRNA)by 
chasing out the radiolabeledsignal with the addition of an excess of unlabeled queuine to the media, while the 
other is treated with queuine-free media to determine the ability of the cells to maintain the radiolabel after the 
initial incorporation. The procedures for analysis of the timed samples are identical to that of the 
incorporation assay. These cell culture methods are highly sensitive (requiring limited ceil culture samples to 
run) and, since these are in vivo assays, represent a method able to measure three facets of queuine metabolism 
(uptake, incorporation,and salvage) under relatively realisticand controllable physiological conditions.
Despite the years of biochemical research on the Q base and the queuosine modificationof tRNA, a 
deflnitivedescriptionof the mammalian queuosine modification system itself, and in relation to the well 
characterizedprokaryoticsystem, has not yet been produced. Unfortunately, the established method for 
monitoring queuosine modification levels, RPC-5 HPLC, is obsolete due to lack o f availability of the column 
matrix and to natural degradation o f the remaining stock. Therefore, alternative methods such as W-Porex C-4 
HPLC and the in vitro and in vivo assays must ae utilized in order to study the queuosine modification system 
in biochemical and physiologicalcontexts.
Physiological Research
Although the biochemical function of and purpose for the Q nucleoside has not yet been established, 
there are strong correlations between queuosine levels and phenotypic variations in prokaryotic and eukaryotic 
organisms. The abilities of cells to survive stressed conditions, and undergo differentiationor neoplastic 
transformationhave been shown to be indicativeof and potentially caused by the presence or absence of 
queuosine-modifiedtRNA.
Studies with a mutant E. coli strain containinga null mutation for the TGTase enzyme suggested that 
queuosine-modifiedtRNA protects the organism from stress invoked by suboptimal growth conditions (47) 
and is necessary for the proper expression of nitrate reductase and an increased amount of b-type cytochromes 
under anaerobic conditions (48). This modification appears to allow these eubacterial cells to recover quickly 
from environmental strains to resume normal growth patterns. Eukaryotic D. discoideum, though able to grow 
in the absenceof queuine, is not able to differentiateaftereithera nutritional or metabolic stress without a 
source of this base (49). These queuine deficient cells exhibit lower levels of lactate dehydrogenase (an 
anoxic stress protein) and the appearance o f a novel cytochrome b with an absorbance maximum at 559 nm 
(50-52) However, with the addition o f queuine to the culture media, the cells rapidly grow in size and 
number and are able to differentiate into stalk cells and spores. Thus, queuosine-modifiedtRNA may be 
involved with management of nutritional and oxidative stress in both prokaryotic and eukaryotic cells.
Cellular and clinical research has generally focused on establishingand strengtheningthe correlation 
between Q-modification levels and development, differentiation,and carcinogenesis in more complex 
eukaryotic organisms. In cells of plants, insects, and mammals a motif has been described noting the existence
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of low levels of Q-modified tRNAs in embryonic and undifferentiatedtissues with a shift towards complete Q- 
modificadon in mature, differendateddssues (53,54) In A. castellanii, vegetative cells (trophozoites)contain 
significantly lower levels of queuosine-modifiedtRNA than mature cysts (55). In D. meianogaster, the levels 
of queuosine-modified tRNAs increase dramatically in the first week after “birth” from non-existent to 
complete modification, but the rate o f modification varies with genotypic strain and diet (56,57)l The same 
pattern is observed during development in the rat, with maximal queuosine-modificationlevels plateauing at 
approximately 5 months post-birth(58). Human placental tissue has been shown to be deficient in this 
modificationdespite the availability o f large amounts o f free queuine within neighboringamniotic fluid (59), 
but normal, mature human tissue is completely modified with respect to Q (60). Thus, the level of queuosine- 
modified tRNA may be indicative o f the developmental stage o f an organism.
In 1980, a study was initiated to determine the effect o f a “queuine-fred’ diet on conventional and 
germ-free mice (6IX It was discovered that the formation of queuosine-modifiedtRNA did require the 
absorption of the dietary nutrient queuine, in that after one year the queuine-starvedmice became entirely 
deficient in the queuosinemodification(29,61X These animals appeared to be physiologicallynormal, 
although unchallengedby foreign immunogens. Thus, it was suggested that queuosine is not necessary for 
development, it may only be an artifact. However, it was discovered that, even after 4 weeks o f the queuine- 
free diet, the mice retained 100% o f queuosine in tRNA*sp and tRNAtyr, as well as 88% of the queuosine in 
tRNAh“ and 85% o f tRNA*“ <6l). It has since been observed that tRNA“p maintains the modification the 
longest of all the isoacceptors(37X Therefore, it is likely that the mice maintained very high levels of the 
queuosine modification throughouttheir formative weeks, significantly decreasing in the levels of the 
modification only after the cells became mature and static. Thus, the queuine-free diet study does not appear 
to rule out an effect for queuosine-modifiedtRNA in developing mouse embryos—particularlywith 
information arising from studies involving cellular differentiationevents both in situ and in cultured cells.
The differentiationof two organisms, D. discoideum  and the topminnow, exhibit a dramatic increase 
in the levels of the queuosine modification from the onset of developments sporulation in the slime mold, 
and formation of the melanophoricsystem in this fish (62,63) Without exposures queuine, the pleuripotent 
cells fail to differentiateand the organisms become senescentor die.
Cell culture studies examining differentiationpatteras of mammalian cell-lines have 
shown a correlation of a rise in queuosine modification levels with chemically-induceddifferentiationevents. 
While dimethylsulfoxide-inducederythroiddifferentiationof murine erythroleukemiacells occurs with an 
early decrease in the level of queuosine-modifiedtRNAs, the actual phenotypic change event concludes with a 
concomitant rise in the modification level during the late phases o f differentiation^,65) This experiment 
was repeated by another research group, this time with the use of multiple differentiation induction agents
(66). Regardless o f the agent added, a sharp increase in the level of the queuosine modification always 
preceded the final differentiationof these cells.
Additionally, the study of the differentiationof erythroleukemiacells was performed using a human
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cell-line with several differentiationagents known to exhibit varying difTerentiation-inductioncapabilities
(67). The use of 5-azacytidineonly weakly effected the cells, causing a minor slowing in cell growth and no 
change in queuosine levels. Exposure to hemin induced a reversible differentiation event that was quickly 
reversed with removal o f the agent by dialysis, and only a transient increase in queuosine-modifiedtRNA was 
observed. Sodium butyrate exposure caused a more stable differentiationevent that required forty eight hours 
of dialysis for reversal. The initial differentiationcorrelated well with an early increase in the levels of the 
queuosinemodificationwithaconcomitantdecreaseafterthe long-term removal o f the agent 1-{J-D- 
arabinofuranosylcytosinewas exposed to the cultures to induce an ineversibledifferentiationevent in the 
cells. The level of queuosine-containingtRNA increased immediately and was maintained when growth 
became inhibited. These studies firmly establish the linkage between an increase in the level of queuosine- 
modified tRNA and the phenotypic alteration toward a more differentiated state.
Unlike the strong evidence o f the reactionary increase in queuosine levels during chemically- 
induced differentiation, there is some dispute about the effect of exposure of cell cultures to high levels of 
queuine. In studies utilizing the HeLa cultured human cervical carcinoma cell-line, the effect o f 
supplementary exogenous queuine appeared to vary widely with regard to oxidative state of the cells from 
enhancing growth rate to blocking growth altogether (68,69). In specific leukemic and carcinomacell-Iines 
and under certain conditions, queuine was shown to prevent differentiationand increase the likelihood of 
proliferation. However the addition of queuine to other cultured cell-lines has shown strong anti-proliferative 
potential (70-72} During the early stages of chemical transfbrmationof Chinese hamster embryo cells a 
decrease in the level o f queuosine-modifiedtRNA was observed (73} Both the rapid growth seen during the 
transformation and the decrease in modification levels were reversed with the exposure of these cells to excess 
queuine added to the growth media. In addition, the rapid growth rate of neoplastic cells placed under the skin 
of a nude mouse was effectively blocked by the subcutaneousadditionof a large dose of queuine (28,29}
Studies involving phorbolester-inducedtransformadonof normal human fibroblasts identified a 
transientdecreaseinqueuosinelevelsjustbeforeaS-to 10-fold increase in saturation density (74} With 
prolonged exposure o f phorbol esters to these cultures, an increase in queuosine modification level was shown 
to precede a decrease in saturation density. The quantity of queuosine-modifiedtRNAs were comparableto 
those in “normal" cultures that had not been exposed to phorbol esters. Simultaneous treatment o f cultures 
with both phorbol esters and additional exogenous queuine prevented the increase in cell growth.
A major facet of the neoplastic transformation(retrograde-differentiation)of cells involves the 
acquisition of anchorage-independentstatus. Thus, the ability o f a cell-line to overcome cell density 
influences in its growth is a major step in the promotion of cancer. Two-stage initiation-promotion 
experiments for the transfbrmationof Chinese hamster embryo cell cultures were undertaken to evaluate the 
effectivenessof the queuine analogue 7-methylguanineto promote transformation(75). 7-methylguaninewas 
able to increase the formation of type III foci and anchorage-independentgrowth, thus functioning as a tumor 
promoter. Since this chemical serves as an inhibitor of the queuine-incorporationenzyme TGRase (76), it was
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suggested that the queuosinemodificationserves as a suppressorof the promotion stage of carcinogenesis. 
Additional studies with phorbol ester-induced transformationof the Chinese hamster embryo cells showed a 
decrease in the levels of the queuosineinodificationin the early stages of their transformation effects (73).
The addition of excess exogenous queuine to the culture media resulted in both an increase in queuosine 
modification levels and the reattainmentof the anchorage-dependentphenotype.
It has long been known that cellular transformation can be induced in cultured ceils when exposed to 
methylated purines and other purine analogues (77,78). In tissue culture studies, transformationof Chinese 
hamster embryo cells (75,79) and human fibroblasts(30,74,80) have been induced by exposure to either a 
classical phorbol ester tumor promoter or the methylated purine 7-methylguanine. These agents both appeared 
to promote a reduction of Q-modification levels in the course o f their transformationeffects.
Many of the studies mentioned with regard to differentiationand transformation and their correlation 
with fluctuating queuosine levels involve the treatment of cultured cells with phorbol ester tumor promoters. 
Phorbol esters are known to directly bind to and hyper-activateprotein kinase C (PKC), an important 
regulatory enzyme in several cellularsignaltransductioncascades(8l,82} Short-term exposure studies 
exploiting the ability o f phorbol esters to activate PKC have been used as the classical ceil culture method for 
the analysis of PKC-directedeffects (83). However, under conditions of chronic exposure the cell’s entire 
supply of endogenous PKC is activated. Thispermitstherapidcataiyticdegradationoftheenzymewhich 
effectively ends the “burst’ o f metabolic activation induced by the phosphorylationof PKC’s target proteins
(84). Chronic exposure to phorbol esters actually decreases the activity of this enzyme. This deactivation 
mechanism has been evolutionarilydevelopedas a feedback-controlloop for PKC, which plays an important 
role in cellularsignal transductionpathways. The idiosyncrasyof this differential effect on PKC by a single 
compound has since been exploited 1) in experimentation to more strongly identify a PKC-catalyzed 
regulatory mechanism in certain cellular processes and 2) in explanationsof why phorbol ester modulation of 
PKC activity has been correlated with both differentiationand retrograde differentiationevents.
As mentioned previously, phosphorylationcontrol mechanisms for the regulation of gene expression 
patterns have been strongly tied to phenotypic change events in many mammalian organisms. PKC, in 
particular, is an importantregulatory switch in differentiationand neoplastic transformationof many cell types
(85). This enzyme is directly tied to a large number of key metabolic processes within the cell by direct 
phosphorylationand activation or inhibitionof the target’s biological activity. PKC’s ability to influence 
phenotypic alterations have been used to explain the effect of phorbol esters on cells, since it was discovered 
that these compounds directly hyper-activate PKC. Thus, if control of the queuosine modification system can 
be tied to PKC regulation, as suggested in a few studies, it would link tRNA metabolism and it’s function to a 
list of other molecular events known to occur in the signal transduction pathway's control of gene expression 
and tumor promotion.
Abnormally low queuosine modification levels in tRNA have been strongly associated with tumor 
promotion and carcinogenicity(neoplastic transformation,a.k.a. retrograde-differentiationjboth in vivo and in
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situ. Transfer RNA isolated from neoplastic tissues and transformed cel 1-lines is queuosine-hypomodifiedto 
various degrees generally corTespondingto the severity of the disease (38,60,86). In situ studies on multiple 
human tumor biopsies have shown a strong correlation between the loss of Q-modificationand the progression 
and aggression of neoplasticdisease. The degree of hypomodificationhas been used to develop diagnostic 
tests for staging of human neoplasticdisease in lymphomas and leukemias(40X and in lung (4IX ovarian (42) 
and brain (43) solid tumors. Explicit levels o f decreasingqueuosine in these cancerous tissues have been 
shown to directly correlate to increased aggression of the associated tumor’s growth and metastasis as 
determined by histopathologicalgrading.
Over the last ten years, physiological research has documented many cases describing abnormally 
low levels ofthequeuosinemodification in undifferentiatedand neoplastic cells. While addition o f queuine 
base to culture media appears to induce differentiationand decrease growth rate in transformed cells, it also 
appears to reverse the transformation induced by chronic exposure of cells to phorbol esters. In addition, it 
has been suggested that the queuosine modification system might be in some way induced by PKC-catalyzed 
phosphorylation. PKC has been recognized as being adversely effected in many forms of transformed cells
(85). Thus, PKC-modulationof the queuosine modification system might be deregulated in these cells, 
causing a cellular deficiency in the productionof properly modified tRNA populations.
Each of the three steps o f  the queuosine modification system (cellular uptake of the free base, 
incorporationof queuine into tRNA, and salvage of the nucleoside) and modulation of their activity by PKC 
are all potential sites for deficienciesthat can occur in neoplasticcells. These are likely to vary based on the 
origin of the tumor and may even involve a multiple lesion scheme that is often observed in cancers.
However, only one queuosinedeficient cell-line has so far been studied with respect to the actual 
malfunctioningstep in the queuosine modification scheme (87). Thus, the likelihood of breakdown for any 
one or more of the steps of the queuosine modificationsystem has yet to be determined. Also, a direct, or 
even indirect, causal relationship between queuine and cancer has not yet been established because o f the lack 
of knowledge concerning the modified base’s natural biological function and purpose.
Statement and Significance of Thesis Research
There have not yet been any attempts to describe the mammalian queuosine modification system in 
depth and only a few to mechanisticallyexplain the effect of this modified nucleotide on cellular physiology. 
Thus, a global hypothesis describing the biological function of and purpose for the Q nucleotide has not yet 
been accepted.
To establish the foundations for a theory describing the reason for Q’s existence, several preliminary 
studies must be completed. 1) A descriptionof the queuosine modificationsystem, in its entirety, in 
prokaryotic and eukaryotic hosts must be established. 2) The interrelatednessor connectivity of the queuosine 
modificationsystem with other physiological processes within the cell must be ascertained. 3) Actual sites for 
queuosine modification system breakdown in abnormal cells must be demonstrated. 4) A plausible function
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of the queuosine modification system with regard to the stability of macromoIecularstructures(tRNA) and to 
effect on interactions within macromolecular complexes must be postulated and supported.
All methods utilized in the research described in this treatise are described in Chapter 2 with 
literature reviews of the protocols and information concemingthe experimental design strategies.
While the prokaryoticqueuosine modificationsystem in £L colihas been well described (23), various 
parts o f the eukaryotic system have been studied in many different organisms and in cell cultures. However, 
all of the components of a single eukaryotic organism’s queuosine modification system have not yet been 
described in a single picture. Chapter 3 o f this treatise describes methods used to study the eukaryotic 
queuosine modificationsystem. These techniques include in vivo assays that are able to dissect the uptake, 
incorporation, and salvage steps within the system in a cell culture model system and an in vitro assay to 
measure the presence of the queuosine incorporation enzyme, TGRase, which is useful for protein isolation 
and characterizationprotocols. Cell culture studies were performed on normal human fibroblasts to measure 
the abilities of these cells to perform the uptake, incorporation, and salvage components that comprise the 
queuosine modificationsystem. To further examine the incorporation step of this system, mammalian 
incorporation enzymes from mouse, rat, and human liver were isolated and characterized. Finally, the 
eukaryotic and previously characterizedprokaryoticqueuosine modification systems were compared in order 
to determine an evolutionary relationship. This information is important to lay the framework for the choice 
of proper model systems to be used in human disease etiology studies in the future.
In the course of attempting to study queuine uptake in cultured human cells and to isolate the 
mammalian queuosine incorporation enzyme it appeared that these systems may be modulated by phorbol 
ester tumor promoters and protein phosphatase inhibitors, respectively. With the known linkage between 
phorbol esters and PKC, and phosphatase inhibitors with an antagonist enzyme for PKC, studies were 
undertaken to determine if  this key secondary messenger system is involved in regulating the modificationof 
tRNA with queuine. Chapter4 describes in vivo uptake, incorporation, and salvage assays performed on 
human cell cultures in the presence of multiple kinase and phosphatase modulators. In addition, protein 
isolation protocols were altered and in vitro assays were performed with the purified mammalian incorporation 
enzymes to assess action of PKC directly on this enzyme. Thus, the interactionof the queuosine modification 
system with PKC, a major cellular regulatory switch, would indicate connectivity o f the queuosine 
modificationsystem with other important physiological processes.
It is well known that the queuosine modification is deficient in neoplastic cells, and that progression 
of cancer is strongly correlated with staged decreases in modification levels. Chapter 5 describes in vivo cell 
culture studies performed on human colon adenocarcinoma(HxGC,) and breast adenocarcinoma(MCF-7) 
cel 1-lines to determine the source of their queuosine deficiencies which measure at 100% and 50-60%, 
respectively. Uptake, incorporation,and salvage, as well as PKC-modulationassays were performed. These 
results would indicate if a single step or multiple lesions of the queuosine modification system are the cause of 
the deficiencies in these cell-lines. This information could have implicationson the use of queuosine
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modification levels for the designation of a tumor’s origin and may be important in any future diagnostic 
protocol or treatment schemes that might be proposed.
Despite the cellular and clinical evidence o f the importance of the queuosine modification, there has 
not yet been a hypothesis suggested which links the presence o f queuosine to a function that could cause the 
observed correlations with wide phenotypic effects, such as differentiationand neoplastic transformation. 
Chapter6 describes the results ofcomputationalchemistry studies which attempt to explain potential effects of 
the queuosine modification on the rate and efficiency o f protein translation by examining the effect of this 
modified base on the structure and dynamics o f the tRNA. With the advent of molecularmodeling techniques 
and comparison to previouslypublishedexperimentalresults, structural studies of the queuosine base itself, of 
tRNA“p with and without the queuosine modification, and in complexation studies within a A-site 
tRNA/mRNA/P-sitetRNA ribosomal model were performed. The results were used to assess queuosine’s 
effect on tRNA structure and function leading to an explanation of queuosine’s possible role in translational 
control of gene expression.
In the conclusion of this document, codon bias patterns for specific mRNA sequences were analyzed 
in orderto correlate the structural effects of the queuosine-modified versus unmodified complex with the 
sequence of certain gene classes (housekeepingand oncodevelopment-related). Finally, a mechanism for the 
queuosine modificationsystem with regard to the regulation o f gene expression is proposed. This hypothesis 
attempts to mechanisticallyillustratethe role o f the queuosine modification in normal cellularphysiologyand 
explain the effect of the lack of this base on development, differentiationand neoplastic transformation.
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CHAPTER TWO 
EXPERIMENTAL DESIGN AND METHODS
Introduction
This chapter describes the use of several in vivo cell culture methods and an in vitro enzymatic 
assay to study the queuosine modification system. (A third technique based on high or medium pressure 
reverse phase liquid chromatography, is discussed in the Appendix of this document). The protocols have 
been optimized for the study of the system in mammalian tissues and cells. The in vivo studies utilized 
human foreskin fibroblast cultures to represent a “normal” mammalian tissue or human colon or breast 
adenocarcinoma cultures to represent neoplastic cells in assays for queuine uptake, incorporation, and 
salvage. In vitro assays were used to purify and further characterize the queuine incorporation enzymes 
from several mammalian sources (mouse, rat, and human liver tissues). This protein catalyzes the actual 
formation of the queuosine modification in what may be considered as the essential step in the synthesis of 
this modification in eukaryotes.
In addition, modified in vivo protocols were performed to identify the involvement o f PKC in the 
regulation of queuine uptake, incorporation into tRNA, and salvage mechanisms. These involved exposure 
of the human Fibroblast cell cultures to PKC activators (TPA and PDD) and inhibitors (H-7, staurosporine, 
sphingosine, and calphostin C) and phosphatase inhibitors (okadaic acid and calyculin A). Protein 
phosphatase activators are not commercially available, thus were not used in this study. Chronic exposure 
of cell cultures to TPA is known to induce proteolytic degradation and down-regulation of PKC activity. 
This phenomenon was exploited to verify the short-term exposure experiments by correlating the PKC and 
phosphatase inhibitor results and scrutinizing the PKC activator (TPA) results. PKC-modulation studies 
were performed in both cell cultures and in modified in vitro assays with semi-purified and purified 
queuine incorporation enzyme samples.
All human cell-lines and mammalian tissues were handled in accordance with Old Dominion 
University’s policy regarding bloodbome pathogens.
In the final section of this chapter, computational chemistry methods for structure and property 
determination are described for guanosine, queuosine-analogue, and queuosine nucleotides. In addition, 
these nucleotides are studied for their effect on the structure and energetics of tRNA“p anticodon stem-loop 
molecules; as part of tRNAs in complexation with a translating mRNA; and located within an A-site 
tRNA/mRNA/P-site tRNA complex. The nucleotide analysis is based on a semi-empirical charge 
assessment and geometry optimization algorithm. Koilman all-atom force field parameters were employed 
for energy minimization and molecular dynamics simulation protocols utilized in tRNA anticodon 
stem/loop structure, tRNA/mRNA interactions, and tRNA/mRNA/tRNA complexations. In addition, a 
description of the methods used for gene transcript sequence analysis for codon bias patterns is outlined.
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Cell Culture Methods
Eukaryotic cells have been shown to require the primary substrate for queuosine synthesis, the 
queuine base, to be imported into individual cells through a specific uptake mechanism. Uptake o f queuine 
at the cellular level has been studied using cell culture techniques with mammalian cell-lines. These cells 
acquire the queuine base horn serum that supplements the nutrient media (88). In 1985, queuine uptake 
studies were performed with diploid human fibroblasts using a tritritiated queuine analogue to observe and 
measure queuine membrane transport (30). The cells were exposed to the radiolabeled nucleotide for a 
given period of time, then the culture was washed extensively to remove extracellular label. The cells were 
lysed and the internal components solubilized with ethanol. Finally, a liquid scintillation analysis of die 
radioactivity contained within this lysate indicated the amount of radiolabeled material transported into the 
cell.
An in vivo method for the investigation o f radiolabeled queuine incorporation into tRNAs in 
cultured cells was developed by Muralidhar et al. in 1988 (46). The cells were exposed to radiolabeled 
queuine for a given period of time, then the culture was washed extensively to remove extracellular label. 
The cells were lysed and the internal components solubilized by incubation in a detergent-based lysis 
buffer. Then, an acid precipitation step was performed on the solubilized cytosolic solution in order to 
precipitate the large nucleotide component of the cytosol. A filter binding step was executed to remove the 
small molecular weight compounds, including unincorporated radiolabeled queuine base. Finally, the filter 
was analyzed by liquid scintillation. Using this method, the levels of intracellular queuine incorporation 
activity were able to be measured in a few cell lines.
Using a monkey kidney cultured cell-line, the maintenance of queuosine levels during queuine 
starvation has been assessed by a radiolabeled queuine pulse-chase methodology (17,31). This protocol 
involved the deprivation of queuine by treatment of cells with charcoal-stripped media, then saturation of 
cellular tRNAs with radiolabeled queuine by pre-incubation for 24 hours just prior to the initiation o f the 
study. Then, cultures o f cells were either maintained in charcoal-stripped media (to measure the ability of 
the cells to maintain the label—salvage the queuine base and reuse it in formation o f the queuosine 
modification), or were exposed to media containing high levels of unlabeled queuine to flush out the label 
(which would indicate the turnover rate of the tRNAs specifically in the cells being studied). The final 
steps of the assay were similar to that utilized for the in vivo queuine incorporation assays.
Materials
The HFF cell-line was established from circumcision tissue by established methods (74). The 
HxGC3 human colon adenocarcinoma cell-line was obtained as a gift from Dr. Jon R. Katze (University of 
Tennessee, Memphis), and the MCF-7 human breast adenocarcinoma cell-line was obtained from the 
American Type Culture Collection (Bethesda, MD). Cell cultures were established and maintained in 
either 10% neonatal calf serum supplemented minimum essential media (HFF and HxGC3 cell-lines) or
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10% neonatal calf serum supplemented Delbecco's modified eagle media (MCF-7 cell-line) (GIBCO, 
Grand rsland NY). The DNA methylase inhibitor, 5-azacytidine (S-azaC), employed in the generation of 
the 5-azaC-treated HxGC3 cultures was purchased from Sigma Chemical Company (St. Louis, MO). 5- 
azaC-treated HxGQ cultures were exposed to S pM 5-azaC for 24 hours, then incubated with minimal 
essential media containing 10% neonatal calf serum until confluence. Queuine-deficient cultures for the 
incorporation and salvage studies were generated by growing the cells in media supplemented with 10% 
charcoal-stripped calf serum (74), for at least three passages before the studies were initiated.
The radiolabeled reduced analog o f queuine, tritiated dOtydroqueuine (rQT3), was a gift from Dr. 
Ronald W. Trewyn (Kansas State University). The addition o f  a radiolabeled analog of queuine, tritritiated 
dihydroqueuine (rQT3), to cell cultures was employed to monitor cellular uptake of this base, it’s 
incorporation into tRNA, or salvage of the incorporated base during tRNA turn-over. Two lots of 
lyophilized rQT3 were dissolved in water to yield stocks concentration o f 1 mM with specific activities of 
0.19 pCi/pg and 3 pCi/pmol and stored at -20°C.
Studies involving protein kinase and protein phosphatase modulators were performed after 
treatment as specified. They were all received in powder form and dissolved in acetone at 1,000 times the 
working concentration to form stock solutions. cGMP- and cAMP-dependent kinase, and PKC activators 
were obtained from Sigma Chemical Company (St. Louis, MO). The cGMP and cAMP analogues 
(dibutyryl and 8-bromo) were applied to cell cultures at a concentration of 10 pM. 12-tetradecanoyl 
phorbol-13-acetate (TPA) and phorbol-12,13-didecanoate (PDD) were used at concentrations of 20 nM. 
The PKC inhibitors sphingosine (used at 20 pM), staurosporine (used at 100 nM), and calphostin C (used 
at 100 nM) were purchased from Biomol Research Laboratories o f Plymouth Meeting, PA. The PKC 
inhibitor H-7 (l-[5-isoquinoline sulfonyl]-2-methyl piperazine dihydrochloride) (utilized at 10 pM) was 
obtained from Seikagaku America, Inc. (St Petersburg, FL). The protein phosphatase inhibitors okadaic 
acid and calyculin A (utilized at varying nM concentrations) were purchased from Biomol Research 
Laboratories (Plymouth Meeting, PA).
All culture work was performed in sterile polystyrene plasticware from Coming (Coming, NY).
rQT3 Uptake Assays
Cells were subcultured into 35 mm dishes at a density of 4xl04 cells/mL in a final volume of 2 
mL of media containing 10% serum. When required, 5-azaC treatment of HxGC3 cultures was performed 
at this point At confluence, the media was decanted from the cells and 1 mL of media supplemented with 
10% calf serum and 100 nM rQT3 (0.10 pCi) was added. In phosphorylation modulation studies, uptake of 
rQT3 was compared between untreated control cultures and with cultures exposed to PKC and protein 
phosphatase modulating agents at concentrations listed above. The modulating agents were added to the 
culture at the same time as the rQT3 for short-term exposure studies or for 7 days prior to the introduction 
of rQT3 for long-term or chronic exposure studies. Incubations for rQT3 uptake analysis were conducted at
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37°C for up to 6 hours and terminated by rinsing the ceil monolayer four times with 5 mL of ice-cold 
phosphate buffered saline. Then, the cells were lysed with 1.0 mL of 95% ethanol for five minutes. The 
lysate was aspirated and radioactivity determined by liquid scintillation. The amount of radioactivity in the 
cell lysate, normalized to the number of picomoles o f rQT3 per 10s cells, was reflective o f rQT3 uptake into 
the cultured cells.
rQT} Incorporation Assays
Prior to the initiation o f the incorporation assays, the generation of queuosine-deficient cultures 
was required to form queuosine-deficient tRNAs in order to effectively assess cellular TGRase activity. 
These cultures were produced by growing the cells in media supplemented with 10% charcoal-stripped calf 
serum for at least three passages before the start o f the experiment. Cells were then subcultured into 35 
mm dishes at a density of 4xl04 cells/mL in a final volume of 2 mL of media containing 10% charcoal- 
stripped neonatal calf serum. When required, 5-azaC treatment o f HxGCj cultures was performed at this 
point At confluence, the media was decanted from the cells and 1 mL of media supplemented with 10% 
charcoal-stripped neonatal calf serum and 100 nM rQT3 (0.10 pCi) was added. Incorporation of rQT3 into 
the acid precipitable fraction (tRNA) of various control cultures and those treated with PKC and protein 
phosphatase modulating agents were compared in phosphorylation modulation studies. PKC and protein 
phosphatase modulators were added to the cultures either at the same time as the rQT3 (short-term 
exposures) or 7 days prior to the rQT3 addition (long-term or chronic exposures) at concentrations listed 
above. Incubations for all rQT3 incorporation analyses were conducted at 37°C for timed intervals of up to 
24 hours. Incubations were terminated by rinsing the cell monolayer four times with 5 mL of ice-cold 
phosphate buffered saline, followed by disruption o f the cells with 0.5 mL of lysis buffer (10 mM Tris (pH 
7.5), 0.01% SDS, 0.01% Triton X-100) for ten minutes at room temperature. The lysate was transferred to 
a small test tube, treated with 0.25 mL of ice-cold 30% trichloroacetic acid (TCA), and placed on ice for 
ten minutes. The resulting precipitate was collected by vacuum filtration through GFA 2.4 cm glass fiber 
filter disks. Each disk was thoroughly rinsed with 40 mL of ice-cold 5% TCA and a final rinse of 5 mL ice- 
cold 95% ethanol. The filters were analyzed for bound radioactivity by liquid scintillation. The amount of 
radioactivity on the filter disks, normalized to number of picomoles of rQT3 per 105 cells, was reflective of 
rQT3 incorporation into the acid precipitable fraction (tRNA) from cultured cells.
rQT} Salvage
Fibroblasts and MCF-7 cells were subcultured into 25 mL culture flasks at a density of IxIO4 
celis/mL in a final volume of 5 mL of media containing 10% calf serum. When the cells reached 
confluence, the media was decanted and 5 mL of media supplemented with 10% charcoal-stripped calf 
serum for one day, one week, or three weeks to induce a possible latent queuine salvage mechanism.
Before the beginning of the salvage study, 100 nM rQT3 (0.10 pCi) was added to the cultures ant then
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incubated for 24 hours to fully saturate the tRNAs with radiolabeled queuine. At the beginning of the 
study, the cell monolayer was washed 4 times with sterile phosphate-buffered saline and then incubated in 
either media containing 10% serum supplemented with 0.10 A ^  units unlabeled queuine (89) or media 
supplemented with 10% charcoal-stripped serum and, if  indicated, PKC and phosphatase modulators at 
conditions listed above. Incubations for rQT3 salvage analysis were conducted at 37°C at 24 hour intervals 
for up to 4 days. Incubations were terminated by rinsing the cell monolayer four times with 5 mL of ice- 
cold phosphate buffered saline, followed by disruption of the cells with 0.5 mL of lysis buffer (10 mM Tris 
(pH 7.5), 0.01% SDS, 0.01% Triton X-100) for ten minutes at room temperature. The lysate was 
transferred to a small test tube and treated with 0.25 mL of ice-cold 30% trichloroacetic acid (TCA), and 
placed on ice for ten minutes. The resulting precipitate was collected by vacuum aspiration through GFA 
2.4 cm glass fiber filter disks, and then thoroughly rinsed with 40 mL of ice-cold 5% TCA and a final rinse 
of 5 mL ice-cold 9S% ethanol. The filters were analyzed for bound radioactivity by liquid scintillation. 
The level of radioactivity on the filter disks was reflective of the amount of remaining rQT3 in the acid 
precipitable fraction (tRNA) from cultured fibroblast cells over time.
Methods for the Isolation and Characterization of the Mammalian Liver tRNA:Guanine 
Ribosyltransferase
In an adaptation of an established in vitro method for the quantification of the queuosine 
modification in tRNAs, an enzymatic assay for the incorporation of queuine into tRNA is utilized to 
monitor the purification process of the queuine incorporation enzyme (tRNA-guanine ribosyltransferase; 
TGRase). This assay is a variation of the one developed by Okada, et ai. in 1978 using the £  coli TGTase 
enzyme (38). This method has been used to measure the increasing levels of queuosine in tRNA during 
differentiation and development in different organisms (55,90,91), as well as to measure the decreasing 
levels of queuosine in tRNA during progressive stages of neoplastic transformation and metastatic 
progression (40-43).
In the in vitro enzymatic assay, a completely unmodified tRNA population with respect to 
queuosine is used as a substrate for the measurement o f tritiated guanine or queuine incorporation 
(TGRase) activity of a sample. Since the yeast organisms are known to not synthesize queuosine nor 
utilize queuine (10), and since purified brewer's yeast tRNA is commercially available, this was the 
substrate of choice for the assay of TGRase activity. In the presence of the enzyme, incorporated 
radiolabeled queuine or guanine substrate in tRNA is separated from the free nucleotidyl bases by acid 
precipitation of the larger tRNA nucleic acid and filtration to remove the low molecular weight free 
queuine base. Since the modification of tRNA with queuosine is irreversible, the ability of the enzyme to 
incorporate tritiated guanine or queuine into tRNA is an inverse measure of the levels of queuosine- 
modified tRNA in a given sample.
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Materials
Yeast tRNA and PKC purified from rat brain were purchased from Boehringer Mannheim 
(Atlanta, GA). ATP (biotech grade) was purchased from Fisher Scientific (Indianapolis, IN). 
Staurosporine and sphingosine were purchased from Biomol Research Laboratories (Plymouth Meeting, 
PA). H-7 (1-[5-isoquinoline sulfonyl]-2-methyl piperazine dihydrochloride) was obtained from Seikagaku 
America, Inc. (St Petersburg, FL). 3H-guanine (1 mCi, 168 Ci/mmol) and [y-32P]ATP (250 pCi, 3000 
Ci/mmol) were purchased from Amersham Corporation (Arlington Heights, IL). The Silver Stain kit was 
purchased from BioRad, Inc. (Hercules, CA). All other chemicals or reagents were purchased from Sigma 
Chemical Company (S t Louis, MO).
Buffers
Homogenization buffo' (20 mM Tris-Cl [pH 7.5], 1 mM MgClj, 1.0 mM EDTA, 0.5 mM 
dithiothreitol, 10% glycerol, 0.05% Triton X-100, and 10 pg/mL o f the following protease inhibitors; 
aprotinin, calpain inhibitor I, chymostatin, leupeptin, pepstatin, phenylmethylsulfonylfluoride), Phosphate 
buffer (20 mM sodium phosphate [pH 7.2], 0 J  mM dithiothreitol, 1 mM MgClj, and 10% glycerol), 
Storage buffer (20 mM Tris-Cl [pH 7.5], 1 mM MgCl^ 0.5 mM dithiothreitol, 1 mM EDTA, and 50% 
glycerol), Mono-Q buffer (10 mM Tris-Cl [pH 7.5], 1 mM MgCl^ and 0.5 mM dithiothreitol), Reaction 
buffer (10 mM Tris-Cl [pH 7.5], 35 mM KCL 1 mM MgCl^ 0.5 mM dithiothreitol), Denaturing Sample 
buffer (10 mM Tris-Cl [pH 7.4], 0.5% SDS, 20% glycerol, and 0.01% bromophenol blue), and Non­
denaturing Sample buffer {10 mM Tris-Cl [pH 7.4], 20% glycerol, and 0.01% bromophenol blue).
Isolation o f TGRase From Mammalian Liver
The purification of TGRase was performed by adaptation of previously published methods (44). 
Livers (42.5 g) were collected from five adult Sprague-Dawley rats that were sacrificed by cervical 
dislocation. 50.0 g liver tissue was obtained from adult BALB/c mice that had also been sacrificed by 
cervical dislocation. Approximately 43.0 g of human liver was obtained from autopsy o f a 62 year old 
man who died of cardiac arrest. The fresh or flash-frozen livers were rinsed in ice-cold Homogenization 
buffer. The tissue was homogenized in 100 mL of cold buffer first by Waring blender and then by Dounce 
homogenizer, filtered through two layers of sterile gauze, and centrifuged at 10,000 x g for thirty minutes 
at 4°C. The resulting supernatant was centrifuged at 100,000 x g for one hour at 4°C. The supernatant was 
decanted through sterile gauze, brought to a final volume o f300 mL in Homogenization buffer, and loaded 
by gravity feed onto a 13 x 5 cm DE-52 ion exchange column in a 2 liter scintered glass funnel pre­
equilibrated with Homogenization buffer. A two liter wash of Homogenization buffer lacking the protease 
inhibitors and triton X-100 was drawn through the column by low pressure vacuum using a water-aspirator. 
TGRase was eluted from the column with one liter of Homogenization buffer containing 0.2 M KC1.
Protein in the 0.2 M KCI fraction was precipitated by adding ammonium sulfate to a final saturation of
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55%. The solution was stirred on ice for 30 minutes, and then allowed to stand an additional 30 minutes. 
The protein precipitate was collected by centrifugation for 20 minutes at 10,000 x g.
The precipitate was redissolved in 25 mL of Phosphate buffer, and dialyzed against 4 liters of the 
buffer overnight at 4°C with at least two changes of buffer. Denatured precipitate in the dialysate was 
removed by centrifugation at 10,000 x g for 20 minutes, and the supernatant was collected and applied to a 
P-11 phosphocellulose column (2x10 cm) which had been pre-equilibrated at 4°C with Phosphate buffer. 
The phosphocellulose column was washed with 100 mL of Phosphate buffer at a flow rate of 1.0 mL/min. 
The sample was eluted with a 200 mL 0 to 1.0 M KC1 gradient in Phosphate buffer. Fractions (2 mL) were 
collected and tested for the capability of 3H-guanine exchange with yeast tRNA. Those fractions that 
resulted in 3H-guanine incorporation were judged to contain TGRase activity. The pooled TGRase-active 
fractions (10 mL) from the 0.25 to 0.30 M KC1 region of the gradient were either stored at sub-zero 
temperatures (-20°C or -70°C), or further purified using a 1 x 10 cm Pharmacia Mono-Q ion exchange 
column.
Samples to be stored were dialyzed against storage buffer for at least three hours and then stored 
in 1 mL aliquots at either -20°C or -70°C. Samples to be purified further by Mono-Q FPLC ion exchange 
chromatography were concentrated to 5 mL in an 50 mL Amicon pressure cell using a YM 10 membrane 
(10,000 MWCO) under 40 psi N2 gas. The sample was then diluted to 50 mL with Mono-Q buffer and 
reconcentrated to 5 mL.
Five to ten milligrams of protein (as determined by Bradford assay (92)) in 1.0 mL aliquots of the 
TGRase preparation were injected onto a pre-equilibrated 1 x 10 cm Mono-Q column. The column was 
eluted at a flow rate o f 1.0 mL/min with a 100 mL 0 to 0.5 M KC1 linear gradient in Mono-Q buffer. The 
fractions collected were assayed for TGRase activity. The protein preparation exhibiting TGRase activity 
eluted in the 0.20 to 0.25 M region of the gradient, and corresponded to the major peak of the A 2*0 profile 
of the elution gradient The Mono-Q fractions were concentrated to 3.0 mL in an Amicon pressure cell as 
before. The 3.0 mL samples were concentrated further using a Centricon 10 concentrator to volumes of 0.5 
mL to 1.0 mL. These preparations were then used as samples in enzyme assays, electrophoresis and 
autoradiography, and Superose 6 size-exclusion chromatography.
Reaction Conditions fo r TGRase Assays
The assay for TGRase activity parallels one described previously(44), and is based on the 
enzyme’s ability to reversibly exchange 3H-guanine for guanine in the first position of the anticodon of 
yeast tRNA. Yeast tRNA is unique in that it does not contain queuosine(10), therefore it is an excellent 
substrate for TGRase. TGRase assays were conducted in a total volume of 0.3 mL Reaction buffer with 20 
pM 3H-guanine (1 pCi), 0.1 A260 unit of yeast tRNA (5 pg), and TGRase. Assays were incubated for one 
hour at 37°C, terminated by the addition of 100 pL of ice-cold 30% trichloroacetic acid (TCA), and chilled 
on ice for 10 minutes. The resulting precipitate was collected by suction filtration through glass fiber
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filters, washed with 45 mL of ice-cold 5% TCA, and analyzed by liquid scintillation.
Reaction Conditions fo r PKC Assays
PKC reactions were performed in a total volume of 0 J  mL Reaction buffer containing I mM 
CaCl2, 5.0 pg diolein, 5.0 pg phosphatidyl serine, and 100 pM [y-32P]ATP (1 pCi). Various concentrations 
of either histone fraction IV (positive control) or the TGRase preparation and PKC were added, incubated 
at 30°C for 30 minutes, and terminated by the addition of 100 pL of ice-cold 30% TCA. The precipitate 
was allowed to stand on ice for 10 minutes, collected by suction filtration through glass fiber filters, 
washed with 40 mL of cold 5% TCA and analyzed by liquid scintillation.
Reaction Conditions fo r the Combined TGRase, PKC and Alkaline Phosphatase Assays
TGRase, PKC, and Alkaline Phosphatase (AP) assays were combined using the aforementioned 
assay conditions. Reactions were performed in a total volume o f 0.3 mL of Reaction buffer containing 1 
mM CaCL, 5.0 pg diolein, 5.0 pg phosphatidyl serine, 20 pM 3H-guanine (1 pCi), 100 pM ATP, 0.1 A ^  
yeast tRNA (5 pg), and various concentrations of TGRase, PKC, and/or AP as indicated. The reaction 
mixtures were incubated 30°C for 45 minutes. The reaction was terminated and prepared for liquid 
scintillation analysis as previously described.
Electrophoretic Analysis
Samples from each stage o f the purification procedure were saved and applied to a denaturing or 
non-denaturing polyacrylamide electrophoresis experiment The samples were boiled for five minutes and 
allowed to cool to room temperature. The samples were loaded onto parallel 16 x 16 cm SDS- and non- 
denaturing-PAGE gels prepared by the method of Laemmli (93). Each gel was run at 50 mA constant 
current for approximately 5 hours. The gels were then fixed and silver-stained using the BioRad Silver 
Stain kit to reveal banding patterns.
Combination reactions using the TGRase and PKC preparations were performed to assess the 
ability of PKC to incorporate 32P from [y-32P]ATP into TGRase. Reaction conditions were as described 
with the PKC assays with the differing reaction mixture samples containing 40 pg histone fraction IV 
(positive control), P-l 1 concentrated sample, or 10 pg of Mono-Q fraction samples. The radioactive 
reaction mixtures were incubated for 45 minutes at 30°C and terminated by the addition of Denaturing 
Sample buffer. The samples were boiled for five minutes and allowed to cool to room temperature. The 
samples were loaded onto a 16 x 16 cm SDS-PAGE gel. The gel was run at 50 mA constant current for 
approximately 5 hours. The gel was then wrapped in cellophane and exposed to X-ray film at -70°C for 48 
hours. The X-ray film was developed by an automated film developer. Finally, the gel was simultaneously 
fixed and stained (40% methanol, 10% acetic acid, 0.05% Coomassie blue). Pictures were taken of the gel.
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Size-exclusion Chromatographic Analysis
Weakly and strongly active Mono Q TGRase samples were analyzed by fast protein liquid 
chromatography (FPLC) on Pharmacia’s Superose-6 high resolution size exclusion column with an LKB 
Bromma GT Chromatography System. Aliquots were initially separated by chromatography under native 
conditions in order to determine sizes of proteins and complexes in the sample. Approximately 800 pg of 
each sample was loaded onto a pre-equilibrated 1 x 30 cm Superose-6 column and eluted with 10 mM 
Tris-Cl [pH 7.5] at a flow rate o f 0.5 mL/min. Molecular weights of major peaks were compared to 
standards on the basis of elution time as detected by UV monitor at 280 tun. Aliquots were then exposed to 
guanidinium-HCl to induce disassociation of protein complexes and separated to identify the sizes of 
protein monomers in the samples. Samples were incubated in a solution containing 4 M guanidinium-HCl 
for 30 minutes at room temperature. Then, the sample was applied to the Superose-6 column and eluted 
with 10 mM Tris-CI [pH 7.5] at a flow rate of 0.5 mL/min.
Computational Design and Methods
In the past decade, computational chemistry methods for structure determination have been 
developed based on more and more accurate algorithms. In 1984 Harvey et al. began molecular dynamics 
simulations of a tRNAphe using a very early Amber force field method (94-96). This was performed only 
on “heavy atoms” and required thousands of CPU hours on either a Cray or VAX supercomputer. In 1986, 
Nilsson and Karplus (97) modeled the dynamics o f the anticodon stem/loop for tRNA1*' based on an early 
version of Karplus’ CHARMM software (98). This greatly decreased the CPU time required and produced 
results very similar to Harvey et al.’s computationally expensive experimentation. Both sets of results have 
maintained good credibility with the more recent examinations of the tRNA by experimental methods of 
temperature-jump experiments, the deciphering of X-ray crystallographic structures, and structural 
fluctuations based on multi-dimensional NMR interpretations.
In this research, Nilsson and Karplus’ methods have been adapted to a very different workstation 
system and software package. However, to incorporate non-standard modified nucleotides within the 
tRNA crystal structure model, full charge and geometric assessment of these nucleotides was first 
performed. Semi-empirical charge assessment and geometry optimization o f nucleotides were determined 
by the most current algorithm that was included with the workstation’s software utilized in this study (AMI 
and PM3 algorithm in MOPAC 6.0 software). Since these algorithms are notoriously inaccurate when 
assessing the geometry and charge distribution of amide linkages, an “mmok” command activating an 
amide correction factor was included in the calculations.
Energy minimization and molecular dynamics simulations of a tRNA anticodon stem-loop, based 
on Nilsson and Karplus’ older methods, are performed with the latest commercially available algorithms 
including the current version of the Amber force field—the Kollman all-atom force field (version 6.0). All 
atoms were treated in these studies and the solvent was implicitly included in the electrostatic calculations
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by use of a constant dielectric constant of 80. There are definite limitations using this new technology: 
among these the limited capacity to treat large complex macromolecular structures and the mathematical 
models that the experiments are based on. The computational system utilized in this study was not 
powerful enough to include solvation and counterion atoms in the simulations, nor to elongate the running 
time of the simulations due to limited processing speed and RAM, however the algorithms employed by 
this workstation are the most powerful to date when limiting the number of atoms explicitly treated. 
Despite these limitations, these calculations provide reasonable data that have been shown (when used 
appropriately) to provide accurate information about the system that is being monitored. When compared 
to a very recent publication reporting molecular dynamics simulation data of a similar molecule with 
counterions, solvation and much longer length of simulations (99), the results described in this treatise are 
virtually identical.
Instrumentation
The computational chemistry experiments performed in this study were performed on a Silicon 
Graphics Power Indigo2 workstation (MIPS R8000 processor) with 64 megabytes o f RAM (Mountain 
View, CA). The modeling software was a commercially available package from Tripos and Associates, 
Inc. (St Louis, MO) and included Sybyl base (62), Dynamics, Advanced Computation, MOLCAD, and 
Biopolymer modules, and MOPAC 6.0.
Nucleotide Analysis
In the initial analysis for determination of wobble base differences effecting tRNA anticodon 
decoding abilities, the structure and electrical potentials of four nucleotides were studied. Guanosine (G) is 
the unmodified “traditional” base found at position 34 in the primary transcript o f the four queuosine- 
related tRNAs. Guanosine remains in these tRNAs unless enzymatically replaced by queuosine synthetic 
mechanisms. 7-deazaguanosine (7-deazaG) is anon-physiologically utilized guanosine analogue and was 
included in the study to examine structural effects caused solely by the lack of the N7 of guanosine which 
exists as a C7 in the queuosine modification. 7-aminomethyl-7-deazaguanosine (7-am-7-deazaG) is the 
first product in the prokaryotic queuosine synthetic pathway, yet only a minor physiological species. This 
residue was included in the study to account for discernible effects of the charged quaternary amine at the 
end of the 7-aminomethyl side chain which also exists in queuosine. Queuosine (Q) is the fully formed 
physiological modification found in prokaryotic and eukaryotic species. At physiological pH, the base 
contains a charged quaternary amine in the 7-aminomethyl side-chain which terminates in a 
cyclopentenediol ring.
The S'-monophosphate nucleotidyl forms G, 7-deazaG, 7-am-7-deazaG, and Q were “sketched” 
and submitted to both AMI and PM3 MOPAC (semi-empirical) charge and geometry optimization 
protocols using the “mmok” amide correction factor. A charged quaternary amine was utilized in the
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design of the side chains for the Q and 7-am-7-deazaG molecules based the recognized crystal structure of 
the Q nucleotide (13). An electron density surface was generated for each molecule and the electrical 
potential o f each molecule was mapped onto the corresponding surface.
The three G analogues mentioned above (7-deazaG, 7-am-7-deazaG, and Q) were also 
incorporated into the Sybyl software’s RNA monomer dictionary (Kollman All-atom Force Field 
parameters, including atom types and charges). These modified ribonudeosides were utilized for further 
experimentation using site-directed mutagenesis protocols for replacement of the G residue in position 34 
of tRNA*9  anticodon stem/loop structures.
Anticodon Stem/Loop Analysis
The ability to perform optimal dynamics simulations through explicit solvation or use of an entire 
tRNA molecule is prohibitive. Therefore, a method developed by Nilsson and Karplus for investigation of 
the tRNAphc anticodon stem and loop was adapted for use in this study (97). The Nilsson and Karplus 
method was originally based on a protocol published by Harvey, Prabhakaran, Mao and McCammon which 
studied motions of bases and lengths of hydrogen bonds m an intact yeast tRNAphc molecule (94).
The Sacchromyces cerevisiae transfer RNA*9  crystal structure coordinates (2.8 A resolution) were 
obtained from Brookhaven Protein Databank for this study (100,101). Two conformations o f this molecule 
were identified in the crystal samples, A- and B-forms, which differ only in the DHU loop region between 
two dihydrouridine residues at positions 16 and 20. Wild-type S. cerevisiae tRNAs do not contain the 
queuosine modification due to the lack of any definable queuosine modification system in the host 
organism (10). Therefore, the yeast crystal structure for the tRNA*9  contains a guanosine residue at 
position 34, and was the basis for a software-based mutagenesis protocol to produce anticodon stem/loop 
structures o f tRNA*9  containing 7-deazaG, 7-am-7-deazaG, or Q at the wobble position. With exception 
of the wobble base, the resulting structures were identical to that o f the original molecule which contained 
a G in position 34.
The Nilsson and Karplus method utilized tRNA1** residues 26 through 44 for model computations 
which comprise the seven anticodon loop nucleotides and the six base-paired nucleosides of the stem. In 
this study, the modified and unmodified tRNA*9  anticodon stem/loop residues 26 to 44 (identical in both 
A- and B-forms) were extracted in order to perform subsequent molecular dynamics simulations. Implicit 
aqueous solvation (constant dielectric function of 80) was added to all calculations in order to mimic an 
aqueous environment
A steepest descent energy minimization protocol of 1,000 fs was performed on each molecule to 
relieve strain inherent in the crystallized structure. The resulting structures were compared with the 
original tRNA*9  crystal structure which served as the reference template. The RMS differences in atomic 
position varied between 0.072 and 0.092 A; therefore, it was assumed that molecular conformations were 
not significantly different before the dynamics run. The dynamics simulation was begun with gentle
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warming of the system to prevent structural distortion and artifacts. Shake constraints were set for the stem 
base pairs between residues 26 to 30 and 40 to 44. The initial velocities and atomic vectors were assigned 
and reassigned for each preceding step by Boltzmann distribution. Temperature steps lasting for 100 fs 
beginning at 45 K and increasing to 273 K by 25 K intervals were performed and monitored at 5 fs 
intervals. A final step o f 100 fs at 298 K. was performed, then a 55 ps constant temperature plateau at 300 
K was monitored at 1 ps intervals with rescaling of velocities at 25 fs intervals to enhance the temperature 
equilibration.
Macromolecular Complex Analysis
In order to analyze the effects o f  queuosine-modified versus unmodified tRNA in interactions 
with a neighboring tRNA (codon context) or cognate mRNA codon (codon bias), a model system of the 
tertiary structure for the tRNA/mRNA/tRNA complex needed to be chosen. Two possible conformations 
have been described for the placement o f  the tRNAs with respect to the mRNA on the ribosome: the 
Sundaralingham (S-) form (102) and the Rich (R-) form (103). Lim et al. investigated both the R- and S- 
form models based on the rigid crystal structure of two yeast tRNA1** molecules with a flexible 6-mer 
mRNA in order to study transcript phosphodiester backbone conformations between the two adjacent 
aminoacyl- (A-) and peptidyl- (P-) site codons (104). It was proposed that the R-form was the most likely 
arrangement on the ribosome due to relatively good agreement with cross-linkage data. MacDonald and 
Rein argued that the S-form was more correct due to a design also based on fixed crystal structures o f yeast 
tRNA’* ' and tRNA*5*1 with a flexible mRNA transcript (105). Prabahakaran and Harvey designed a model 
utilizing experimental cross-linkage data that was based on flexible anticodon loops with a fixed helical 
mRNA, instead of those parameters mentioned above (106). The results also describe a conformation that 
resembles the S-form, however the true ribosomally-bound configuration was suggested to be somewhere 
in between the previously described S-forms and this model due to the reliance o f all of these models on 
one “fixed1' component in each system.
In 1994 Easterwood, Major, Malhotra and Harvey built a model of the ternary complex 
nucleotide-by-nucleotide based on the cross-linkage data and crystal structure constraints for two tRNA1*' 
molecules (107). This method did not require a fixed arrangement for either the mRNA or the tRNAs 
involved in the complex. The results o f the protocol (the Easterwood structure) were compared with that 
of both Lim R- and S-forms for agreement with experimental fluorescent energy transfer data (108,109). 
Both the Lim S-form and the Easterwood structure (also an S-form) were closest in agreement with this 
information as compared with the Lim R-form. However due to the method of the model design, the 
Easterwood form contained less potential conflicts. Subsequently, a three dimensional structure o f the 
Escherichia coli ribosome programmed with three tRNA1*0 molecules was described at a resolution of 18 A 
( 110,111). The positions of the A-, P-, and exit-site tRNAs were determined by high resolution cryo- 
electron microscopy and molecular modeling “fit” methods. This conformation was described as being
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significantly different than either Lim R- or S- models. In comparisons with the cryoelectron microscopy 
structure and the aforementioned computational, the cryoelectron microscopy model and the Easterwood 
model constraints were in best agreement with the experimental data. Thus, the Easterwood model was 
chosen as the basis of the ternary complex conformation for analysis in this paper.
Macromolecular Complex Analysis: Interaction o f A- and P-site tRNAs (Codon Context)
The Easterwood model for the ternary complex of A- and P-site tRNAs with 6-mer mRNA was 
used to assess the likelihood of interaction between the anticodon loops. Two of the largest modified 
nucleotides known are Q in position 34 of tRNA"*1, tRNA”", tRNA1*, and tRNA*  ̂and wyebutine (Y) at 
position 37 in tRNA1*" (existing in the crystal form of tRNA1*" and utilized in the Easterwood model).
Both of these modifications have been shown to be absent in clinical cases of rapidly growing neoplastic 
cells in which protein synthesis levels are increased (45). Therefore, steric interaction between these two 
large anticodon modification side-chains, if positioned next to each other on adjacent codons, has been 
suggested to have the potential of effecting the stability of the A- and P-site tRNAs in the translating 
ribosomal complex resulting in altered translational efficiency via codon context effects (112).
The Easterwood model’s poly-uridine RNA molecule was adapted to contain a GAU codon at 
either the 5’ end (the A-site) or the 3 ’ end (the P-site). The backbone and x torsions were set to mimic that 
of the originally derived poly-uridine structure. Finally, a queuosine-modified tRNA”p anticodon 
stem/loop structure, as described above, was superimposed to replace either the A-site tRNA1*" or the P-site 
tRNA1*" of the Easterwood complex. A steepest descent energy minimization protocol of 1,000 fs was 
performed on these complexes to relieve torsional strain and produce reasonable structures for the study. 
Then, the two complexes were examined; A-site Q-modified tRNA”*1 anticodon stem/loop with P-site Y- 
containing tRNA1*", and vice versa. Distances were measured for the closest potentially interacting atoms 
for the Y and Q modifications in both complexes.
Macromolecular Complex Analysis: Anticodon-Codon Association at the A-site (Codon Bias)
The ternary Easterwood structure was utilized to develop a model for anticodon/codon interaction 
at the modeled A-site to assess the effects of specific wobble nucleosides on the association of tRNA with 
either of the two cognate codons. The original Easterwood 6-mer poly-uridine RNA molecule was mutated 
to contain a GALJ or a GAC codon at the 5’ end o f the mRNA (the A-site) and backbone and x torsions 
were set to mimic that of the original poly-uridine structure. Finally, individual modified tRNA anticodon 
stem/loop structures derived from the site-directed mutagenesis protocol of the G-containing 5. cerevisiae 
tRNA<sp crystal structure, as previously described, were superimposed into the A-site of the Easterwood 
complex. For this portion of the study, the P-site tRNA1*" was deleted.
Four tRNA“p anticodon stem/loop structures were investigated; G-containing, 7-deazaG-modified, 
7-am-7-deazaG-modified, and Q-modified molecules. Each anticodon stem/loop was complexed with
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either of two mRNA models (5’-GACUUU-3’ (GAC-mRNA) or 5’-GAUUUU-3’ (GAU-mRNA)). A 
steepest descent energy minimization protocol o f 1,000 fs was performed on each of these eight complexes 
to relieve torsional strain and produce reasonable starting structures for the study. They were compared 
and exhibited significant similarity as modeled starting structures (RMS differences o f0.082-0.098). Then, 
each complex was subjected to a protocol of 100 fs per step ramping of 25 K increases from 48 K up to 
323 K with a constant dielectric function of 80. “Actual” temperatures were monitored and levels for 
kinetic energy, potential energy, and total energy were calculated at 5 fs intervals. The results for each step 
were examined and when an equilibrium for the “programmed” temperature was approached, calculations 
were made for average “actual” temperature, kinetic energy, potential energy, and total energy. As 
expected, “actual” versus programmed temperatures averaged per step were shown to be linear with a 
correlation coefficient o f0.999 and a slope of 1.000 for all complexes.
Codon Usage Analysis for Growth Control versus Housekeeping Transcripts
Coding sequences for various mammalian growth control and housekeeping genes were acquired 
from published reports and manually analyzed for their content of codon triplets encoding asparagine, 
aspartate, histidine, and tyrosine amino acids. Then, the ratio ofNAU versus NAC codons for each amino 
acid type was determined and an overall assessment of total NAU/NAC ratio was made for each sequence. 
Finally, a NAU/NAC ratio trend was determined and codon bias assessed for all transcript sequences 
examined.
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CHAPTER THREE 
DEFINITION OF THE QUEUOSINE MODIFICATION SYSTEM
Introduction
Prokaryotic synthesis of the queuosine modification has been well studied and is reasonably well 
understood, however until recently the design of the eukaryotic system was still relatively ambiguous. Due 
to the similarities in structure of the modification in organisms of these two Kingdoms, it was initially 
assumed that the systems were evolutionally conserved, thus similar. New information concerning the 
eukaryotic queuosine modification system in mammals and other classes o f organisms has shaded this with 
doubt.
Based on the results of studies involving in vivo ceil culture and in vitro protein assay methods, 
this document introduces a description of the mammalian queuosine modification system. This scheme is 
compared with the well characterized prokaryotic modification pathways of Escherichia coli, and 
Zymomonas mobilis. A hypothesis concerning the evolutionary relationship of prokaryotic and eukaryotic 
modification systems is presented and a suggestion of the importance of the queuosine modification in all 
organisms is offered. In the end an assessment is made for the appropriate choice o f a model system to be 
used for future studies of human pathology.
Definition o f the Queuosine Modification System in Prokaryotes
In prokaryotic systems, particularly the most studied organism E  coli, the queuosine modification 
is formed by a four-step intracellular pathway which involves enzymatic synthesis o f the unique base in 
intact tRNA (Figure 3-1) (23). The first step involves the conversion of a guanosine triphosphate (GTP) 
molecule to a 7-aminomethyl- or 7-cyano-7-deazaguanine derivative of the guanine base. This step is 
performed by a GTP cyctohydrolase-like enzyme which involves the removal of both the N7 and C8 atoms 
of the nucleotide base and incorporation of some aminopropyl or cyanopropyl group, respectively, to 
reform the ring. The two currently known GTP cydohydrolase enzymes (type I and II) have been ruled 
out as the catalyst for this reaction. GTP cydohydrolase I is involved in pteridine biosynthesis for the 
conversion of GTP into dihydroneopterin triphosphate. However, there have been no intermediates found 
in this reaction which could account for possible 7-deazaguanine synthesis. GTP cydohydrolase II is 
involved in riboflavin synthesis and catalyzes the formation of GTP into 2,5-diamino-6-oxy~4-(5'- 
phosphoribosylamino) pyrimidine. A ribA mutant of £. coli deficient for this enzyme has been isolated, 
but is still able to synthesize the queuosine modification. Thus, it has been proposed that there is an 
undiscovered GTP cydohydrolase that catalyzes the formation of 7-aminomethyl-7-deazaguanine (preQ,) 
and 7-cyano-7-deazaguanine (preQ0).
The second and third steps for the synthesis of the queuosine modification are performed by two 
enzymes that have been shown to be encoded in a single operon (113). This queuine operon, as it has been
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Figure 3-1. The Prokaryotic Queuosine Modification System in Escherichia coli and Zymomonas mobilis. The prokaryotic system is a synthetic one based on a 
four step process. I) Sep one is a reaction catalyzed by an unknown GTP cydohydrolase, requiring guanosine triphosphate and an unknown aminopropyl or 
cyanopropyl donor to form preq, or preq0, repectively. II) Reaction two is catalyzed by tRNA'.guanine transglycosylase (from the gene tgt) which performs a 
base-exchange reaction with preq, or preq„ for a transcriptionally-encoded guanine base (G) in position 34 of tRNA"", tRNA“p, tRNAhi', or tRNAl>T, The 
formation of incorporated preq0 (known as preQ0) terminates the synthetic reaction, but appears to be reversible. Ill) Incorporated preQ,, however, is reacted 
upon by the enzyme £-adenosylmethionine:tRNA ribosyltransferase (from the gene QueA) with the aid of s-adenosylmethionine to convert preQ, into epoxyQ. 
IV) The formation of epoxyQ was only recently discovered and is reduced by an unknown mechanism with the aid of coenzyme B,2 to queuosine (Q). After the 
degredation of tRNAs by non-specific RNases, the fully formed nucleoside Q is secreted by the cel) and is not reused in the prokarytic system.
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called, includes five coding regions at nine minutes on the £. coli genome. The genes are queA, tgt,yajC. 
secD, and secF, in that order. The secD and Fgene products are involved in protein translocation and 
export, while that ofyajC  is unknown. The gene products of tgt and queA are involved in the second and 
third steps of queuosine synthesis, the expression of this operon is regulated by the "factor of inversion 
stimulation" (FIS protein) which, when bound to an upstream activation sequence, increases the 
transcription of this operon (114). The FIS protein is also involved in the transcriptional activation of 
several tRNA genes as well as all rRNA operons. Thus, the synthesis o f queuosine formation enzymes 
appears to be directly modulated with the production of the target substrate, the tRNA.
The product of the tgt gene, tRNA:guanine transgiycosyiase (TGTase), is a 43 kDa zinc- 
containing protein consisting o f369 residues with a pH; of 4.6 to 4.8 (1 IS). In vivo it functions as a 
monomer in a reaction requiring tRNA, guanine or guanine analogue, and magnesium ions, but does not 
need adenosine triphosphate-derived energy. The TGTase enzyme appears to utilize either guanine (KM= 
S.3 xlO'*M), preQ0 (Km undetermined), or preQ( (KM= 1.4 xlO**M) as substrate for incorporation into 
tRNA (116). However, only the reactions with guanine and preQ0 are reversible. Due to the Km value, the 
irreversibility of the reaction, and the relative abundance of the incorporated preQ,, it was suggested that 
this compound serves as the natural substrate for this enzyme. It is noted, however, that for unknown 
reasons the recombinant form of TGTase appears to often act as a multimer and in this state can reverse the 
incorporation of preQ, as well as the other substrates (117). Site-directed mutagenesis studies on the 
tRNA47 substrate have indicated that the identity determinants for the association of this molecule with the 
TGTase enzyme is the anticodon loop sequence U33G34U35 (118). Since the U33 is conserved in all tRNAs, 
it was thus determined that only the first and second anticodon bases were factors in tRNA recognition for 
this enzyme. Discovery of an E. coli TGTase mutant and subsequent site-directed mutagenesis studies on 
this enzyme have provided evidence that a major catalytic residue in the function of the enzyme is a serine 
residue at position 90. Sequence homology studies showed regions of the prokaryotic TGTase in common 
with the serine protease family, with the spatial orientation of residues immediately adjacent to serine 90 
(asp89-ser90-gly91-gly92) similar to those found around the catalytic serine residues in trypsin and 
chymotrypsin (119). More recent evidence has shown the presence of an important aspartate residue at 
position 102 in prokaryotic TGTase (120). This amino acid is proposed to serve as a critical catalytic 
nucleophile in the prokaryotic queuosine synthesis reaction as suggested by the recent description of the 
crystal structure of the Zymomonas mobilis TGTase.
Once the preQ, is incorporated into tRNA, it can serve as a substrate for the gene product of queA, 
s-adenosylmethionine:tRNA ribosyltransferase isomerase (SAM:TGTase isomerase) (121). Although 
preQ0 is often inserted into tRNA by TGTase, it is not a substrate for SAM:TGTase isomerase and has 
therefore been suggested to exist only in significant amounts as a side product within an £. coli mutant 
blocked in preQ! synthesis (122). The presence of the enzyme activity was discovered relatively early in 
queuosine research that demonstrated E. coli and S. typhimurium cells, when starved of methionine, do not
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synthesize the queuosine modification. Only recently was it discovered that s-adenosylmethionine (SAM) 
plays an unprecedented and critical role as a ribose donor for the formation of queuosine (25,26). This 
compound, usually a methlonyl or methyl group donor, serves a substrate for SAM:TGTase isomerase in 
the attachment o f the cyclic ring to the end of the 7-aminomethyl side chain of the incorporated 7- 
deazaguanosine residue. With a weight of 39 kDa and a pH; of 5.4, this enzyme has no sequence 
homology to currently known proteins. A reaction mechanism was suggested for this reaction which 
produces a 2,3-epoxy-4,5-dihydroxycyclopentyl-7-aminomethyl-7-deazaguanosine residue (epoxy-Q or 
oQ).
In the final reaction of the queuosine modification system identified in both £. coli and S. 
typhimurium, an unknown enzyme requiring coenzyme Bl2 performs a complete reduction o f the epoxy 
group to form the final prokaryotic queuosine (Q) modified nucleoside (123). This reaction appears to be 
environmentally regulated by the availability o f the B,2 vitamin nutrient, as neither prokaryotic organism 
studied has the ability to synthesize this compound.
In the formation of the prokaryotic queuosine modification the only exogenous requirement is that 
o f vitamin Bu- The formation of the modified nucleotide appears to be regulated by the availability of the 
metabolic substrates (for example, GTP), FIS* induced expression of the enzymes and queuosine-associated 
tRNAs, and the availability of vitamin B,2. After synthesis of the folly-formed queuosine base, natural 
tRNA-tumover events occur to renew the important participants of the protein synthetic mechanism. The 
queuine base is not salvaged during degradation of the tRNA, as it is not a substrate for any of the four 
enzymes involved in queuosine synthesis, but is secreted into the environment by prokaryotes.
Definition o f the Queuosine Modification System in Eukaryotes
Many of the mechanisms involved in the formation of the eukaryotic queuosine modification 
appear to be significantly different from that of the prokaryotic system. For example, unlike prokaryotes 
eukaryotes are unable to synthesize queuosine and must rely on uptake of the free queuine base from their 
diet or from secretions of symbiotic prokaryotes in gut flora. Eight week old mice that were fed specially 
prepared queuine-free diets were shown to be deficient in queuosine modification levels (29,61). After 
four weeks the queuosine levels in tRNA*”  and tRNA1** decreased from a baseline of 85% to 15% 
modified tRNA, however tRNA*sp and tRNAIyr levels were maintained at 100%. It was not until after one 
year of exposure to the queuine-free diet that all queuosine modification levels in the tRNA decreased to 
zero percent. Thus, it was suggested that in order to create the queuosine modification in tRNA in a 
mammalian organism, queuine must be somehow taken into the system—presumably by ingestion.
The use of an in vivo uptake assay method has been used to identify and determine the kinetics of 
a specific queuine transport system (74). The uptake of tritiated queuine exhibited burst kinetics over two 
to four minutes o f initial exposure, then a linear import until plateauing at three to four hours showing 
evidence of saturation. Lineweaver-Burke analysis indicated biphasic kinetics with a KM of 30 + 4 nM and
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a Vm„  of 0.33 pmol queuine taken up per 106 cells for physiological concentrations of 1 to 10 nM. At 
higher concentrations, 10 nM to 1,000 nM, the Km rose to 350 + 150 nM and a V„,, of 22.5 + 2.5 pmol 
queuine taken up per hour per 10s cells. Treatment of the cells with guanine, 7-methyl guanine, adenine, 
hypoxanthine, or 7-deazaguanine did not affect the transport rate of queuine. However, addition of 10 pM 
dipyridamole (a generalized transport inhibitor) reduced the uptake by 50 to 70%. These results indicated 
that a specific queuine transport pathway exists for physiological levels of queuine, with additional 
transport by general nucleotide transporters at higher concentrations.
The second step of the queuosine modification system involves a queuine utilization mechanism 
for the formation of this modified base in eukaryotes rather than the synthetic mechanism demonstrated in 
prokaryotes. Incorporation of the base into tRNA has been studied in vivo and in vitro in many organisms, 
but has not been definitively explored in any one eukaryotic organism.
In another difference from the prokaryotic queuosine modification system, eukaryotic cells have 
the ability to salvage this base from tRNA turnover products to maintain queuosine modification levels 
under queuine deprivation. In the early 1980s, GQndQz and Katze developed an in vivo method to study 
what they suggested was evidence of a salvage capability for retrieval of queuine from tRNA turnover 
products (16). They discovered that these cells had the ability to salvage queuine from degraded tRNA 
molecules and reuse it to maintain queuosine levels in the absence of an exogenous supply of queuine. It 
was later discovered that only queuosine-5’-monophosphate was the substrate for the queuine salvage 
mechanism, as none o f the other possible tRNA degradation products (queuosine, queuosine-3'- 
monophosphate, or mannosyl queuosine-5-monophosphate) allowed for the maintenance of queuosine 
levels during queuine starvation (17).
In both prokaryotic and eukaryotic organisms, the key step for the formation of the queuosine 
modification is the only one so far studied in depth using in vitro methods. In a 1983 review of "Queuine, 
the Q-containing tRNAs and the Enzymes Responsible for their Formation", Farkas describes the three 
eukaryotic queuine incorporation enzymes (rabbit erythrocyte (20), rat liver (44), and wheat germ (124)) 
that had been purified to pseudo-homogeneity. He drew comparisons amongst these and to the well 
characterized E. coli enzyme (115). The plant TGRase, isolated from wheat germ in 1983, was shown to 
be a homodimer of 68 kDa subunits, and the prokaryotic monomer has been shown to be of 42.5 kDa. 
Recently, published descriptions of isolations and characterizations of three additional mammalian TGRase 
enzymes; bovine liver TGRase (125), rat liver TGRase (126), and rabbit TGRase (127) have been reported. 
These purified mammalian proteins appear to exist as a heterodimer complex of Mr 100 to 104. The larger 
subunit o f the complex ranges from 60 to 66 kDa, with a smaller subunit of 34 to 45 kDa.
A 1980 protocol (44) for the partial purification o f the rabbit liver TGRase by Shindo-Okada, et 
al. was the basis for purification strategy developed for the isolation of mouse, rat, and human liver 
samples described in this chapter. The isolation protocol used in this study involves several steps of 
gravity-based liquid chromatography, differential salt precipitation, and fast protein liquid chromatography
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(FPLC). After each of these steps an enzymatic assay was performed to assess the retention and purity of 
the TGRase enzyme activity in each sample collected. The enzymatic assay for the incorporation of 
queuine into tRNA was used to monitor the purification process for the isolation of the TGRase protein. 
Final characterization o f the enzyme preparation involved non-denaturing and denaturing electrophoresis 
and size-exciusion FPLC.
In the studies presented here, a human fibroblast cell culture model is used to gain a better picture 
of the queuine uptake, incorporation, and salvage mechanisms in “normal” human tissues. The results of 
the purification and characterization of three mammalian liver queuine incorporation enzymes were used to 
strengthen the description of the incorporation step o f the queuosine modification system. It is suggested 
that the basic design of the mammalian queuosine modification system is significantly different from that 
described for prokaryotes. However, the evolutionary relationship between the eukaryotic and prokaryotic 
systems has not yet been examined. The information gained in this research on the eukaryotic queuosine 
modification system of several mammalian organisms adds another dimension of knowledge to that of the 
well characterized prokaryotic queuosine modification system. A comparison of the two systems may help 
to ascertain the evolutionary development of the queuosine modification systems that have been detected in 
species as diverse as prokaryotes, eukaryotic algae, many fungi, plants, insects, fish, birds and mammals.
In order to determine which model system to use for studies of human pathology, the assessment of a 
physiologically similar and experimentally viable system still needs to be determined. Furthermore, the 
details of how the queuosine modification system is tied into physiological metabolism within the 
mammalian cell is also unknown.
Results
Characterization o f the Mammalian Queuosine Modification System via In Vivo Studies o f Normal Human 
Fibroblast Cell Cultures
The results of this study with human foreskin fibroblast (HFF) cell cultures indicate that the 
maximal rQT3 uptake rate occurs up to one hour, then gradually decreases until six hours at which time an 
equilibrium o f uptake and export is established (Graph 3*1). Incorporation o f 100 nM iQT3 into cellular 
tRNA populations occurs in these cells in a linear fashion (approximately 0.25 pmol/105 cells/hour) until 12 
hours, at which point the rate of incorporation decreases to an equilibrium at 24 hours (Graph 3-1). The 
initial rate of uptake for rQT3 is ten-fold that of incorporation, and after 24 hours (at equilibrium) the 
amount of intracellular rQT3 that is incorporated in tRNA remains at a constant level of approximately 
30%.
Degradation o f tRNA molecules occurs as a regular process o f cellular component regeneration. 
The normal turnover of tRNAs in human cells occurs between 24 to 48 hours (128). The half-life of 
queuosine-modified tRNAs in the HFF cells studied was measured at 2 days by the pulse-chase salvage



























Graph 3-1. Queuine Uptake and Incorporation into the tRNA o f Human Fibroblast Cell Cultures, Culture flasks of human fibroblast cells (HFF) were grown to 
near confluence in normal media, fed with charcoal-stripped serum (lacking queuine) for 24 hours, then submitted to either an in vivo queuine uptake assay (•) 
or an in vivo queuine incorporation assay (■). A tritritiated analogue of queuine (rQT3) at a concentration of 100 nM was placed in the media at time zero, The 
uptake of this base into the cytosolic fraction of the cells was measured in multiple parallel cultures hourly starting at time zero until 6 hours, and the 
incorporation of this base into the acid-precipitable fraction of the cells (containing large proteins and nucleic acids, including tRNAs) was measured at 0 ,3 ,6,9, 
12, and 24 hours. The uptake of rQT} to 24 hours was extrapolated (shown as a dashed line), this line is based on other uptake studies in HFF cells that have 
been run for 24 hours. The counts per minute values obtained via liquid scintillation were normalized to the number of pmol rQT3 taken up or incorporated in 
103 cells. Deviation bars indicated represent the standard deviation with n = 6.
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method, regardless of the amount o f time that the cells were exposed to charcoal-stripped media (Graph 3- 
2). Charcoal-stripped media treatment of the cells for one day, one week, or three weeks was used to 
induce queuine starvation. These cells were assessed for the ability to maintain rQT3 levels in the 
incorporated state for up to 4 days. At one day o f induction by queuine-starvation, rQT3 is maintained in 
the tRNA population at 100% for up to 4 days. One week of treatment appears to maximally induce the 
salvage mechanism with full maintenance of rQT3 levels also for four days. After three weeks of queuine- 
starvation, the salvage of rQT3 decreases to 60% after four days.
Isolation and Characterization o f Mammalian Queuine Incorporation Enzymes
In order to further characterize the queuine incorporation step, the queuine incorporation enzyme, 
TGRase, was isolated from mouse, rat, and human liver samples. The conditions of isolation for each step 
are summarized and outlined in Table 3-L Samples o f each TGRase preparative step were stored at -20°C 
or -70°C in two aliquots as either direct hard-freeze samples or with the addition of an equal volume of 
glycerol.
During early isolation procedures for the rat liver enzyme, it was observed that the activity of the 
enzyme preparation was generally labile regardless o f storage conditions. Measurable TGRase activity in 
cold stored preparations decreased rapidly to a low background level within only one to four weeks (Graph 
3-3). In one instance a TGRase preparation lost activity within only three days. A preliminary test for 
phosphatase activity in the TGRase preparation indicated phosphatase contamination (unpublished 
observations). This was measured by the sample's ability to convert the colorless phosphatase substrate, p- 
nitrophenylphosphate, to the yellow colored p-nitrophenoxide anion under basic conditions. Addition of 
10 |iM phosphatase inhibitors sodium fluoride and sodium pyrophosphate to the homogenization buffer 
served to enhance the recovery of TGRase activity from rat liver isolates (Graph 3-4). From then on, these 
general phosphatase inhibitors were added to all homogenization buffers used for the mouse, rat, and 
human liver isolation procedures.
The optimized conditions (homogenization and initial centrifugation steps) indicate that this 
enzyme is likely to be located in the cytoplasm, and that it may have a slight association with cytosolic 
membranes. This supposition is based on the ability to increase yields o f isolations performed with 0.01% 
Triton X-100 added to the homogenization buffer.
Data in Table 3-II represents a typical isolation protocol and the resulting enzymatic 
characterization of the most evident TGRase-active fractions in the major steps of mouse, rat, and human 
liver TGRase isolation protocols. The rQT3 incorporation percentage yield of TGRase-active protein, unit 
activity, specific activity, and purification factor of each isolation step was compared amongst mammalian 
species and exhibited similar values. The results are very similar to published results obtained for the 
isolation of bovine liver TGRase by Slany and MQller (125).
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Graph 3-2. Queuine Salvage in Human Fibroblast Cell Cultures, Cultures of human fibroblast cells (HFF) were grown to near confluence in normal media, fed
with charcoal-stripped serum (lacking queuine) for 1 day, I week, or 3 weeks with regular media changes, then submitted to an in vivo queuine salvage assay. A
tritritiated analogue of queuine (rQT3) at a concentration of 100 nM was placed in the media 24 hours before the start of the assay to saturate the tRNA with the
radiolabeled base--“pulse”. In two sets of parallel cultures at time zero, extracellular rQT3 was washed away, then a media change with charcoal-stripped media
was performed. In one set of cultures unlabeled queuine (0.10 A260 units) was loaded (solid line) this represents the “chase” of the radiolabel out of the degraded
tRNA population and is an indication of the tRNA turnover rate within those cells. No queuine was added to the other set of cultures (dashed line) which
represents the ability of the cells to retain the radiolabel in the cell’s tRNA despite the degredation processes involved in normal tRNA turnover (a measure of
salvage ability). The counts per minute values obtained via liquid scintillation were normalized to the number of pmol rQT3 contained within the acid-
precipitable fraction of the I05 cells that had been devoid of queuine for I day, I week or 3 weeks. Deviation bars indicated represent the standard deviation


















Table 3-1. Isolation Characteristics of Mammalian Liver tRNA.Guanine Ribosyltransferase in Key Steps of the Purification Protocol
Fractionation
Step
Separation Method Characteristic Isolation Condition 
of TGRase Activity
Homogenate cheesecloth filtration soluble after homogenizing 
with a tissue grinder and filtering
Centrifuged Supernatant super- and ultra-centrifugation soluble after 1 hour at 10,000 x g at 4°C 
and 1 hour at 100,000 x g at 4°C
DE-52 Cellulose LC anion-exchange liquid chromatography: 
increasing linear or step gradient 
of 0 to O.S M KCI
eluted from the 
diethylaminomethyl-cellulose matrix 
at approximately 0.15 M KCI
(NH4)2S04 Precipitant salt precipitation at 35% saturation 
and super-centrifugation
insoluble at 55% salt saturation 
and 30 minutes at 10,000 x g at 4°C
P-ll LC cation-exchange liquid chromatography: 
increasing linear gradient of 0 to 1 M KCI
eluted from the phosphocellulose matrix 
at approximately 0.25 M Kcl
Mono Q FPLC anion-exchange fast protein liquid chromatography: 
increasing linear gradient of 0 to O.S M KCI
eluted from the trimethyl aminomethyl-conjugated monobeads 
at approximately 0.15 M KCI
Superose 6 FPLC size-exclusion fast protein liquid chromatography: 
isocratic elution
eluted from the cross-linked agarose beads 




















Graph 3-3. The Decay o f Two Samples o f Purified tRNA'.Guanine Ribosyltramferase Activity. The graph indicates the decay of TGRase activity in two 
different rat liver Mono Q-FPLC preparations (•  and ■) stored at -20°C and -70 °C, respectively. Five micrograms of purified protein isolate was analyzed using 
the standard TGRase activity assay to measure the ability to incorporate 3H-guanine into 0.10 Am  units of yeast tRNA in one hour at 37°C. An early sample (■) 
displayed residual TGRase activity of background levels after only four days, thus the activity trend after this time to 42 days is extrapolated (dashed line).
Standard deviation values are indicated for each sample with n = 4.
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Graph 3-4. The Recovery o f Crude tRNA.Guanine Ribosyltransferase Activity with the Addition o f Protein 
Phosphatase Inhibitors to the Homogenization Buffer. The bar designated “No tRNA” indicates the non­
specific binding of 3H-guanine to protein within the sample (no tRNA substrate added). The “Control” bar 
shows the residual TGRase activity recovered from homogenization of a sample of rat liver tissue with no 
protein phosphatase inhibitors added. The remaining bars indicate the TGRase activity recovered from the 
homogenization of samples of the same rat liver tissue using homogenization buffer containing lOpM 
sodium fluoride or 10 pM sodium pyrophosphate, respectively. Five micrograms of protein isolate from 
the phosphocellulose column step were used for each assay. All assays were performed using the standard 
TGRase activity assay method. Standard deviation values are indicated for each sample with n = 4.

















Table 3-2. Detailed Summary of Mammalian Liver tRNA: Guanine Ribosyltransferase Purification Steps




Liver n/a n/a n/a 42,500 100 n/a n/a
Homogenate 150 5.3 16.6 2,490 5.9 0.32 1
Centrifuged Supernatant 100 49 15.4 1,540 3.6 3.2 9.9
DE-52 LC 450 99 1.42 639 1.5 70 218
(NH4)zS04 Precipitant 60 nd nd nd nd nd nd
P-ll LC 15 371 1.63 24.4 0.057 228 712
MonoQ FPLC 1 1480 4.85 4.85 0.011 305 953
Mouse Isolate Total Volume (mL) Unit Activity* Concentration Total Mass Percent Yield Specific Activity11 Purification
(mg/mL) (mg) (%) Factor” ’
Liver n/a n/a n/a 50,000 100 n/a n/a
Homogenate 250 5.8 12.0 3,000 6.0 0.48 1
Centrifuged Supernatant 200 58 9.25 1,850 3.7 6.3 13
DE-52 LC 500 224 2.12 1,060 2.1 106 221
(NH4)2S04 Precipitant 80 nd nd nd nd nd nd
P-ll LC 25 341 1.09 27.2 0.054 313 652
MonoQ FPLC 1 2255 5.30 3.74 0.0075 603 1256
Human Isolate Total Volume (mL) Unit Activity* Concentration Total Mass Percent Yield Specific Activity^ Purification
(mg/mL) (mg) (%) Factor*”
Liver n/a n/a n/a 43,000 100 n/a n/a
Homogenate 150 5.8 17.0 2,550 5.9 0.34 1
Centrifuged Supernatant 100 63 15.8 1,580 3.7 4.0 12
DE-52 LC 425 177 2.12 901 2.1 83 242
(NH4)2S04 Precipitant 65 nd nd nd nd nd nd
P-ll LC 14 520 1.97 27.6 0.064 264 776
MonoQ FPLC 1 1360 3.10 3.1 0.0072 439 1250
•Unit Activity: pmol 3H-G incorporated/mL sample/hour at 37°C. **Specific Activity: pmol 3H-G incorporated/mg protein/hour at 37°C. ♦♦♦Purification 
Factor: enzyme activity ratio of experimental sample as a factor of the homogenate specific activity.
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Results of the phosphocellulose (P-ll) cation-exchange liquid chromatography procedure 
demonstrate the first step indicating variance amongst samples. This occurs as an isolation-to-isolation 
variation between species and within tissue samples, and may be due to differences in levels of 
phosphorylation and possibly subunit stability in isolates. Early in the development of the rat liver enzyme 
preparations, TGRase activity assays of fractions from P-l I chromatography and succeeding steps 
indicated two distinct regions of TGRase activity, one major and one minor. Samples taken from mouse 
Mono Q anion-exchange liquid chromatography preparations and those found in human P-l 1 fractions also 
showed evidence o f these two regions of TGRase activity. The major TGRase active fraction was used to 
determine specific activity and is the source o f the data recorded in Table 3-iI, with the second weaker 
TGRase activity fraction initially ignored. Much later studies with protein kinase C phosphorylation of 
these two peaks indicated that the second region of weaker TGRase activity is dramatically increased under 
phosphorylating conditions (see Chapter 4 for a more thorough explanation).
Since there was evidence of the importance of phosphorylation levels for the success of isolation 
procedures, SDS-PAGE analysis and a protein kinase C catalyzed 32P-Iabeling study was performed with 
isolates from a TGRase-active P-l 1 fraction and two MonoQ regions exhibiting strong and weak rat liver 
TGRase activity to attempt to distinguish any differences between the highly active and weaker TGRase 
fractions. 32P-labeled and unlabelled P-l 1 and Mono-Q rat TGRase fractions in a protein kinase C- 
catalyzed reaction mixture were analyzed by denaturing and non-denaturing PAGE. The unlabeled 
denaturing gel was stained by Coomassie stain, destained and photographed (Figure 3-2). A parallel 
denaturing PAGE gel of the 32P-labeled samples was then exposed to film, and banding appeared in lanes 
containing the P-l 1 concentrate and in one of the consecutive Mono-Q fractions. A band at approximately 
60 kDa was observed in the P-l 1 sample and in a very weakly TGRase-active Mono-Q fraction sample. A 
very faint band of potential 32P-incorporation was also observed in this region of the strongly TGRase 
active Mono Q fraction. These bands matched up well with the Coomassie-stained bands in the gel (Figure 
3-2). The lane containing the P-l 1 fraction does not exhibit distinguishable banding patterns with respect 
to the autoradiograph, however in the lanes containing fractions o f the Mono Q step two distinct bands 
fairly equal in intensity appear at approximately M, 60 and 34.5 in the fraction exhibiting weak TGRase 
activity, with a strong 34.5 kDa band and a faint 60 kDa band in the strongly TGRase-active Mono Q 
fraction. By comparison, a non-denaturing PAGE exhibited a very simple banding pattern in these lanes 
(unpublished observations). In the strongly TGRase-active Mono-Q fraction a single band was visible and 
was of small size (between 30 and 45 kDa). This correlated well with the denaturing PAGE results. 
However in the non-denaturing gel, the following Mono-Q fraction (which exhibited good 32P- 
incorporation, but limited TGRase-activity) exhibited a single very large molecular weight band. This 
suggested possible multiple subunit involvement evidenced as banding differences under non-denaturing 
vs. denaturing conditions, so a study using native and denaturing chromatography was undertaken.
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Figure 3-2. SDS-PAGE Electrophoretic and Autoradiographic Analysis o f Protein Samples During 
Isolation o f the tRNA:Guanine Ribosyltransferase Enzyme, a) Two silver-stained 8% SDS-PAGE gels 
were run and the important lanes are shown together above. Each lane shows the separation of protein 
isolates from various steps of the human liver tRNA:guanine ribosyltransferase (TGRase) procedure. Fifty 
micrognuns of protein were applied for the first four lanes and 40 pg for the P-l 1 eluent on one gel. On a 
second gel, 10 pg was applied for the MonoQ fractions. Molecular weight markers run for each gel were 
used for alignment of the lanes in this graphic, and their locations are shown on the left On the right, 
double-headed arrows indicate the “interesting” bands at 60 and 34.S kDa. b) A radiolabeling 
phosphorylation reaction assay was performed with 10 pU of protein kinase C (PKC) and y32P-ATP, and 
either 40 pg of histone fraction IV (positive control for phosphorylation by PKC) or 40 pg of rat liver P-l I 
eluent or 10 pg of rat liver MonoQ fraction sample. The reactions were quenched with the addition of 
SDS-PAGE sample buffer and heating. They were then applied to an 8% SDS-PAGE gel and 
electrophoresis was performed. The gel was then exposed to X-ray film at -70°C for 48 hours and 
developed. Finally, bands of the gel were developed by simultaneous fixing and staining using 0.05% 
coomassie blue in 40% methanol, and 10% acetic acid. Molecular weight markers were also run and their 
migration positions are indicated on the left Double-tailed arrows indicating “interesting” bands at 60 kDa 
and a group of four between 28 and 38 kDa (bracketed), corresponding to the positive control locations of 
histones, are shown on the right.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
43
Comparisons were made between native Superose 6 FPLC chromatographs of the strongly 
TGRase-active and ^P-incorporating, weakly TGRase-active Mono-Q fractions (Figure 3-3). Compared to 
identifiable protein standards, the 32P-incorporating, weakly TGRase-active Mono-Q fraction maintains it's 
major peak at approximately 100 to 110 kDa with minor peaks visible in the 55 to 65 kDa and 30 to 38 
kDa ranges. Integration of the chromatograph showed 56% o f the protein in the 104 kDa range with 32% 
and 12% in 60 and 34.5 kDa ranges, respectively. When this fraction was denatured by the presence of 4 
M guanidinium-Cl a definitive shift in it's peaks occurred. The 100 to 110 kDa peak virtually disappeared, 
while the main peak appeared to shift to the right and plateaued between 65 and 30 kDa. The TGRase- 
active Mono-Q fraction appeared to have the major peak at approximately 30 to 38 kDa, with a possible 
minor peak between 55 and 65 kDa. Integration of these peaks indicated that the strongly TGRase-active 
fraction contained approximately 80% of the protein in the smaller peak with less than 10% in the mid­
sized peak. The retention time overlaps for the peaks in the chromatographs are suggested to be due to the 
presence of differing complexes of subunits. This is explained by the presence of TGRase as a large 104 
kDa complex able to dissociate into subunits o f 60 and 34.5 kDa, which corroborates the electrophoretic 
data.
Discussion
Eukaryotic organisms acquire the main substrate for the formation of the queuosine modification 
by either dietary ingestion of the queuine base or absorption o f secreted queuine produced by intestinal gut 
flora. The queuosine modification system in mammalian cells is shown to consist of cellular uptake of the 
queuine base, incorporation o f this nucleotide into tRNA, and salvage of the degraded transcript to recycle 
the base for reuse (Figure 3-4). The characteristic uptake activity of a queuine-specific transporter in 
human foreskin fibroblast cell cultures was determined using an in vivo assay method that approximates 
human physiological conditions. Linear uptake of queuine occurs at a rate of 2.5 pmol/10s cells/hour until 
saturation between four and six hours. The characteristic profile o f the queuine incorporation mechanism 
was also assessed in the human fibroblast cells under the same conditions, with linear incorporation rates at 
ten-fold less than uptake. Not until 24 hours does the incorporation rate plateau, and it appears that 
approximately 30% of intracellular queuine is maintained in the incorporated queuosine-modified tRNA 
form. Finally, the ability of these cultures to salvage the incorporated queuine base and recycle was 
described. A wildtype baseline salvage activity is measurable in these cells, and can be induced to 
maximal activity by queuine starvation for up to one week. At three weeks and thereafter, the ability to 
salvage queuine decreases with an apparent acclimation of the cells.
The incorporation step of the queuosine modification system was studied in three mammalian 
organisms in order to more fully describe this important synthetic step. All three isolated mammalian 
(mouse, rat and human) liver TGRase enzymes appear to be composed of two subunits of approximately 
60 and 34.5 kDa. These more recent results for the mouse and human TGRase enzymes confirm previous
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Figure 3-3. Absorbance Profiles ofSuperose 6 FPLC Separation o f Rat Liver tRNA:Guanine 
Ribosyltransferase-Active MonoQ FPLC Fractions. Two MonoQ-FPLC fractions were collected. Fraction 
one exhibited very high tRNArguanine ribosyltransferase (TGRase) activity, and fraction two showed very 
weak activity but above the background level. An aliquot of each of these fractions were submitted to 
denaturing conditions (4 M guanidinium chloride at room temperature for 30 minutes). Injections of 800 
fig protein onto Pharmacia’s Superose 6 FPLC column were made for each sample and an on-line UV 
monitor measured the elution absorbance at 280 nm. The first minor peak at three minutes represents the 
injection peak. The first major peak indicated the void volume. Comparison’s to molecular weght 
standards were made, and the three subsequent peaks were identified as being of approximately 104,66 
and 34.5 kDa, respectively. The denatured fraction two sample contained an extra peak at approximately 
45 minutes that represents the elution of the guanidinium salt. The denatured fraction one profile is not 
shown due to limited differences from the nondenatured fraction’s profile.





































Figure 3-4. The Proposed Eukaryotic Queuosine Modification System in Normal Human Fibroblast Cells, The eukaryotic system is based on usage of an 
available resource. Queuine (q) is a nucleotidyl base that is secreted by gut flora and is digested from virtually all dietary sources. It is absorbed in the intestines 
and distributed around the body in the vasculature. A specific queuine transporter is responsible for uptake of the base into the cell. In the cytosol 
tRNArguanine ribosyltransferase incorporates it into tRNA**", tRNAup, tRNAhi\  or tRNAlyr via a base-exchange reaction with q for a transcriptionally-encoded 
guanine base (G) located in position 34. After the degredation of tRNAs by non-specific RNases during normal tRNA turnover, the q nucleotidyl base is 
salvaged by an unknown mechanism from queuosine-S’-monophosphate and reused for the incorporation step to form queuosine-modifted tRNA.
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findings regarding the rat liver enzyme (126) and are similar to that o f the bovine liver TGRase (125).
The results of this experimentation and that o f others suggest that mammalian TGRase enzymes 
are a heterodimer complex of a larger subunit (60 to 66 kDa) and a smaller subunit (31 to 35 kDa). There 
is speculation among laboratories both in the U.S. and in Germany about the stability o f this dimer 
complex. In these studies, isolation of two regions o f TGRase activity during the isolation protocols of 
both the P-l 1 cation-exchange liquid chromatographic and the Mono Q anion-exchange fast protein liquid 
chromatographic steps suggest that the large salt gradient required by these methods may induce 
disassociation o f  the TGRase subunits. The composition of the enzyme complex has also been suggested 
to be a problem for the isolation of TGRase by phosphocellulose cation-exchange as well as tRNA-afflnity 
chromatography in the isolation of bovine TGRase (125).
Characterizations of mouse, rat, rabbit, bovine and human TGRase enzymes have shown these 
isolates to be heterodimers of very similar size (Table 3-III). However, a eukaryotic plant TGRase from 
wheat germ (124) and two bacterial TGTase enzymes form £. coli (39) and Z  mobilis (129) involved in the 
formation of the queuosine modification have been shown to contain subunit make-ups different from that 
of mammals or plants. The plant enzyme appears to be a homodimer o f subunits similar in size to the 
larger subunit o f the mammalian enzyme and utilizes queuine as it’s major substrate.
The prokaryotic systems are unique in that they are the only systems where the queuine-related 
enzymes have been purified, cloned and well-characterized. The £. coli version of TGRase has been 
suggested to be functional as either a monomer or as hexamer made up of two homotrimers (130). The 
monomers of both £1 coli and Z  mobilis enzymes (Mr=42.5) are o f an identical size that does not appear 
to correspond with either of the eukaryotic subunits. More recent studies of these proteins indicate that 
they are both likely to function in vivo as 42.5 kDa monomers, rather than oligomers (129).
Partial nucleotide and amino acid sequences for the rabbit (Genbank accession number L37420) 
(I27)and bovine (125) enzymes, respectively, have been compared with known nucleotide sequences of 
the prokaryotic enzymes from £  coli (Genbank accession numbers M63939 & M35286) (130)and Z 
mobilis (Genbank accession number L33777) (129). There is no sequence homology between the 
eukaryotic and prokaryotic species.
Metal ion requirements for the function of prokaryotic, plant and mammalian enzymes also differ. 
The £. coli (131) and wheat germ (124) enzymes were suggested to require a divalent cation for activity. 
More recently, the £. coli enzyme has been shown to contain a structural Zn2+-binding motif that appears to 
be required for tRNA association (132,133). This region of the prokaryotic enzyme is highly conserved in 
the Z  mobilis nucleotide sequence which has now been resolved to 1.85 A by X-ray crystallographic 
methods (134). Therefore, the Zn2+ requirement for TGTase function is likely to be important in many 
prokaryotic forms of the enzyme. The bovine (125) and rat (44) liver enzymes have been shown not to 
require any metal ions to function.
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Table 3-3. Comparison o f Queuine Incorporation Enzymes (tRNA:Guanine 




Escherichia coli 46 1(46) preQ, (22,130)
Zymomonas mobilis 45 1(46) preQi (129)
Wheat Germ 140 2(68 + 68) queuine (124)








Rabbit Erythrocyte 104 2(60 + 43) queuine (20)
Bovine Liver £100 2(66 + 31) queuine (125)
Human Liver 104 2 (60 +34.5) queuine (current work)
* Relative molecular weight (Mr) is listed in kilodalton units (kDa).
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Differences in substrate specificity between the prokaryotic and eukaryotic enzymes are also in 
evidence. While both enzymes catalyze the exchange of guanine-for-guanine in the wobble position of 
tRNA, their substrates in the formation of the queuosine modification are very different The £1 coli 
enzyme utilizes 7-aminomethyl-7-deazaguanine as it’s primary substrate and does not associate with the 
fully formed queuine nucleoside at all (I IS). The incorporation of both prokaryotic substrates (guanine 
and 7-aminomethyl-7-deazaguanine) are reversible. Both plant (124) and animal (44,116) enzymes, 
however, preferentially bind queuine for incorporation into tRNA while exhibiting 102- to I03-fold less 
affinity for 7-aminomethy 1-7-deazaguanine and 7-deazaguanine, respectively. Similar to the prokaryotic 
enzyme, the guanine-for-guanine reaction is reversible. However the eukaryotic enzymes incorporate 
queuine-for-guanine in an irreversible reaction. The removal of queuosine’s base from the tRNA in both 
prokaryotic and eukaryotic systems is only accomplished by turnover and degradation of the entire tRNA 
molecule.
The results of the comparisons between these prokaryotic and eukaryotic enzymes for sequence, 
complex structure, metal ion cofactor, and substrate specificity indicate significant differences in this 
family of enzymes. Although historically placed under one classification (E.C. 2.4.2.29) and name (tRNA- 
guanine transglycosylase), the prokaryotic and eukaryotic modification enzymes involved in the formation 
o f queuosine appear to have arisen from distinct sources. The prokaryotic “queuine operon”, encoding at 
least two enzymes involved in the formation of the queuosine modification is not likely to be the 
evolutionary source of the eukaryotic queuosine modification enzyme. It is proposed that the prokaryotic 
enzyme should retain the historical name of tRNA-guanine transglycosylase, and that the eukaryotic 
enzyme should attain the new E.C. name of tRNA-guanine ribosyltransferase with a new E.C. number in 
sequence.
This description of the incorporation step of the queuosine modification system provides an 
important example for the differences between the prokaryotic and eukaryotic mechanisms. In addition, it 
is important to point out that the existence of the uptake and salvage steps described in the human 
fibroblast cells insinuate a dramatic design difference in these two systems. Prokaryotic cells cannot utilize 
the folly formed queuine base in the incorporation step and, instead of transporting a useable substrate for 
the synthesis of the modification into the cell, have developed a complicated series of reactions to form the
7-aminomethyl-7-deazaguanine (preQ,) substrate for the first step of the prokaryotic queuosine synthetic 
mechanism. In addition, the lack of a salvage mechanism in prokaryotes is not surprising due to the 
inability of the incorporation mechanism to utilize the folly formed queuine base. The differences in the 
prokaryotic and eukaryotic systems lead to the conclusion that these are not evolutionarily related, but may 
be products of convergent evolution. The development of two mechanisms to form the same strange tRNA 
modification also suggests that this product may have an important role in cellular function of ail 
organisms, with the exception of yeast. Just what this role is, however, has not yet been determined.
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With the discovery of the overwhelming differences between the prokaryotic and eukaryotic 
queuosine modification systems, the current focus of basic research regarding queuine and the queuosine 
modification may need to be reevaluated. Although the bulk of the enzymatic research has been focused 
on the prokaryotic queuosine incorporation enzyme for characterization, it may be necessary to concentrate 
on the examination of the mammalian queuosine modification system and the TGRase enzyme for 
application to human development and disease research. This research, involving the development of a 
human foreskin fibroblast cell culture model, provides a physiologically “normal” baseline for future 
comparisons for modulative effects within a cell, as well as a guideline for studying apparently “abnormal” 
neoplastic cells.
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CHAPTER FOUR 
MODULATION OF THE MAMMALIAN 
QUEUOSINE MODIFICATION SYSTEM
Introduction
The queuosine modification of tRNA is universally conserved in mature, static cells of eukaryotic 
organisms from Dictyostelium discoideum to Homo sapiens. However, in rapidly dividing and 
undifferentiated cells the levels of this modification are dramatically decreased. Transfer RNA isolated 
from neoplastic tissues and transformed cell lines is also hypomodified with queuosine to various degrees 
(38,45,60,86). Neoplastic transformation of cells involves retrograde-differentiation events that are very 
similar but reverse processes of differentiation. Both differentiation and retrograde-differentiation events 
are induced and progress by the action of neighboring cell and environmental stimuli. These include such 
mechanisms as cytokine-induced signaling cascades and G-protein associated secondary messenger 
systems. The action of one class of experimental activators of an important intracellular signalling cascade 
has been linked to both phenotypic change events in mammalian cultured cells and an alteration in tRNA 
metabolism within those cells. There is some evidence that tumor promoting induction of cultured cells via 
exposure to phorbol esters also has a direct effect on the queuosine modification system.
In both murine and human cell culture experiments, chemically-induced differentiation, tumor 
promotion, and cellular growth potentiation have been inversely correlated with alterations in queuosine 
levels. Murine erythroleukemia cells are typically queuosine-deficient. These cells can be forced to 
differentiate and have been demonstrated to concurrently increase in levels of queuosine-modified tRNA 
(66,67). The differentiation of these cells and the increase in queuosine-modification level was effectively 
blocked by chronic treatment with the tumor promoter, 12-0-tetradecanoylphorbol-13-acetate (TPA) (66). 
These observations suggest that the hypomodification of tRNA with regard to queuosine is related to 
growth enhancing or tumor promoting events. Chronic exposure o f cultured normal human fibroblasts to 
phorbol-12,13-didecanoate (PDD), another classic phorbol ester, induces a large inhibition of the 
queuosine modification of tRNA (74). The decrease in queuosine content of tRNA precedes an increase in 
the population density of the fibroblast cultures. Concurrent addition o f purified queuine effectively blocks 
the population density increase in fibroblast cultures exposed to PDD, and maintains the queuosine level in 
those cells at near normal levels. These results suggest that the queuosine modification system may be 
connected to controlling the growth rate of normal human fibroblasts and is regulated by the action of 
phorbol esters.
In the mid-1980s it was discovered that phorbol esters directly bind to and activate protein kinase 
C (PK.C), a major player in the Ca2+ signaling cascades (81,83). Not long thereafter, it was demonstrated in 
in vivo cell culture studies of a few mammalian cell lines that cellular uptake of queuine is sensitive to
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
51
phorbol esters (30,80). Thus, it was suggested that queuine uptake may be modulated by PKC (135). 
Chronic exposure o f cultured cells to phorbol esters has been shown to induce a proteolytic down 
regulation of PKC and its activity (84). Since a decrease in the level of queuosine-modified tRNA was also 
observed with chronic exposure o f human fibroblasts to PDD (80), it was proposed that the down- 
regulation of PKC activity levels in cell culture may have decreased the rate of queuine uptake needed for 
the formation of queuosine-modified tRNA.
Over the many years of attempting to isolate and purify a mammalian queuine incorporation 
enzyme (tRNArguanine ribosyltransferase; TGRase), it was observed that the activity o f TGRase enzyme 
preparations were generally labile regardless of storage conditions. Measurable TGRase activity in cold 
stored (-20°C or -70°C) preparations would decrease rapidly to a low background level within only one to 
four weeks. In one instance a TGRase preparation lost activity within only four days (see Chapter 3, Graph
3-3). Since the suspected linkage between queuosine modification levels and the level o f phosphorylation 
in cell culture studies appeared to be plausible, preliminary tests for phosphatase activity in the mammalian 
TGRase preparations were undertaken to see if this was the cause o f the loss of TGRase activity. Tests 
indicated that there was significant protein phosphatase contamination in the samples. In addition, the 
addition of general protein phosphatase inhibitors sodium fluoride and sodium pyrophosphate to the 
homogenization buffer used in the initial isolation step dramatically increased the recovery o f activity (see 
Chapter 3, Graph 3-4). Thus, it was suggested that the incorporation step o f the queuosine modification 
system of mammals might also be influenced by the action of phosphorylation, possibly by PKC.
A multifaceted study, described here, was performed to investigate possible phosphorylation- 
based post-translational modification schemes using modified forms of both the in vivo and in vitro assay 
methods used in the experiments described in Chapter 3. These were undertaken in order to assess 
potential regulatory mechanisms concerning the queuosine modification system by phosphorylation. The 
description of the mammalian system, as described in the previous Chapter, is also revised to incorporate 
knowledge gained in these regulation control studies. Finally, the significance of this entire modification 
scheme is assessed with regards to the evolutionary relationship of prokaryotic and eukaryotic queuosine 
modification systems, to the ability o f this system to be integrated within cellular metabolism, and to an 
explanation of possible deficiencies observed in many neoplastic cell-lines and tumor biopsies.
Regulation o f Cellular Metabolism by Phosphorylation and Protein Kinase C
In 1992, the Nobel Prize for Physiology or Medicine was awarded to E. H. Fischer and E. G.
Krebs for their work concerning “reversible protein phosphorylation as a biological regulatory mechanism” 
(136). They discovered a reciprocal kinase/phosphatase system that had the ability to regulate intracellular 
events such as mobilization of glucose from glycogen stores, prevention of organ transplant rejection, and 
development o f chronic myeloic leukemia.
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The list o f protein kinases discovered since the early days of Fischer and Krebs’ work has grown 
very large and has been grouped into families based on either a similar target for the enzyme (such as 
creatine kinase) or by the compound that activates the kinase’s activity. Protein kinase C was discovered 
as a kinase that is activated by calcium ions (hence the “C”), therefore it is exquisitely sensitive to one of 
the major second messenger systems that exists in all cells (82). The activation of voltage-gated calcium 
pores as well as by the formation o f inositol-triphosphate by phosphoiipase C and it’s subsequent induction 
of release of internal calcium stores both serve to activate the activity o f protein kinase C. In addition, the 
list of targets for protein kinase C-catalyzed phosphorylation is very long and diverse, including 
cytoskeletal targets (such as vinculin, filamin, profilin, desmin, MARCKS, troponin T and I, and the C- 
protein associated with cardiac myofibrils), intracellular second messenger systems (protein kinase M- 
catalytic fragment, myosin light chain, neuromodulin and neurogranin), and transcription factors (CREB, 
CRE, C/EBPa, the vitamin D3 receptor, and IkB in the IkB/NFkB complex) (137) Thus, protein kinase C 
has been implicated as playing a role in the regulation of the cell cycle, cellular growth rate, multidrug 
resistance, and phenotypic shifts during differentiation and neoplastic transformation (85).
Protein kinase C is a key regulatory enzyme in mammalian cells, however there is evidence of a 
protein kinase C-like activity in organisms from yeast to humans, and in all mammalian tissues sampled.
In addition to the connection of abberant PKC activity with cancer, abnormal levels of protein kinase C 
activity have been implicated in disorders ranging from learning disabilities (138) to diabetic retinopathy 
(Mandarino, 1992) to suicidal tendencies (139). Protein kinase C control over the queuosine modification 
system would provide a link between tRNA metabolism and a long list o f other metabolic shifts known to 
occur during differentiation and neoplastic transformation.
In Vivo Studies o f Phosphorylation Control o f the Queuosine Modification System
Cell culture studies of human fibroblasts were used to measure the three facets of the queuosine 
modification system in normal cells (see Chapter 3). Modified in vivo uptake, incorporation, and salvage 
assays were repeated in these cells to assess the effect of different modulators of cellular phosphorylation 
on queuine and queuosine metabolism. The initial study involved exposure of the normal human fibroblast 
cultures to activators o f three different protein kinases; cAMP-dependent protein kinase (PKA), cGMP- 
dependent protein kinase (PKG), and PKC. The observations of cellular exposure to dibutyryl- and 8- 
bromo- analogues o f cAMP and cGMP and two phorbol esters, TPA and PDD, on uptake and 
incorporation both suggested the involvement of PKC (140,141).
In this treatise, more comprehensive experiments were performed to verify the involvement of 
PKC in the regulation of queuine uptake and queuosine incorporation into tRNA. These involved exposure 
of the human fibroblast cell cultures to PKC activators (TPA and PDD), PKC inhibitors (H-7, 
staurosporine, sphingosine, and calphostin C), and phosphatase inhibitors (okadaic acid and calyculin A) 
(Figure 4-1). Phosphatase activators are not commercially available, thus were not used in this study.
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Protein Kinase C Inhibitors
Figure 4-1. Structures o f Phosphorylation Modulating Agents. To ascertain if phosphorylation provides a mechanism for regulation of the queuosine 
modification system, an approach was developed using kinase and phosphatase modulators to measure their effect on queuine uptake, incorporation, and 
salvage rates. Several kinase and phosphatase modulators were used to identify the kinase and phosphatase families involved in the regulation scheme. 
Activators for protein kinase A (butyryl-cAMP and 8-bromo-cAMP), protein kinase G (butyryl-cGMP and 8-bromo-cGMP), and protein kinase C (TPA and 
PDD) were employed to identify the participating kinase family. Protein kinase C activators (TPA and PDD) and inhibitors (calphostin C, sphingosine, 
staurosporine, and H-7), and phosphatase inhibitors (okadaic acid and calyculin A) were studied to determine if phosphorylation, particularly by protein kinase 
C, is involved in the regulation of the queuine uptake, incorporation, and/or salvage steps of the queuosine modification system.
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Chronic exposure of cell cultures to TPA is known to induce proteolytic degradation and down-regulation 
of PKC activity (84). This phenomenon was exploited to verify the results of the short-term exposure 
experiments. While the effect of exposure to PKC and phosphatase inhibitors should not change with 
prolonged exposure to the agents, long-term exposure to the PKC activator TPA should instead inhibit the 
enzyme. In preliminary studies for the experimentation involving phosphatase inhibitors, concentration 
ranges were performed for exposure o f  agents to the cultures. This enabled the determination of IC50 
values which were compared to published standards of these compounds in order to suggest the family of 
phosphatases involved in the inhibition of the queuosine modification system at any of the uptake, 
incorporation, and/or salvage steps.
In Vitro Studies o f Phosphorylation Control ofthe Incorporation Step ofthe Queuosine Modification 
System
Purification strategies for the isolation of mammalian TGRases were modified to assess the 
likelihood that direct phosphorylation o f the enzyme helps to maintain their activity levels. Addition of 10 
pM phosphatase inhibitors sodium fluoride and sodium pyrophosphate to a homogenization buffer used in 
the early stages of purification served to enhance the recovery of TGRase activity from rat liver isolates 
(see Chapter 3, Graph 3-4). Thereafter, when native in vitro TGRase incorporation assays showed minimal 
activity, PKC was added during a duplication of the assay. Through this procedural addition, it was 
possible to trace the purification of the enzyme through subsequent isolation steps. These efforts were able 
to eventually produce a homogeneous TGRase isolate.
To confirm direct phosphorylation and activation by PKC with regard to the TGRase enzyme, as 
was suggested by in vivo cell culture studies, additional experiments were performed with the addition of 
commercial PKC to the reaction assays. Control reactions were performed to assess the effect of PKC 
modulators directly on TGRase activity, and their effect on TGRase activity in the presence of PKC. 
Finally, reciprocal control of TGRase activity by a classical kinase/phosphatase regulatory mechanism was 
studied with the sequential addition o f PKC and alkaline phosphatase to a single TGRase assay reaction.
Results
Regulation o f Cellular Queuine Uptake
Cultured human fibroblasts (passages 3-5) were exposed to the phosphorylation modulators to 
discern influences on rQT, uptake after a three hour incubation (Graph 4-1). The agents that are reported 
to stimulate the cAMP or cGMP dependent kinase systems had no effect on the rate of rQT3 uptake. 
However, activators of PKC increased the rate of rQT3 uptake by fifty percent when compared to untreated 
controls. By contrast, cellular exposure to inhibitors of PKC all decreased the rate of rQT3 uptake. 
Additional fibroblast cultures were exposed to the protein phosphatase inhibitors in order to maintain
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Graph 4-1. The Effect o f Protein Kinase and Protein Phosphatase Modulators on Queuine Uptake in Human Fibroblasts. Each bar represents rQT3 uptake in 
cultures exposed to various kinase and phosphatase modulators for three hours. The cultures were treated with modulators at the following concentrations: 10 
pM dibutyryl-cGMP, 8-bromo-cGMP, dibutyryl-cAMP and 8-bromo-cAMP, 20 nM TPA and PDD, and 10 nM okadaic acid, I nM calylculin A, 100 nM 
calphostin C, 20 pM sphingosine, 100 nM staurosporine and 10 pM H-7. The uptake of the radiolabelled queuine in all cultures (4 x I05 cells) was measured 
after a three hour incubation with 100 nM rQT3 and modulators at 37°C. These values were normalized to the number of pmol rQT3 taken up by I05 cells, and 
converted to percentage uptake with the control culture value (5.5 ± 0.3 pmol/109 cells) serving as 100%. The value and standard deviation of the control culture 
is indicated as the line at the y-axis value 100% and in the shading surrounding this line. Deviation bars indicated represent the standard deviation with n ~6.
UtUt
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higher protein phosphorylation levels within the cell. These cultures showed a similar increase in queuine 
uptake when compared to those treated with PKC activators, further suggesting that phosphorylation is 
involved in the regulation of queuine transport.
Parallel time-course studies of rQT3 uptake with short-term exposure to staurosporine, calphostin 
C, TPA, calyculin A, and okadaic acid were performed and compared to the rQT3 uptake rate in control 
cells at hourly intervals over four hours (Graph 4-2). Treatment of the cells with the PKC inhibitors 
resulted in a decrease in the uptake rate for rQT3 as compared to untreated control fibroblast cultures. The 
PKC activator (TPA) nearly doubled the rate of rQT3 uptake, while the protein phosphatase inhibitors also 
stimulated the rQT3 uptake rate. This further indicates that queuine uptake efficiency is linked to protein 
phosphorylation levels.
Fibroblast cultures were pre-treated for 7 days with TPA, staurosporine, and okadaic acid in order 
to measure effects of long-term exposure to these modulators on queuine uptake (Graph 4-3). This is 
particularly revealing since chronic exposure to TPA results in proteolytic down-regulation of PKC activity 
(84). As expected, exposures to the PKC inhibitor significantly decreased the uptake of queuine at 3 hours 
of exposure to rQT3, while treatment with low levels of the phosphatase inhibitor induced a two-fold 
increase in rQT3 uptake. Furthermore, chronic exposure to TPA resulted in an inhibition of rQT3 uptake 
rate when compared with untreated control cultures. This is a reversal of the effect observed with short­
term exposure to TPA, and supports the PKC modulation scheme for queuine uptake based on the 
idiosyncrasy of differential effects on PKC with short-term vs. long-term exposure to phorbol esters.
The relatively high concentrations of the protein phosphatase inhibitors used in the short-term 
exposure study was cause for concern given their reported toxicity levels (142-144). A range of 
concentrations of calyculin A and okadaic acid were studied to analyze their effects on the 3 hour time 
point for rQT3 uptake relative to untreated control fibroblast cultures (Graph 4-4). These studies were 
performed for both short-term (simultaneous exposure to inhibitor and rQT3) and for chronic exposure to 
the inhibitors (pre-treatment: 7 days prior to addition of rQT3).
Concentrations of okadaic acid in excess o f 100 nM proved to be cytotoxic for the 3 hour short­
term exposure studies. However, increasing concentrations of okadaic acid from 5 to 100 nM 
demonstrated progressively increasing rQT3 uptake. Similar trends were observed in studies of chronic 
exposure to this phosphatase inhibitor. Increasing concentrations o f okadaic acid from I to 10 nM 
demonstrated progressively increasing rQT3 uptake rates, while concentrations over 10 nM were cytotoxic 
to the fibroblast cultures. Comparable results were seen with studies using the protein phosphatase 
inhibitor calyculin A. However, the fibroblast cultures were much more sensitive to this compound. 
Exposure for 3 hours to 1 nM calyculin A effectively increased the rate of rQT3 uptake. For chronic 
exposures (7 day pre-treatment), 0.2 nM calyculin A demonstrated equivalent maximal induction of rQT3 
uptake rate. Concentrations above these levels were cytotoxic in both short-term and chronic exposure 
studies, respectively.


























Graph 4-2. The Effect o f Short-Term Exposure to Protein Kinase C and Protein Phosphatase Modulators on Queuine Uptake in Human Fibroblasts, The graph 
on the left displays the uptake of rQTj during short-term exposure to a protein kinase C activator and protein phosphatase inhibitors. The bottom line ( + )  
represents rQTj uptake in untreated control cultures, with the upper lines representing cultures treated with 10 nM okadaic acid ( <* ), 0.2 nM calyculin A ( O ) 
and 20 nM TPA (□  ), respectively. The graph on the right illustrates the uptake of rQTj during short-term exposure to protein kinase C inhibitors. The top line 
( + )  represents rQT, uptake in untreated control cultures, with the lower lines representing cultures exposed to 100 nM staurosporine ( ■ ) and 100 nM 
calphostin C ( •  ), respectively. In these short-term exposure studies, modulators were added to the cultures at time 0. The uptake of the radiolabeled queuine 
in all cultures was measured after a 37°C incubation with 100 nM rQTj at 0, 1,2,3, and 4 hours. These values were then normalized to the number of pmol 














Graph 4-3. The Effect o f Long-Term Exposure to Protein Kinase C and Protein Phosphatase Modulators 
on Queuine Uptake in Human Fibroblasts. This graph displays the uptake of rQT3 after a week of 
exposure to a protein kinase C activator and inhibitor, and a protein phosphatase inhibitor. The solid line 
( + )  represents rQT3 uptake in untreated control cultures, with the other lines representing cultures treated 
with 20 nM TPA ( □  ), I nM okadaic acid ( v  ), and 100 nM staurosporine ( ■ ), respectively. In these 
long-term exposure studies, cultures were pre-incubated with the modulators for 7 days before the initiation 
of the uptake assay with the addition of the rQT3 at time 0. The uptake of the radiolabeled queuine in all 
cultures was measured after a 37°C incubation with 100 nM rQT3 at 0, 1,2,3, and 4 hours. These values 
were then normalized to the number of pmol rQT3 taken up by 105 cells. Deviation bars indicated 
represent the standard deviation with n =4.
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Graph 4-4. The Effect o f Short-Term and Long-Term Exposure to Protein Phosphatase Inhibitors on Queuine Uptake in Human Fibroblasts, These bar graphs 
represent the effects of exposure of varying concentrations of okadaic acid (top graphs) and calyculin A (bottom graphs) on rQT3 uptake in cultures. Short-term 
exposure studies (those graphs displayed on the left) were conducted with simultaneous initiation of the experiment and exposure of the cells to the modulator at 
time 0. Long-term exposure studies (graphs on the right) were conducted alter pre-treatment of the cultures for 7 days before initiation of the experiment. The 
uptake of the radiolabeled queuine in all cultures (4 x I0} cells) was measured alter a three hour incubation with 100 nM rQTj at 37 °C. These values were 
normalized to the number of pmol rQTj taken up by 10s cells, and converted to percentage uptake with the control culture value (S.S ± 0.3 pmol/105 cells) 
serving as 100%. Deviation bars indicated represent the standard deviation with n = 6. UlsO
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It has been reported that calyculin A l s  a more effective inhibitor of protein phosphatase I than 
okadaic acid. In one study, IC*, values o f approximately SO nM for okadaic acid and 03 nM for calyculin 
A were reported for muscle phosphatase I in studies of long-term exposure to the agents (142). Based on 
the reported sensitivity of protein phosphatases type I and II to okadaic acid and calyculin A with pre­
treatment exposure (142-144), the strong similarity of the data obtained in this study (Graph 4-4) to this 
reported characteristic suggests that protein phosphatases of the type I group are participating in the 
modulation of rQT3 uptake in human fibroblasts.
Regulation o f Queuine Incorporation into tRNA
Although the rate of uptake can be modulated, it was observed that maximal uptake of the queuine 
base to a saturating level occurs in six hours. After this point, uptake and efflux are balanced (30). It is 
suggested that the modulation of the uptake mechanism might not be solely responsible for the dramatic 
queuosine-modification deficiency seen in neoplastic transformation and progression of cancer ceils to 
metastasis. Thus, the queuine incorporation mechanism (TGRase) was studied to determine if PKC acts in 
a dual role in modulating both components of the queuine modification system.
First, cultured human fibroblasts (passages 3-5) were exposed to dibutyryl and 8-bromo analogs 
of cAMP and cGMP, as well as TPA, PDD, calphostin C, sphingosine, staurosporine, H-7, okadaic acid or 
calyculin A for 8 hours in order to determine effects on the incorporation o f rQT3 into tRNA by TGRase 
(Graph 4-5). The queuine incorporation rates o f cells exposed to these modulators were compared to an 
untreated control culture and three additional control (positive and negative) cultures. These additional 
control fibroblast cultures were utilized to establish both the maximum and minimum incorporation limits 
for comparison to the experimental samples. Queuosine-deficient tRNA cultures (cells treated with 
charcoal-stripped media for three passages) were used as substrate targets for demonstrating the maximal 
incorporation rate o f rQT3 into tRNA by TGRase (positive control). These cells demonstrated a nearly 
two-fold increase in rQT3 incorporation rate when compared to normal serum-supplemented controls. The 
slower rate of incorporation in serum-supplemented control cells is likely due to partial queuosine- 
modification of the existing tRNA population in the cell. Two negative control cultures were grown in 
10% serum-supplemented media. One culture was treated with additional 100 nM queuine and the other 
was treated with 10 pM 7-methylguanine. Addition of excess queuine completely and irreversibly saturates 
the cell's tRNA with queuosine and eliminates the cell’s tRNA as a substrate for rQT3 incorporation. 7- 
methylguanine is a competitive inhibitor of TGRase and blocks the ability of TGRase to incorporate rQT3 
into tRNA at concentrations used here (76). These two cultures represent the background levels of non­
specific rQT3 association to the acid precipitable fraction of solubilized cell cultures, which is expected in 
the absence of TGRase activity.
Cell cultures treated with agents that increase the activity of cAMP and cGMP dependent kinases 
appear to have no effect on the incorporation rate of rQT3 (Graph 4-5). However, PKC activators and
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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phosphatase inhibitors increase the incorporation of rQT3 toward levels observed in totally queuosine- 
deficient cells, while cells treated with inhibitors of PKC reduce the incorporation of rQT3 to a base-line 
level just above that of the negative control cultures. These results demonstrate that PKC-catalyzed 
phosphorylation is important in regulation of TGRase activity, thus the formation of the queuosine 
modification o f tRNA.
A 12 hour thne-course for rQT3 incorporation into tRNA of queuosine-deficient tRNA fibroblast 
cultures was the performed in cells grown for three passages in 10% charcoal-stripped serum (queuine- 
free) supplemented media (Graph 4-6). In short-term exposure studies, rQT3 and various modulating 
agents (staurosporine, sphingosine, calphostin C, TP A, okadaic acid and calyculin A) were simultaneously 
added to parallel cultures. Then, these were analyzed for rQT3 incorporation into tRNA at four-hour 
intervals for 12 hours. Inhibitors of PKC decreased the rate of rQT3 incorporation into tRNA to a base-line 
level as compared to untreated controls. The protein kinase activator and phosphatase inhibitors, when 
added to cell cultures at the same time as rQT3, both increased the rQT3 incorporation rates when compared 
to untreated control cells.
In long-term exposure studies, queuosine-deficient cells pre-treated with various agents for 7 days 
were studied for rQT3 incorporation rates into tRNA over a 12 hour time-course (Graph 4-7). Chronic 
exposure to TPA, which induces a proteolytic down-regulation of PKC (84), resulted in a decrease in rQT3 
incorporation into tRNA. However, treatment with staurosporine was more effective at inhibiting the rate 
of rQT3 incorporation in cell cultures. It is both possible and likely that residual PKC activity may still be 
present in the cells chronically exposed to TPA. In addition, chronic pre-treatment of these cells for 7 days 
with okadaic acid showed rQT3 incorporation levels lower than that of the control. Since this treatment 
maintains the phosphorylation level in the cell, the activity o f TGRase should be enhanced during this 
preparative step and TGRase would effectively recycle queuine from tRNA turnover and incorporate it into 
new transcripts o f tRNA. At the time of the rQT3 addition, the cognate tRNA would be saturated with the 
queuosine modification and would no longer be used as a substrate for incoming rQT3 due to the 
irreversible nature of the queuine incorporation reaction. Therefore, chronic exposure to okadaic acid 
should decrease the rate of (QT3 incorporation into tRNA as compared to control cultures, and this is 
indeed the case.
Regulation o f Queuosine Salvage
The final step of the queuosine modification system, salvage of the queuine base from queuosine- 
S’-monophosphate (Q5P), was studied with regard to it’s ability to be modulated by PKC. The in vivo 
salvage assay method, described in Chapters 2 and 3, was modified to integrate phosphorylation modulator 
treatment into the standard assay much as was done for the in vivo uptake and incorporation assays (Graph
4-8). Cells were grown to near confluence, then a media change to charcoal-stripped (queuine free) media 
for one day or two weeks was performed to induce any queuine salvage mechanism prior to the beginning

































Graph 4-5. The Effect o f Protein Kinase and Protein Phosphatase Modulators on Queuine Incorporation into tRNA in Human Fibroblasts, Each bar represents 
rQTj incorporation into the tRNA of cultures exposed to various kinase andphosphatase modulators for eight hours at concentrations of 10 pM dibutyryl-cGMP,
8-bromo-cGMP, dibutyryl-cAMP and 8-bromo-cAMP, 20 nM TPA and PDD, and 10 nM okadaic acid, 0.2 nM calylculin A, 100 nM calphostin C, 20 pM 
sphingosine, 100 nM staurosporine and 10 pM H-7. The incorporation of the radiolabelled queuine into the tRNA of all cultures (4 x 10 cells) was measured 
after an eight hour incubation with 100 nM rQT} and modulators at 37°C. These values were normalized to the number of pmol rQTj incorporated into the acid- 
precipitable fraction of 10s cells. An untreated control represents rQT} incorporation into tRNA of untreated "normal’’ cultures (measured at 3.0 ± 0.2 pmol/10s 
cells), and was the basis for the normalization of experimental cultures’ values to percentage uptake with the untreated control culture value serving as 100%, 
The value and standard deviation of the control culture is indicated as the line at the y-axis value 100% and in the shading surrounding this line. In addition, 
negative control cultures for rQTj incorporation in cells treated with 10 pM 7-methylguanine, a competitive inhibitor for the queuine incorporation enzyme, and 
cultures of queuine-saturated cells (preincubated with 0.10 A2i0 queuine for three passages) enabled the minimum amount of rQTj for a null incorporation 
baseline, which measure at 9 ± 3 % and 5 ± 2 %, respectively. These are shown in the line and shading at the y-axis value near zero. Finally, a sample of 
queuine-deflcient cells that were preincubated with charcoal-stripped media for three passages established the maximum amount of rQTj able to be incorporated 
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Graph 4-6. The Effect o f Short-Term Exposure to Protein Kinase C and Protein Phosphatase Modulators on Queuine Incorporation into tRNA o f Human 
Fibroblasts. The graph on the left displays the incorporation of rQTj into acid-precipitable fractions of cultures during short-term exposure to a protein kinase C 
activator and protein phosphatase inhibitors. The bottom line (+  ) represents rQT} incorporation in untreated control cultures, with the upper lines representing 
cultures treated with 10 nM okadaic acid (< “■ ), 20 nM TPA ( □ )  and 0.2 nM calyculin A ( O ), respectively. The graph on the right illustrates the 
incorporation of rQTj into acid-precipitable fractions of cultures during short-term exposure to protein kinase C inhibitors. The top line ( + )  represents rQTj 
incorporation in untreated control cultures, with the lower lines representing cultures exposed to 100 nM calphostin C ( •  ), 100 nM staurosporine ( ■ ), and 
20 pM sphingosine ( ♦ ), respectively. In these short-term exposure studies, modulators were added to the cultures at time 0. The incorporation of the 
radiolabeled queuine into tRNA in all cultures was measured after a 37°C incubation with 100 nM rQT3 at 0 ,3 ,6,9, and 12 hours. These values were then 









T im e (hours)
Graph 4-7. The Effect o f Long-Term Exposure to Protein Kinase C and Protein Phosphatase Modulators 
on Queuine Incorporation into tRNA o f Human Fibroblasts. This graph displays the incorporation of rQT3 
into the acid-precipitable fraction of cultures after a week of exposure to a protein kinase C activator and 
inhibitor, and a protein phosphatase inhibitor. The solid line ( +  ) represents rQT3 incorporation in 
untreated control cultures, with the other lines representing cultures treated with 20 nM TPA ( □  ), 1 nM 
okadaic acid ( <> ), and 100 nM staurosporine ( ■ ), respectively. In these long-term exposure studies, 
cultures were pre-incubated with the modulators for 7 days before the initiation of the uptake assay with 
the addition of the rQT3 at time 0. The incorporation of the radiolabeled queuine into the acid-precipitable 
fraction o f all cultures was measured after a 37°C incubation with 100 nM rQT3 at 0 ,3 ,6,9 , and 12 hours. 
These values were then normalized to the number of pmol rQT3 incorporated into the acid-precipitable 
fiaction o f 10s cells. Deviation bars indicated represent the standard deviation with n =4.
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Graph 4-8. The Effect o f Short-Term Exposure to Phosphorylation Modulators on Queuine Salvage in Human Fibroblasts. Cultures of human fibroblast cells
(HFF) were grown to near confluence in normal media, fed with charcoal-stripped serum (lacking queuine) for 1 day or 2 weeks with regular media changes,
then submitted to an in vivo queuine salvage assay with the addition of phosphorylation modulators. A tritritiated analogue of queuine (rQTj) at a concentration
of 100 nM was placed in the media 24 hours before the start of the assay to saturate the tRNA with the radiolabeled base. In two sets of parallel cultures at time
zero, extracellular rQT} was washed away, then a media change with charcoal-stripped media was performed with the addition of 20 nM TPA (a protein kinase
C stimulator), 1 nM okadaic acid (a protein phosphatase inhibitor), and 100 nM staurosporine (a protein kinase C inhibitor). In one set of cultures 0.10 A260
units of unlabeled queuine was added (black bars) indicating the tRNA turnover rate within the cells. No queuine was added to the other set of cultures (light
grey bars) which represent the ability of the cells to salvage and retain the radiolabel in the cell’s tRNA. The counts per minute values obtained via liquid
scintillation were normalized to the number of pmol rQTj contained within the acid-precipitable fraction of the 10s cells that had been devoid of queuine for I
day or 2 weeks. Deviation bars indicated represent the standard deviation with n =4. ov
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of the study. In short-term exposure studies, addition of TPA, staurosporine, H-7 or okadaic acid at the 
start of the assay produced no dramatic effect on the maintenance of rQT, levels in the acid-precipitable 
fraction of the human fibroblast cells over the four days of the study. The same was observed for both sets 
of cultures that had been subjected to one day or two weeks of queuine starvation. Thus, it is suggested 
that phosphorylation by PKC is not a regulating factor in the control of the salvage step o f the queuosine 
modification system.
Direct Action o f Protein Kinase C on the Queuine Incorporation Enzyme In Vitro
In order to verify the results of the in vivo assay results with regard to the incorporation step of the 
queuosine modification system, TGRase was isolated from rat liver as described in Chapter 3 and tested for 
modulation o f enzymatic activity and the ability to be directly phosphorylated by PKC. Early evidence of 
the influence of PKC on TGRase activity was shown with an induction of the queuine incorporation 
activity in cold-stored TGRase samples (see Chapter 3, Graph 3-3). In combined TGRase and PKC 
enzyme assays on the P-l 1 phosphocellulose fraction of a rat liver preparation an increase was observed in 
the activity of cold stored TGRase (Graph 4-9). Both partially active and totally inactive TGRase samples 
were restored to their original P-l 1 phosphocellulose isolate activity by exposure to activated PKC. The 
greater-than-100% return of activity seen in one isolate is suggested to reflect a loss of TGRase activity 
during the isolation protocol from the original homogenate to the phosphocellulose fraction.
Purified TGRase preparations after the Mono Q FPLC step were subjected to a PKC 
phosphorylation assays to determine the ability of the TGRase enzyme to serve as a substrate for PKC- 
catalyzed phosphorylation. The PKC was able to incorporate n P from yn P-ATP into the acid precipitable 
component of the TGRase preparation derived from Mono-Q column, and at levels greater than that for 
histones in the positive control sample (Graph 4-10). The phosphorylation of TGRase by PKC is 
corroborated by the SDS-PAGE/autoradiograph discussed in Chapter 3 (Figure 3-3), where the larger of 
the two subunits (approximately 60 kDa) appeared to be radiolabeled with 32P by PKC.
In control experiments, the direct effect of PKC modulators on TGRase activity, PKC 
phosphorylation of TGRase, and TGRase activity in the presence of PKC were tested. TGRase 
preparations were assayed for 3H-guanine incorporation into yeast tRNA in the presence of PKC activators 
(diacyiglycerol, phosphatidyl serine, and CaClj, as well as ATP) and PKC inhibitors (H-7, sphingosine, or 
staurosporine). None of these agents directly effected the TGRase activity (Graph 4-11). The methylated 
purine, 7-methylguanine, a known competitive inhibitor of TGRase demonstrated strong inhibitory effects 
and served as the inhibited control for this assay. Direct phosphorylation of TGRase by PKC was 
measured in the presence of PKC activators and PKC inhibitors. As expected, the phosphorylation of 
TGRase by PKC was induced by the presence of PKC activators (diacyiglycerol, phosphatidyl serine and 
calcium) and dramatically inhibited by H-7, sphingosine and staurosporine (Graph 4-12). This inhibition 
was observed even in the presence of the activators. The PKC preparations demonstrated no evidence of




















































Graph 4-9. The Decay o f Two Samples o f Purified tRNA .Guanine Ribosyltransferase Activity and Reactivation by Protein Kinase C. These graphs indicate the 
decay of residual TGRase activity in two different rat liver Mono Q-FPLC preparations and recovery of activity with the addition of protein kinase C. Five 
micrograms of purified protein isolate were analyzed using the standard TGRase activity assay to measure the ability to incorporate 3H-guanine into 0.10 A260 
units of yeast tRNA in one hour at 37°C (solid bars). Assay of these same samples by the combined TGRase and PKC activity assay was also performed under 
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Graph 4-10. The Phosphorylation o f Histones and tRNA:Guanine Ribosyllransferase by Protein Kinase C, The control bars of histones and tRNA;guanine 
ribosyltransferase (TGRase) only indicate the non-specific binding of (y- JP]ATP and any contaminating kinase activity in 5.0 pg histone fraction IV and 
TGRase samples, respectively. The protein kinase C (PKC) bar indicates the background levels of (y-wP]ATP binding to 10 pll PKC with no histone or TGRase 
substrate added. The remaining bars indicate the levels of 10 pU PKC-catalyzed phosphorylation of 5.0 pg histone and TGRase, respectively. All assays were 
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Graph 4-11. The Effect o f Protein Kinase C Modulators on the Activity o f lRNA:Guanine Ribosyllransferase, The bar representing “no tRNA" indicates 
background levels of 3H-guanine adhering to protein within the tRNA:guanine ribosyltransferase (TGRase) sample (no tRNA substrate added). “TGRase only" 
indicates the TGRase activity level of the S.O pg protein sample with the addition of 0.10 A260 units yeast tRNA substrate. Another negative control for the 
TGRase activity is shown in the “TGRase + 7mG" bar, with the TGRase activity in the presence of 10 pM 7-methylguanosine (7mG), a competitive inhibitor for 
TGRase. “TGRase + PKC act.” indicates the TGRase activity in the presence of traditional protein kinase C (PKC) activators activators (1 mM calcium chloride, 
S.O pg diacyiglycerol, and S.O pg phosphatidyl serine). Adenosine triphosphate (ATP), an important substrate for PKC, is also required for catalytic function of 
the phosphorylating enzyme PKC. So, the activity of TGRase in the presence of 10 pM ATP, and with PKC activators and ATP was assessed. Finally, the 
activity of TGRase in the presence of three different PKC inhibitors (50 pM H-7, 100 nM staurosporine and 25 pM sphingosine) was measured in the presence 
of calcium chloride, diacyiglycerol, phosphatidyl serine and ATP. All assays were performed using the standard TGRase activity assay method. Standard 
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Graph 4-12. The Effect o f Protein Kinase C Modulators on the Phosphorylation o f tRNA:Guanine Ribosyltransferase by Protein Kinase C. The “PKC only" 
bar indicates the background level of [y-32PJATP adherence to 10 pU protein kinase C (PKC) sample with no substrate added, but including the traditional PKC 
activators I mM calcium chloride, S.O pg diacyiglycerol, and S.O pg phosphatidyl serine. The “TGRase only” bar indicates the presence of contaminating kinase 
activity in the tRNA:guanine ribosyltransferase (TGRase) sample, by assaying the TGRase sample without the presence of PKC. The “PKC + TGRase” 
indicates the incorporation of the radiolabeled phosphate into S.O pg TGRase by 10 pi) PKC. The remaining bars indicate the ability of PKC to phosphorylate 
TGRase with the addition of three PKC inhibitors (SO pM H-7, 100 nM staurosporine and 2S pM sphingosine). All assays were performed using the standard 
TGRase activity assay method. Standard deviation values are indicated for each sample with n =4. o
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latent TGRase activity and the TGRase preparations exhibited no evidence of PKC activity. Finally, in 
assays that measured the effect of the presence of PKC on TGRase activity, 3H-guanine incorporation was 
increased when exposed to activated PKC as seen before (Graph 4-13). However, inhibitors of TGRase (7- 
methylguanine—negative control) and PKC (H-7, staurosporine, and sphingosine) all appeared to reduce 
the activity of PKC-activated TGRase to background. Thus, the effect of the PKC on ^-guanine 
incorporation into tRNA is suggested to be due to direct phosphorylation causing activation of the TGRase 
enzyme.
Combined assays were run with TGRase, PKC and alkaline phosphatase (AP) (Graph 4-14). The 
results of TGRase activity assays with the presence of PKC and an antagonist phosphatase (AP) verify the 
phosphorylation-modulation that has been suggested so far. Again, the TGRase activity was greatly 
enhanced by the presence of PKC. This induction was reversed upon the addition o f AP. In fact, baseline 
TGRase activity was decreased by the presence of the phosphatase enzyme. This suggests that during the 
isolation procedures there is some basal level of phosphorylation maintained in the isolated TGRase-active 
fractions.
3ZP-Iabeled and unlabelled P-l 1 and Mono-Q TGRase fractions were analyzed by denaturing and 
non-denaturing PAGE as described in Chapter 3. To summarize, the mammalian liver TGRase enzyme is 
likely a dimer with a 60 kDa subunit that appears to be phosphorylated at a serine residue by PKC and a 
34.5 kDa subunit that appears to contain the active site for the enzyme. Superose 6 FPLC analysis of 
weakly TGRase-active and strongly TGRase-active Mono Q fractions verified the composition suggested 
by SDS- and native-PAGE. TGRase assays were performed on the rat liver Mono Q fractions with and 
without the addition of PKC to assess the effect of the kinase on the dimer versus the active subunit 
monomer form of the TGRase enzyme (Figure 4-2). The fraction containing primarily the 34.5 kDa 
subunit exhibited almost three-fold greater TGRase activity than the dimer fraction without the addition of 
PKC, and did not appeared to be effected by it’s addition. The weak TGRase-active fraction, containing 
primarily the dimer form of the enzyme, showed a near tripling of it’s TGRase activity with the addition of 
PKC which increased it’s specific activity to that of the other fraction and both within the ballpark of that 
reported in the isolation protocols for the purified rat liver TGRase enzyme.
Discussion
The uptake of queuine into “normal” cultured human fibroblasts appears to be modulated by 
phosphorylation. Activators of cAMP and cGMP dependent kinases have no effect on rQT3 uptake, while 
increasing PKC activity with phorbol ester treatment elevates the rate of rQT3 uptake. Conversely, chronic 
exposure of TPA to fibroblast cultures, which is known to down-regulate PKC activity, decreases rQT3 
uptake. A spectrum of protein kinase inhibitors, with various specificities to PKC, all inhibit rQT3 uptake 
into fibroblast cultures in concentration ranges reported to be most specific for PKC. These results make a 
strong case for the role of PKC in enhancing the uptake rate of queuine into fibroblast cultures.
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Graph 4-13. The Effect o f Protein Kinase C Modulators on tRNA:Guanine Ribosyltransferase Activity in the Presence o f Protein Kinase C, The “no tRNA" bar 
indicates background levels of *H-guanine that adheres to protein in a combined tRNA:guanine ribosyltransferase (5.0 pg TGRase) and protein kinase C (10 pU 
PKC) reaction mixture with no tRNA substrate added. The “TGRase only" bar indicates the TGRase activity level of the TGRase sample (S.O pg) in the 
presence of 10 pU PKC, but without the addition of PKC activators (1 mM calcium chloride, 5.0 pg diacyiglycerol, 5.0 pg phosphatidyl serine, and 10 pM 
ATP). “PKC only” represents a negative control for TGRase activity in the reaction mixture containing 10 pU PKC, PKC activators and TGRase assay reagents, 
but without the TGRase sample. The “TGRase + PKC” bar indicates the TGRase activity of the sample in the presence of PKC and PKC activators. Another 
negative control shows the “TGRase + PKC” reaction mixture’s activity in the presence of 10 pM 7-methylguanine, a competitive inhibitor for TGRase. The 
remaining bars represent the activity of TGRase in the presence of both PKC, PKC activators, and three PKC inhibitors H-7 (50 pM), staurosporine (100 nM) 
and sphingosine (25 pM), respectively. All assays were performed using the standard TGRase activity assay method. Standard deviation values are indicated 
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Graph 4-14. The Modulation o f Purified tRNA:Guanine Ribosyltransferase Activity by Phosphorylation. The “no tRNA" bar indicates the non-specific binding 
of }H-guanine to protein within the 5.0 pg tRNA:guanine ribosyltransferase (TGRase) sample (no tRNA was added). The bar identified as TGRase only 
indicates the residua) TGRase activity in this sample. “TGRase + AP” indicates the TGRase activity with the addition of 0.40 mil alkaline phosphatase (AP), a 
general phosphatase. “TGRase + PKC” indicates the sample’s TGRase activity with the addition of 10 pi) protein kinase (PKC). The remaining bar indicates 























MonoQ FPLC Fraction Specific Activity*
1 no PKC 295.2 ±12.8
1 with PKC 285.9 ±13,5
2 no PKC 124.8 ±9.7
2 with PKC 292.5 ±12.9
Figure 4-2. Superose 6 FPLC Absorbance Profiles and Results o f Assays Measuring MonoQ FPLC Fractions' tRNA.Guanine Ribosyltransferase Activity With 
and Without Exposure to Protein Kinase C, The two MonoQ-FPLC fractions, corresponding to the Superose 6 FPLC profiles shown in Figure 3-3, were 
examined for tRNA:guanine ribosyltransferase (TGRase) activity. Parallel assays were run using either the traditional in vitro TGRase assay method with or 
without the addition of 10 pU protein kinase C (PKC) and it’s activators (1 mM calcium chloride, S.O pg diacyiglycerol and 5.0 pg phosphatidyl serine). 
Negative controls for TGRase activity in the PKC and the PKC activator samples indicated no contaminating activity (data not shown). 'Specific activity for 
each protein sample was calculated based on the number of pmol }H-guanine incorporated into 0.10 A260 units yeast tRNA per mg protein per hour at 37°C. The 
star on the FPLC profile over the peak, estimated at 66 kDa, indicates the corresponding size subunit identified by autoradiograph (Figure 3-2) as containing the 
phosphorylation site for PKC attachment of a phosphate.
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The inhibition of protein phosphatases by both okadaic acid and calyculin A also induces an 
increase in the uptake of rQT3. These results indicate that maintenance o f protein phosphorylation is 
important to maximize the rate o f queuine uptake. Due to the concentrations of the two phosphatase 
inhibitors involved, it is suggested that protein phosphatases of type I are down-regulating queuine uptake 
activity by removing a phosphate group from the queuine-specific membrane transporter. This analysis is 
based on reported sensitivity o f protein phosphatases type I and II to okadaic acid and calyculin A (142- 
144).
The incorporation o f queuine into tRNA in cultured human fibroblasts also appears to be 
modulated by PKC and protein phosphatase activity. Activators of cAMP and cGMP dependent kinases 
have no effect on rQT3 incorporation. However, activators of PKC and inhibitors of protein phosphatase 
both increase TGRase incorporation rates above a base-line incorporation level, while inhibitors of PKC 
decrease incorporation rates o f rQT3 to the base-line level. Chronic exposure to TPA, which is known to 
induce a proteolytic down-regulation of PKC, also decreases rQT3 incorporation into fibroblast tRNA when 
compared to untreated controls. These results make a strong case for the role of PKC in enhancing the 
incorporation rate o f queuine into tRNA in fibroblast cultures.
The TGRase enzyme, which is responsible for the production o f the queuosine modification, has 
been under scrutiny since its discovery in 1973. However, most published reports document only partial 
purifications of the enzyme and limited storage half-lives (44,115). Over the past thirteen years, TGRase 
isolated from rat, rabbit, and human tissues has always shown instability and loss of assayable activity with 
short term storage (three days to four weeks). The results of these in vitro studies suggest that PKC activity 
is essential in maintaining the activity of TGRase in addition to activation of the cellular uptake mechanism 
for it's substrate, queuine. Several stored TGRase preparations isolated from rat liver with low levels of 
activity all have been shown to be fully reactivated upon exposure to PKC. Inactivation of PKC in 
combined TGRase and PKC assays with H-7, staurosporine or sphingosine resulted in a large decrease in 
the activity level of TGRase as compared with the PKC activated control. Neither the PKC inhibitors nor 
the PKC activators exerted effects on TGRase directly. In addition, several 32P incorporation assays were 
run demonstrating that PKC appears to be directly phosphorylating TGRase.
It is proposed that the TGRase enzyme exists as a heterodimer of approximately 104 kDa, with a 
PKC-substrate regulatory subunit of 60 kDa and a catalytic subunit of 34.5 kDa. The subunit composition 
of the fully active TGRase protein is still under debate. The 34.5 kDa subunit has been shown to contain 
significant TGRase activity, but it is not activated by PKC. A preparation containing primarily the dimer 
form exhibits very weak TGRase activity which is dramatically increased by the addition o f functional 
PKC. It has been suggested that PKC phosphorylates the large subunit which induces dissociation of the 
dimer and releases the 34.5 kDa catalytic subunit which would then be free to perform it’s apparent 
queuine-insertion activity into tRNA (126). However, Slany and Langgut have suggested that the dimer 
form is the active form an that phosphorylation just alters the conformation of the dimer to induce it’s
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activity (125).
Despite the strong circumstantial evidence that both queuine uptake and incorporation are 
regulated by PKC, the mechanism catalyzing the salvage of intracellular queuine does not appear to be 
effected by PKC.
Revised Description o f the Mammalian Queuosine Modification System
It is proposed that PKC and protein phosphatase are important modulators of both queuine uptake 
and incorporation into tRNA in “normal” mammalian cells. These are likely to be independently regulated 
sites for PKC due to 1) the ability of the uptake mechanism to fully saturate the cell with queuine in six 
hours despite down-regulation by dephosphorylation, 2) the observation o f the modulation of TGRase 
activity up to 24 hours in cultured cells, and 3) in vitro evidence that shows direct phosphorylation and 
regulation of rat liver TGRase activity by PKC.
When fully integrated into the description o f the queuosine modification system in “normal” 
mammalian cells, the ability to be regulated by PKC adds another layer o f functionality to the “big picture” 
of queuine metabolism (Figure 4-3). This regulatory enzyme is strongly connected to many other cellular 
and extracellular processes that serve to dramatically shape the metabolism and eventually the function o f a 
cell. Any agent or treatment regiment that could lead to a down-regulation in PKC activity, such as 
chronic exposure to phorbol-ester tumor promoters, would have an inhibitory effect on both TGRase 
activity and queuine uptake into the cell leading to queuine-hypomodified tRNA.
In vivo cell culture experiments with human fibroblasts and in vitro assays with purified rat liver 
TGRase suggest that control of TGRase activity by phosphorylation may be a universal mammalian 
phenomenon. Due to organismal structure (multicellular and differentiated nature of eukaryotic 
organisms), different regulatory design schemes have been evolutionarily developed for eukaryotes and 
prokaryotes. In the well known £. coli (prokaryotic) model, the formation of queuosine is transcriptionally 
regulated by the FIS protein (114). There is no known PKC-like activity in prokaryotes and only vaguely 
similar PKC-like activities in yeast which are early evolutionarily transitional eukaryotes.
Additionally, as mentioned in Chapter 3, the TGRase and TGTase enzymes are composed of 
widely divergent physical compositions. It is reasonable to suggest that these two enzymes developed from 
different origins, with different substrates (preQ, for the prokaryotic system and Q for the eukaryotic 
system). Thus, the TGRase and TGTase enzymes are very likely derived from different genes and may 
have only a superficial connection through the production of what is a universally conserved highly 
modified nucleoside. Even the design of the two systems is based on different processes, the prokaryotic 
version is a synthetic mechanism that builds Q from intracellular compounds while the eukaryotic version 
is a utilization mechanism that imports and salvages an exogenous compound. The evolutionary 
development of two independent but convergent systems seems to indicate that the queuosine modification 
has great physiological importance for it’s existence, in that both the prokaryotic and eukaryotic kingdoms































Figure 4-3. The Revised Eukaryotic Queuosine Modification System in Normal Human Fibroblast Cells, The eukaryotic system is based on usage of an 
available resource as described in Figure 3-4. It involves an uptake step facilitated by a specific queuine transmembrane transporter, tRNA'.guanine 
ribosyltransferase which catalyzes the incorporation reaction of q into tRNA“", tRNA“p, tRNAw\  or tRNA* ,̂ and a salvage step to recycle free queuine base for 
the incorporation step from queuosine-S’-monophosphate. The rates of both the uptake and incorporation steps are shown to be stimulated by direct 
phosphorylation by protein kinase C (PKC), while preliminary studies of the salvage step do not appear to be effected by PKC or a PKC regulated modulation 
system.
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have independently developed mechanisms for creating this nucleoside.
Cellular and Clinical Ramifications o f Protein Kinase C Regulation ofthe Queuosine Modification System
Protein kinase-protein phosphatase reciprocal control systems are important components of the 
cell's signal transduction system, and are known to be critical components involved with differentiation, 
control of cell growth and neoplastic transformation (see Chapter 1). The results of the queuosine 
modification system modulation studies tie an important signal transduction network to mechanisms 
responsible for tRNA modification with queuine. Alterations in the signal transduction system can effect 
both the availability of queuine base and the activity of TGRase which can potentially lead to the 
queuosine-hypomodification of tRNA commonly observed in neoplastically transformed and 
undifferentiated cells. In addition to the effect that the shift in tRNA modification might on it’s function in 
protein translation, queuosine deficiencies could be used as an indication o f cellular metabolic changes that 
often lead toward neoplastic transformation and progression toward metastatic cancer.
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CHAPTER FIVE 
DEFICIENCIES OF THE QUEUOSINE MODIFICATION SYSTEM
Introduction
In normal adult human cells the tRNA population is known to be fully saturated with the 
queuosine modification (60). However, neoplastic cell-lines derived from human biopsies exhibit 
profound deficiencies in the levels of queuosine. The deficiencies vary in their degree of 
hypomodification, as seen in such cell-lines as T-84 colon carcinoma (17% deficient), MCF-7 breast 
adenocarcinoma (SO to 60% deficient), HL-60 promyelocytic leukemia (60 to 80% deficient), and HxGC3 
colon adenocarcinoma (100% deficient) (45,87). The extent of this hypomodification may be exaggerated 
in successive passages by the conditions of tissue culturing, however this appears not to be an artifact of 
the method due to similar observed deficiencies in primary tissue biopsies.
There have been several published reports utilizing human biopsied tissue in order to determine 
the extent of the queuosine deficiency in tumors. In one study, breast adenocarcinomas were tested at 3% 
deficiency in intraductal and invasive cancer, progressing to 8% deficiency in metastatic invasive tumors, 
to 20% deficiency in a metastasis to the neck (87). Examination of ovarian tumors demonstrated an even 
greater decline in queuosine levels; 12% deficiencies is stage I cancers, progressing to 37% in stage III, and 
finally to 63% queuosine hypomodification in stage IV and metastatic ovarian cancer (42). Additionally, 
brain tumor biopsies were tested for their queuosine modification levels and demonstrated a similar trend 
of292%  deficiency in meningiomas progressing to 66.9% in metastatic astrocytomas (43). While 
diagnostic procedures have been developed based on queuosine deficiencies in Ieukemias and lymphomas 
(40), lung cancers (41), and ovarian tumors (42), it is still not known if the breakdown of a single 
component or multiple steps of the queuosine modification system are the cause of the deficiencies. In 
fact, only one published report regarding the examination of the incorporation step in a neoplastic human 
cell-line has yet come to light
Studies characterizing the queuosine modification system have been performed in “normal” 
human cell culture experiments and with enzymes isolated from “normal” mammalian liver tissues.
Chapter 3 of this treatise describes the three components of the queuosine modification system; 
transmembrane uptake o f  the queuine base, cytoplasmic incorporation of this base into tRNA to form the 
queuosine modification, and salvage of the base from the tRNA turnover product queuosine-5’- 
monophosphate (QSP). Chapter 4 provides evidence in “normal” cells that the rates of both the uptake and 
incorporation steps of the queuosine modification system are increased by protein kinase C (PKC)- 
cataiyzed phosphorylation, while it appears that salvage is only minimally effected by PKC, if at all. Thus, 
the mammalian queuosine modification system has been relatively well described in “normal” fibroblast 
cells and other mammalian tissues, however the individual components of this system have yet to be
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substantially studied in abnormal cells.
The studies presented in this chapter attempt to identify the malfunctioning sites of the queuosine 
modification system in two human adenocarcinoma cell-lines. As with many cancers, the human colon 
adenocarcinoma (HxGC3) and human breast adenocarcinoma (MCF-7) cell-lines are both significantly 
deficient in queuosine modification levels. The HxGC, cell-line is completely unmodified with respect to 
this particular modification, while the MCF-7 cell-line is greatly diminished in it’s population of 
queuosine-modified tRNAs (SO to 60% deficient). Parallel in vivo uptake, incorporation, salvage, and 
modulation assays were performed on the colon and breast adenocarcinoma cell-lines and with human 
foreskin fibroblasts (HFF) as a “normal” reference. Comparisons between the results of the “normal” 
fibroblast cultures and those o f the cancerous cell-lines were made in an attempt to determine the site or 
sites of the deficiency within the established components of the queuosine modification system.
These results can be used to explain the observed queuosine hypomodified levels found in these 
cultures. They can also be used to suggest sites for deficiencies in other known queuosine deficient tumors 
and cell-lines, as well as whether a multiple-site deficiency scheme is necessary to cause the substantial 
queuosine modification loss that is often seen in progressive neoplasia. Finally, results of the in vivo assay 
methods will likely give an indication if the cell culture methods utilized in this treatise are a viable and 
realistic model system for future basic and clinical studies.
Description o f the HxGCj Human Colon Adenocarcinoma Cell-line
In 1978, the HxGQ cell-line was derived from a biopsy of a 61 year old male suffering from 
colon polyps. The diagnosis o f this cancer was described as a poorly-differentiated adenocarcinoma o f the 
transverse colon. The cells were maintained as xenografts in male immune-deprived CBA/lac mice and 
eventually a cultured cell-line was established (14S). In a 1986 article describing phorbol ester modulation 
of queuine uptake in diploid human fibroblasts, several transformed cell-lines, including the HxGC3 cells, 
were analyzed for queuine uptake kinetics and their responsiveness to phorbol ester-induced inhibition of 
uptake (80). In experiments similar to the in vivo uptake assays described in Chapters 3 of this work, the 
HxGC3 cells were shown to exhibit biphasic kinetics for their uptake mechanism in a similar pattern similar 
to that observed for the “normal” fibroblast cultures. The low KM for the HxGC3 cells was determined to 
be 40 ± 2 nM which is similar to 30 ± 4 nM for the fibroblasts, while the high KM was determined to be 
440 ± 60 nM corresponding to 350 ± 150 nM for the fibroblast cultures.
In 1992, the same laboratory examined the HxGC3 cell-line for it’s ability to produce queuosine- 
modified tRNAs using an indirect RPC-5 medium pressure liquid chromatographic method for the 
quantification of queuosine-negative and queuosine-containing tRNAs (87). It was discovered that these 
cultures were dramatically deficient in queuosine-modified tRNA. However, if the cells were exposed in 
vivo to a treatment of the DNA demethylating agent 5-azacytidine (5-azaC), a small peak appeared at the 
same retention time as queuosine-modified tRNA. Since the uptake mechanism for queuine in the HxGC3
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cells appeared to be normal, it was suggested that a defect in the incorporation or salvage components of 
the queuosine modification system might be present. Additionally, it was proposed that the 5-azaC 
treatment might be inducing the gene expression o f an important protein in one o f these two systems.
Activity of the HxGC3 queuine incorporation enzyme was measured after partial purification by 
cell lysis, homogenization, centrifugation, separation on a DEAE-cellulose column, and simultaneous 
concentration and desalting of the active fractions with a microconcentrator (87). Finally, an in vitro assay 
was performed on the concentrate in order to measure it’s ability to incorporate tritiated-dihydroqueuine 
into bulk yeast tRNA. The HxGCj cell-line was not shown to contain the queuine incorporation activity, 
nor did the addition of HXGC3 cell lysate to functional HL-60 TGRase preparations influence this activity. 
Thus, it was inferred that the HxGCj cell-line contained no functional queuine incorporation enzyme. Any 
in vitro assays that may have been performed on S-azaC treated cell homogenates were not mentioned.
The salvage mechanism for Q5P was studied in a different method from that of the queuine 
incorporation enzyme. The HxGCj cells were lysed and centrifuged. The samples were added to an in 
vitro assay that measured the ability of the lysate to catalyze the formation of free tritiated dihydroqueuine 
base from tritiated Q5P. There was concern that phosphatase contamination of the lysate would produce an 
inactive queuosine substrate from the QSP in a competing reaction with the salvage enzyme. Therefore, 
sodium fluoride or a,P-methylene-ADP were added to the reaction mixtures to prevent dephosphorylation 
of the QSP substrate. However, this also reduced the reaction to a semi-quantitative method due to the 
partial inhibition of the salvage mechanism by these compounds. After the completion of the reaction, the 
mixture was separated by CIS high pressure liquid chromatography to detect the presence of tritiated QSP, 
queuosine or queuine. A mouse liver homogenate was prepared to serve as a salvage standard and the 
results of the HXGC3 lysate reaction were determined as a percentage of the mouse liver salvage. The 
HxGC3 cell-line was significantly deficient in both tRNA“p and tRNA1”  levels and exhibited 18% 
efficiency in queuine salvage.
Since this cell-line was shown to be entirely deficient in queuosine and also to contain no 
observable queuine incorporation activity, it was proposed that the incorporation step of the queuosine 
modification system was malfunctioning in the HxGC3 cells. The low efficiency of salvage, therefore, 
would not be a major player in the low queuosine modification levels because the maintenance of 
intracellular queuine concentrations would not be able to induce the queuosine synthesis to occur without 
the presence of a functional queuine incorporation enzyme. Since in vivo 5-azaC treatment of the cells 
produced measurable queuosine-modified tRNA levels, it was also suggested that the incorporation was the 
component likely effected by S-azaC induced DNA demethylation and induction o f gene expression.
These studies, with the exception of the HXGC3 in vivo uptake assays, were not utilizing methods 
developed to measure the queuosine modification system components under near physiological conditions. 
The assay methods described in this treatise in chapters 2 and 3 may be a better model to examine these 
mechanisms. The in vivo techniques for assaying uptake, incorporation, salvage, and the PKC-modulated
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steps are used to verify that the uptake mechanism is similar to that of “normal” fibroblasts. Additionally, 
these methods will be used to demonstrate that the incorporation mechanism is compromised in the HxGC3 
cells and is the mechanism that is directly effected by the 5-azaC treatment. In vivo salvage assays were 
not performed in these cells. This decision was made based on the futility of the in vivo method for 
measuring the salvage efficiency of cells which cannot create the modification, nor modify the tRNA at 
easily measurable levels even when induced by 5-azaC treatment.
Description o f the MCF-7 Human Breast Adenocarcinoma Cell-line
The MCF-7 cell-line was derived from a pleural effusion excised from a 72 year old female that 
had previously undergone a radical mastectomy for malignant mammary adenocarcinoma (146). The cells 
were cultured into a stable cell-line and retained several differentiated characteristics of the mammary 
epithelium including the ability to express the cytoplasmic estrogen receptor and the capability of forming 
domes. The cell-line, at passage 138, was donated to the American Type Culture Collection by C.M. 
McGrath in April 1982. Since this time, the MCF-7 cell-line has become a well established standard for in 
vivo studies of estrogen receptor function and multidrug resistance development. Thus, while existing in 
many labs it has also been utilized for other studies as an example o f a human transformed cell-line, and 
more specifically as an estrogen-dependent human breast adenocarcinoma model.
No known queuosine modification system studies have yet been performed using the MCF-7 cell- 
line. Since it is a well known and well studied example of neoplasia, it was selected for study as another 
transformed cell-line for contrast to or comparison with the HxGC3 cell-line. The in vivo techniques for 
assaying uptake, incorporation, salvage, and PKC-modulated activity of the first two steps are utilized to 
describe and assess the three components of the queuosine modification system in these cells. The MCF-7 
cell-line has been determined to be 50% to 60% undermodified with respect to queuosine (data not shown). 
The results of experimentation, described in this chapter, will be used to decipher the source of this 
deficiency as compared with results of “normal” human fibroblast cultured cells.
Results
Uptake o f Queuine
The HxGC3 and MCF-7 cell-lines exhibit rQT3 uptake rates and levels that are comparable to that 
observed in normal HFF cells (Graph 5-1). Both neoplastic cultures tested demonstrate linear uptake of the 
radiolabeled queuine analogue through 60 minutes and plateau at approximately 120 minutes. In addition, 
the maximal quantities of rQT3 taken up by the three cell-lines are all very close in range (7.4 to 7.8 
pmol/10s cells). 5-azaC-treated HxGC, cells were also assayed for the ability to take up the rQT3 and were 
shown to exhibit the same uptake profile as the untreated HxGC3 cell cultures. This culture set was studied 
to ensure that any incorporation differences observed in this cell-line were due solely to the incorporation
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step and not due to uptake insufficiencies.
Incorporation o f Queuine into tRNA
It has been reported the HxGC3 cell-line is deficient in the levels of queuosine-modified tRNA due 
to transcriptional deactivation of a component of the queuosine modification system (87). In these in vivo 
studies, despite the proper functioning o f the queuine uptake step, direct tune-course incorporation assays 
show only background levels of incorporated rQT3 in HXGC3 cells even after 24 hours of exposure to this 
queuine analogue (Graph 5-2). Treatment o f these cells with the DNA methylase inhibitor and 
transcriptional activator 5-azaC does not appear to effect the uptake of rQT3, however incorporation of 
rQT3 into tRNA is distinguishable above the background as early as six hours after exposure to the rQT3. 
The level of tQT3-modified tRNA elevates to 4.5-fold background levels at 12 hours, and continues to rise 
through 24 hours. This pattern is in contrast to the HFF cell-line’s incorporation profile which is linear 
through nine hours and plateaus at twelve. The level o f queuosine modification in the HxGC3 cultures is 5- 
fold lower than the incorporation levels in the HFF cells at 24 hours, nonetheless it remains significantly 
above that of the background.
In contrast to the HxGC3 cell-line, MCF-7 cultures exhibited no deficiency in queuine 
incorporation activity. Incorporation of rQT3 in MCF-7 cells is linear to 6 hours and plateaus at 12 hours. 
This is very similar to the profile of HFF culture incorporation assay. Maximal incorporation levels of 
rQT3 in these two cell-lines are also similar.
Modulation o f Uptake and Incorporation by PKC-catatyzed Phosphorylation
In the rQT3 uptake studies both neoplastic cell-lines exhibited sensitivity to modulators of PKC 
activity and inhibitors of protein phosphatase activity and to a similar extent as the “normal” HFF cells 
(Graph 5-3). However, exposure to phosphorylation modulators produced results for the rQT3 
incorporation step that were comparable in only MCF-7 and HFF cell-lines. Even after 5-azaC-induction 
of the queuine incorporation system in the HxGCj cell-line, the incorporation of rQT3 does not appear to be 
effected by exposure to the PKC or phosphatase modulators (Graph 5-4). It is proposed that the absence of 
regulation is due to the 5-azaC-induced synthesis of only the smaller catalytic subunit and not the larger 
regulatory subunit that makes up the “normal” tRNArguanine ribosyltransferase dimer.
Queuine Salvage
The queuine salvage mechanism of the HxGC3 cell-line was not studied due to the requirement of 
the cell culture assay method to measure the salvage of queuine via maintenance of the level of 
incorporated nucleotidyl base. Previous reports, however, suggest that the queuosine-deficient HxGC3 
cells maintain a poor queuine salvage efficiency of 18% (17,31).













Graph 5-1. Time-Courses o f Queuine Uptake in Human Foreskin Fibroblast (HFF), Colon 
AdenocarcinomafHxGCi), 5-azaCytidine-TreatedHxGCp and Breast Adenocarcinoma(MCF-7) Cell- 
Lines. These cell-lines were grown to near confluence, then 100 nM rQT3 (a tri-tritiatedqueuine 
analogue) was added at time 0, and uptake assays performed. The amount of radioactivity taken up into 
the cells was measured at 0,0.5,1,1.5,2,2.5,3, and 6 hours. The values were normalized to the 
number of picomoles of rQT3 per 10s cells. Deviation bars indicated representthe standard deviation 
with n =6.
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Graph 5-2. Time-CoursesofQueuine Incorporation into tRNA o f Human Foreskin Fibroblast (HFF), Colon 
A denocarcinoma (HxGC]), 5-azaCytidine-TreatedHxGCj, and Breast Adenocarcinoma(MCF-7) Cell-Lines. 
These ceil-lines were grown to near confluence, then 100 nM rQT3 (a tri-tritiatedqueuine analogue) was 
added at time 0, and incorporation assays performed. The amount of radioactivity inserted into tRNA was 
measured at 0 ,3 ,6,9 ,12 and 24 hours. The values were normalized to the number of picomolesof rQT3 per 
I05 cells. Deviationbars indicated represent the standard deviation with n =6.
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Graph 5-3. The Effect o f Exposure to a Protein Kinase C Activator (TPA), Inhibitor (Staurosporine), and 
Phosphatase Inhibitor (Okadaic Acid) as Compared to UntreatedCultures on Queuine Uptake in Human 
Foreskin Fibroblast (HFF), Colon Adenocarcinoma (HxGCi), S-azaCytidine-TreatedHxGCj, and Breast 
Adenocarcinoma(MCF-7) Cell-Lines. These cell-lines were grown according to methods. Then, rQT3 (a tri- 
tritiated queuine analogue) was added at time 0, and uptake assays performed. Uptake assays were measured 
at 3 hours. The amount of radioactivity taken up into ceils was measured by liquid scintillation. The values 
were normalized to the number of picomoles of rQT3 per 105 cells. Deviationbars indicate the standard 
deviation with n = 6.
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Graph 5-4. The Effect o f Exposure to a Protein Kinase C Activator (TPA), Inhibitor (Staurosporine), and 
Phosphatase Inhibitor (Okadaic Acid) as Comparedto Untreated Cultures on Queuine Incorporation into 
tRNA o f Human Foreskin Fibroblast (HFF), Colon Adenocarcinoma(HxGCj), 5-azaCytidine-TreatedHxGCp 
and Breast Adenocarcinoma(MCF~7) Cell-Lines. These cell-lines were grown according to methods. Then, 
rQT] (a tri-tritiatedqueuine analogue) was added at time 0, and incorporationassays performed. The 
incorporation assays were stopped at 8 hours. The amount of radioactivity inserted into tRNA was measured 
by liquid scintillation. The values were normalized to the number of picomoles of rQT3 per 10s cells. 
Deviation bars indicate the standard deviation with n = 6.
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tRNA-tumover baselines measured for MCF-7 and HFF cells showed slightly faster degradation 
rates for the tRNA of the neoplastic cell-line, and the MCF-7 cell-line was observed to have a slightly 
faster growth rate over the four days o f the experimentation. However, the values are still reasonably close 
(Graph 5-5). In these studies the HFF cells are able to retain nearly 100% of incorporated rQT3 for up to 
four days with one day to over a week o f  queuine starvation, with only a small decline in rQT3 retention 
after three weeks of starvation. In contrast to queuine salvage in the “normal” cells, the MCF-7 cell-line 
exhibits virtually no latent salvage capability. At only one day of queuine starvation, these cells show a 
similar turnover pattern of rQT3-modified tRNA retention with and without a non-radioactive queuine 
chaser. After one week of queuine starvation approximately 50% salvage of rQT3 is evident Three week 
queuine starvation dropped rQT3 maintenance levels to that of just above background.
Discussion
Due to the multistep process o f the queuosine modification system, this research attempts to 
investigate four critical aspects to it’s proper functioning. Studies were undertaken to address whether the 
malfunctions of the queuosine modification system in HxGC3 and MCF-7 neoplastic cell-lines were due to 
lack of adequate uptake, incorporation ability, salvage capability or to aberrant PKC-catalyzed modulation 
of uptake or incorporation. Experiments involved experimental and control cultures o f each cell-line in 
order to diffuse arguments regarding the modification differences of varying cell types (fibroblasts, and 
colon and breast adenocarcinomas). Comparisons of “normal” (HFF cells) and neoplastic (HXGC3 and 
MCF-7 cell-lines) cells were performed verifying that the characteristic hypomodification observed in 
cancer cells (45) occurs in these cultures. Additionally, an investigation of each step o f the queuosine 
modification system was executed to determine the site or sites for malfunction of this system in the two 
representative tumor cell-lines.
There appears to be no abnormality in the uptake mechanisms of either of the two neoplastic cell- 
lines which could create the queuosine deficiency observed in the cultures.
Results of the HxGC3 cell-line incorporation studies directly support the hypothesis that there is 
no incorporation of queuine into tRNA in these cells, and confirms that this is due to the lack of a cellular 
TGRase activity. This result verifies the presence of 5-azaC-induced incorporation o f queuine in the 
HxGC3 cell-line that had been previously seen only indirectly by RPC-5 liquid chromatography and is 
much stronger evidence for the theory that the HxGCj cell-line is deficient in the queuosine modification 
due to a null mutation in the functional alleles for the TGRase protein. Malfunction o f the incorporation 
step in the queuosine modification system is not the cause for the observed MCF-7 queuosine deficiency.
“Normal” HFF cells have been shown to contain a dual-modulation scheme for both the uptake 
and incorporation of queuine (Chapter 4, (126,147)). These two components of the queuosine modification 
system have been shown to be directly activated by PKC. In contrast, protein phosphatases are able to 
reverse this process by removing the phosphate group and thereby inhibiting both systems. Purified
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Graph 5-5. Comparison o f Queuine Salvage in "Normal" Human Fibroblasts and Mammary Adenocarcinoma Cell Cultures, Cultures of human fibroblast 
(HFF) or breast adenocarcinoma (MCF-7) cells were grown to near confluence in normal media, fed with charcoal-stripped serum (lacking queuine) for I day, I 
week, or 3 weeks with regular media changes, then submitted to an in vivo queuine salvage assay. A dose of 100 nM tritritiated analogue of queuine (rQT3) was 
placed in the media 24 hours before the start of the assay to saturate the tRNA with the radiolabeled base. For each cell-type, two sets of parallel cultures were 
established. At time zero extracellular rQT3 was washed away, then a media change with charcoal-stripped media was performed. One set of cultures was 
exposed to 0.10 A26o units of unlabeled queuine (solid line) to provide an indication of the tRNA turnover rate within those cells. No queuine was added to the 
other set of cultures (dashed line) which represents the ability of the cells to retain the radiolabel in the cell’s tRNA despite the degredation processes involved in 
normal tRNA turnover. The counts per minute values obtained via liquid scintillation were normalized to the number of pmol rQT} contained within the acid- 
precipitable fraction of the I05 cells that had been devoid of queuine for 1 day, 1 week or 3 weeks. Deviation bars indicated represent the standard deviation 
with n =4.
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mammalian queuine incorporation enzymes from mouse, rat, cow, and human liver tissues have been 
isolated and shown to exist in a dimeric form with a regulatory and a catalytic subunit (Chapter 3 
(125,126)). In order to determine if similar regulation schemes are functional in the neoplastic cell-lines, in 
vivo uptake and incorporation assays were performed with cells exposed to a PKC activator (TPA), a PKC 
inhibitor (staurosporine), and a protein phosphatase inhibitor (okadaic acid) in concentrations most specific 
for modulation o f these cellular PKC and phosphatase enzymes. The response o f the queuine uptake 
mechanisms in both HxGC] and MCF-7 cell-lines when exposed to these modulators was comparable to 
that of the “normal” HFF cultures. In studies of the incorporation step of 5-azaC-treated of HxGC] cells, 
however, the induced queuine incorporation activity effected by exposure to PKC or phosphatase 
modulators. This may be due to the transcriptional activation of only the mRNA for the active subunit of 
the enzyme. The MCF-7 cell-line, however, exhibited a comparable response to the “normal” HFF cell- 
line upon exposure to phosphorylation modulators.
While it was reported that the HxGCj cell-line maintains a level of only 18% salvage activity 
(17,31), it was not possible to measure the levels using the in vivo assay method employed in these studies. 
However, queuine salvage studies demonstrated a distinct deficiency in the salvage ability of the MCF-7 
cell-line. With no latent salvage activity to only mildly inducible salvage activity available to the cells, a 
deficiency in the concentration o f the queuine substrate for the incorporation step could arise. If either a 
decrease in the availability o f dietary queuine or an increase in cell division rate were to occur, these cells 
would not be able to sustain high levels of queuosine-modified tRNA by salvage o f the queuine base alone. 
The lack of an efficient salvage mechanism in the MCF-7 cell-line could help to explain the relatively 
moderate level of queuosine deficiency (50 to 60%) exhibited as compared with the HxGC] cells (100%) 
which exhibit no queuine incorporation activity.
The results of this research suggest that the deficiencies of the queuosine-modified tRNA 
population found in cancer cells, such as the HxGC] and MCF-7 ceils used in this study, may arise from 
the malfunction of any of a number o f steps. Due to the known importance of PKC in tumor biology and 
existence of defects of this enzyme in several neoplastic systems (85), it is also likely that ineffective 
phosphorylation-based modulation o f the uptake and incorporation systems of other tumor cell-lines might 
also be a cause for observed queuosine hypomodification levels. However, two specific and distinct sites 
for queuosine modification system breakdown have been identified in this study. The HxGC3 cell-line is 
an example of a cell-type containing a transcriptional inability to produce the queuine incorporation 
enzyme that is required to create this modification (Figure 5-1), while the MCF-7 cell-line is an example of 
the disruptive effect of an inefficient queuine salvage mechanism (Figure 5-2).
In addition to the identification of the multifocal nature of the queuosine modification system and 
it’s malfunction, the identification of the etiology for queuosine deficiency has suggested three potential 
benefits for this knowledge. First, biopsied tumors that are identified as containing contrasting sites for 
queuosine modification system deficiency may be ruled out as a metastatic byproduct of a primary mass.
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In addition, sites for potential chemotherapeutic treatments concerning queuine (if developed) can be more 
explicitly targeted to the specific neoplastic cells of a patient. Finally, a human cell-line with a null genetic 
mutation for a major component o f the queuosine modification system has been found-the HxGC3 cell- 
line. This appears to mimic the situation seen in only the yeast organism where the queuosine modification 
does not exist (10). The discovery o f a mammalian cell-line that does not contain a functional queuine 
incorporation enzyme provides a good subject for gene expression studies that allow for the experimental 
investigation of the effect of the queuosine modification on cells in general, and especially in determining 
the importance o f the observed queuosine hypomodification in human neoplastic cells.
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Figure 5-1. The Eukaryotic Queuosine Modification System in HxGCj Human Colon Adenocarcinoma Cells. The eukaryotic system is based on usage of an
available resource and is regulated by the direct action of protein kinase C (PKC) on both uptake and incorporation steps as described in Figure 4-3. In HxGCj
cells, which contain no queuosine in their tRNA, the incorporation step appears to be entirely deficient. Despite a very weak ability to salvage incorporated
queuine from degraded tRNA, these cells lack the ability to synthesize the modified nucleoside in any capacity. Treatment with the DNA methylase inhibitor 5-
azacytidine for 24 hours induces a weak but measurable induction of tRNAiguanine ribosyltransferase (TGRase) activity in these cells and provides evidence of
the formation of queuosine-modified tRNAs. This induced activity, however, is not susceptible to stimulation by PKC. Thus, it is suggested that at least one

































Figure 5-2. The Eukaryotic Queuosine Modification System in MCF-7 Human Breast Adenocarcinoma Cells. The eukaryotic system is based on usage of an 
available resource and is regulated by the direct action of protein kinase C (PKC) on both uptake and incorporation steps as described in Figure 4-3. In MCF-7 
cells, which contain a significant deficiency of 50-60% queuosine in their tRNA, the salvage step appears to be deficient. Despite the ability to take up queuine 
from the surrounding environment and incorporate it into tRNA, these cells show a pronounced inability to salvage the modified nucleoside. Latent salvage 
activity does not occur in these cells with only one day of queuine starvation. In addition, strong induction of the salvage mechanism by queuine starvation for 
one week, which is seen in “normal” human fibroblasts, appears to be compromised in these cells (approximately 50% effective). After three weeks of queuine 
starvation the ability to salvage queuine from tRNA is completely lacking. Thus, despite the ability to take up exogenous queuine and incorporate it into tRNA, 
reduced salvage efficiency predisposes these cells to significant queuosine deficiencies in a shortage of exogenous supply or under fast growing conditions. o
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CHAPTER SIX 
EFFECTS OF THE QUEUOSINE MODIFICATION SYSTEM 
ON THE STRUCTURE AND FUNCTION OF tRNA
Introduction
Queuosine is a modified nucleoside found in position 34 (the wobble position) o f the anticodon 
hairpin loop of tRNA“p, tRNA*” , tRNA1” , and tRNA^in every organism yet studied with the sole 
exception of yeast (10,11). Chapters 3 and 4 o f this treatise folly describe the mechanism and regulation of 
the queuosine modification system in human systems. The control o f this system by protein kinase C- 
catalyzed phosphorylation allows the formation o f queuosine to be coordinated with other cellular 
processes that control the life cycle of a cell. The aberrant functioning of the queuosine modification 
system is directly correlated with neoplastic transformation and metastatic progression of abnormal cell 
lines. Chapter S describes a series of assays used to determine the exact point at which the system failure 
occurred in two cancer cell-lines. However, despite the understanding of the normal cellular dynamics of 
the queuosine modification, there is still relatively little subcellular knowledge regarding the function of 
this modified nucleoside within a tRNA.
Modifications of RNAs have been shown to have a strong influence on the alteration of steric and 
electrostatic properties of these important molecules. Aspects o f RNA structural stabilization and of 
anticodon hydrogen bonding potentials are crucial components for tRNA function. Weiss proposed that a 
mispairing of the anticodon wobble base could dramatically effect the binding kinetics o f the tRNA to it’s 
mRNA codon—which, he suggested, has the potential to regulate the rate of translation (148). Grosjean, 
Houssier & Cedregen have demonstrated the presence of different conformers of anticodon regions (i.e. 
flexibility) in temperature-jump relaxation experiments due to the presence of altered binding kinetics for 
queuosine versus guanosine-containing tRNAs (149). It was further proposed that the formation of the 
queuosine nucleoside is involved in “a mechanism of translational control (coordinated modulation) 
relying on the interdependence of metabolic pathways, modified nucleotide synthesis and codon usage...”.
The crystal structure of the S’-monophosphoryl-queuosine nucleotide indicates the likely presence 
of a hydrogen bond between the aminomethyl group of the modification’s side-chain and the 06 of the 
purine ring structure (13). This intramolecular association may have a role in altering the hydrogen bond 
accepting ability of this position in tRNA. Additionally, the anticodon loop is the most flexible region of 
the tRNA molecule, with the most variable configuration adjacent to the site of the queuosine-modification 
at the phosphoryl linkage between residues 33 and 34 (ISO). Thus, it is likely that the effect of a modified 
wobble base (position 34) on the function of tRNA would be influenced by alteration of either electrostatic 
or steric properties of the anticodon based on the mobility of residues in the anticodon loop. In view of the 
extended multi-fonctional group structure of queuosine and its location in the wobble position of tRNA, it
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is likely that this modified nucleoside plays a significant role in the decoding properties of tRNA through 
adjustment of the molecular dynamics of the anticodon or anticodon loop structures.
The structural stability of RNA loops have been shown to be influenced by changes in the 
nucleoside sequence of the molecule. Singh and (tollman have recendy studied the relative mobility of 
RNA hairpin loop residues based on thermodynamic properties of a molecule before and after the 
introduction of a point mutation (151). Their calculations indicated that a simple C to U point mutation in 
the RNA loop was capable o f dramatically increasing the flexibility of the loop by dissolution of an 
intramolecular (cross-loop) hydrogen bond.
The alteration of nucleosides by modification in tRNA also plays a significant role in the 
structural dynamics o f RNA stem/loop structures. Due to steric hindrance o f functional groups, 2’0  ribose 
methylation and base thiolation o f non-anticodon residues have been shown to cause the shift of ribose 
puckering toward the C3’-endo conformation which stabilizes base stacking interactions throughout 
neighboring residues (152). These modifications enhance the structural stabilization of the anticodon while 
influencing proper codon recognition and preventing misreading of non-cognate codons (152). Recently, 
an alternative ribose puckering conformation (C2’-endo) was shown to be induced by the presence of 
dihydrouracil (153). In addition to this modified base’s non-aromatic nature, the promotion o f the different 
ribose configuration caused a disruption of base-stacking interactions within the RNA molecule. This 
causes increased regional flexibility which is important in the hinge region o f the tRNA molecule.
An increase in the strength o f base-stacking interactions (154) and the formation of extended 
hydrogen bonding networks was shown to be promoted by the presence of the anticodon loop 
pseudouridine nucleotide (155). Both of these factors caused an increase in the rigidity of the entire 
anticodon. Thus, modification of RNA primary transcripts has been shown to be involved with the overall 
structural dynamics of the molecule through the modulation of hairpin loop stability. Due to the extended 
multi-functional group structure of the queuosine modification, this wobble base may play a role in RNA 
loop stabilization based on potential extended intra-anticodon loop interactions.
It has been suggested, due to the size of a few large modified nucleosides in the anticodon loops 
of various tRNA molecules, that some modified bases have the potential to sterically interact with a 
neighboring tRNA anticodon loop in aminoacyl-/peptidyl-site tRNA interactions (112). The lack of the 
normal wyebutine modification at position 37 of tRNA1** molecules, a tricyclic purine analogue with a 
large branched side-cbain, has been suggested to increase the speed of translation around UUU and UUC 
phenylalanine codons, while the folly modified tRNA exerts unspecified restrictive codon context effects 
(156). Experimental evidence supporting context effects exerted by the queuosine modification has been 
reported in studies demonstrating the ability of unmodified (guanosine-containing) form of tRNA1*7 to 
read-through UAG stop codons (157,158). Queuosine-modified tRNA'5'1 do not appear to possess this 
amber suppression capability. Additional codon context effects have been proposed for both queuosine- 
modified tRNA*“  and wyebutine-modified tRNAphe in frameshifting events essential to the translation of
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gag-pol gene products of human immunodeficiency virus (HIV), human T-cell leukemia virus (type I) 
(HTLV-l), and bovine leukemia virus (BLV) (159). It was demonstrated that absence of the queuosine 
modification in tRNA*”  enhanced the ribosomal frameshiftmg around an AAC codon at the shift signal in 
HTLV-l and BLV. Wyebutine-deficiency in tRNAphc enhanced frameshiftmg at a UUU codon 
fiameshifting signal in HIV. These fiameshifting events are essential to the production of gag-pol products 
for these viruses, and codon context effects exerted by these two modified nucleotides appear to have 
important modulating effects in the efficiency o f the fiameshifting mechanism. Since neighboring tRNA 
loop interactions are plausible in the framework of adjacent ribosomal aminoacyl- and peptidyl-sites, and 
since bulky tRNA modifications, such as wyebutine and queuosine, could be positioned in immediate 
proximity with sequential UUPy and GAPy codons, it is conceivable that steric interference at these codon 
pairs (restrictive codon context) could be significant Thus, codon context-based steric restriction o f tRNA 
association by anticodon loop modified nucleosides could effect the translation efficiency of mRNAs for 
proteins based on the existence of specific codon pairs and the levels of modified-tRNAs.
The function of queuosine in the wobble position of the anticodon has also been investigated with 
regard to its decoding properties. Results of experimentation, which included the injection of drosophila 
tRNA1”  and turnip yellow mosaic coat protein mRNA into Xenopus oocytes, demonstrated that guanosine- 
containing tRNA11* has a strong preference for codon sequences of CAC over CAU. However, queuosine- 
modified tRNA1"* does not exhibit a preference for either histidine codon, indicating that queuosine 
eliminates codon bias between histidine codons in this system (160). Another study examined the effects 
of rabbit reticulocyte queuosine-modified tRNA1* on the decoding properties for histidine codons found in 
rabbit globin mRNA using a reticulocyte lysate translation system (161). The authors also demonstrated 
that the queuosine-modified tRNA1* has no preference for either U or C in the third position of the 
histidine codons. Grosjean, Houssier and Cedregen utilized temperature-jump relaxation experiments and 
verified that while guanosine-containing and queuosine-modified tRNAs are equally stable in complexes 
with NAU codons (162), guanosine-containing tRNAs are significantly more stable in complexation with 
NAC codons (149,163,164). Thus, it is suggested that the queuosine modification serves to alter the codon 
binding properties of tRNAs by reducing the C over U codon bias apparent with guanosine-containing 
tRNAs.
This study was initiated to explore the effects of queuosine on the decoding properties of the 
tRNA using computational chemistry approaches of molecular modeling, including molecular dynamics 
simulations. The experimentation was designed to study the intramolecular effects of the modification on 
the electrostatic and steric structure of the tRNA anticodon loop, as well as the effects of the modification 
on the complexation of tRNAs with a neighboring tRNA (codon context effects) or mRNA (codon bias 
effects).
Initially, nucleotide analysis was performed to assess the electrical potential of the hydrogen- 
bonding regions for guanosine and modified guanosine analogues, including queuosine. The method
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involved semi-empirical charge assignment and geometry optimization algorithms, with visualization of an 
electrical potential map on the electron density surface for each molecule. In addition, anticodon stem/loop 
analysis was performed on tRNA“p anticodon stem/loop structures modified or unmodified at position 34 
(the wobble position) in order to determine the effect of guanosine and guanosine analogues, particularly 
the queuosine modification, on the configuration and flexibility of the anticodon loop. This method 
involved the use of energy minimization techniques and extended molecular dynamics simulations.
Accordingly, macromolecular complex analysis was performed on a tertiary organization of 
tRNA“p anticodon stem/loop molecules, whole tRNA1** molecules, and a mRNA transcript in a 
configuration consistent with that associated at the aminoacyl- and peptidyl-sites o f a translating ribosome 
(107). Evidence of potential interaction between aminoacyl- and peptidyl-site tRNAs at the queuosine and 
wyebutine modifications of the anticodon loop were visually analyzed in order to determine the presence 
of a potential codon context phenomenon based on steric interaction. In addition, the A-site tRNA and 
mRNA association was analyzed to explore potential differences between queuosine-modified and 
guanosine-containing tRNA“p anticodon stem/loop structures with cognate GAC and GAU mRNA codons. 
Energy minimization and molecular dynamics simulations and energy calculation algorithms were used to 
determine relative tRNA anticodon/mRNA complex stabilities and evidence of preferred (biased) pairings.
Results and Discussion
Nucleotide analysis
Initially, structural analysis of guanosine (G) and the guanosine nucleoside analogues 7- 
deazaguanosine (7-deazaG), 7-aminomethy 1-7-deazaguanosine (7-am-7-deazaG), and queuosine (Q) 
(Figure 6-1) was studied using semi-empirical methods. AMI and PM3 charge assessment with geometry 
optimization was performed. Both MOPAC algorithms provided essentially the same values for 
electrostatic potential and for geometric arrangement of atoms. Since the PM3 method is more recent and 
appears to be more accurate when applied to nucleic acids with significant hydrogen bonding potential 
(165), the results of these calculations were used for further modeling.
Conformational search via simulated annealing was employed to determine reasonable 
conformations and differences in intermolecular associations and in the hydrogen bonding abilities of the 
three functional groups for nucleoside base-pairing of purine residues. After an extensive search, the 
quaternary amines of both the Q and 7-am-7-deazaG molecules appeared to be in reasonable positions for 
hydrogen bonding interactions with respective carbonyl oxygens at the C6 position (Figure 6-2). A 
hydrogen bond prediction algorithm built into the Sybyl software, which takes into account both distance 
and bond angle parameters, verified the likely presence of this interaction. This corroborates preliminary 
molecular dynamics simulations of the bases under gas phase, and under implicit and explicit solvation 
conditions, which indicated greater than 60% of the structures observed during the simulation were likely



















Figure 6*1. Modified Nucleoside Bases Studied in this Treatise. Guanine is the traditional base found at 
position 34 (wobble position) of tRNA*” , tRNA*sp, tRNA1*, and tRNA1̂ . Queuine, a guanine analogue, is 
a physiological modified nucleoside that replaces guanine in these sites in “normal” mature cells of every 
prokaryotic and eukaryotic organism with the exception of yeast (10). 7-deazaguanine and 7- 
aminomethyl-7-deazaguanine are intermediates in the formation of queuosine in prokarytoes. The three 
major structural differences between guanine and queuine involve position 7 of the base, the charged 
quartemary amine of the aminomethyl side-chain, and the cydopentenediol ring of the side chain. In these 
studies, the intermediates were included to serve as a control for the effects of each of these differences. 
Arrows indicate the position of n-giycosidic linkages to ribose.



















Figure 6-2. Skeletal Structures o f  Guanosine and  Us Analogues. Models are shown o f  guanosine (upper right), 7-deazaguanosine (upper left), 7-aminomethyl-7- 
deazaguanosine (lower right), and queuosine (lower left) after MOPAC 6,0 semi-empirical energy minimzation and geometry optimization, The orange arrows 




to contain parameters consistent with the presence of this hydrogen bond.
A study of the three sites for base pairing complexation (06, N1, and N2) was performed to assess 
the effect of the hydrogen bond between the 06 and the quaternary amine of the aminomethyl side chain. 
The MOLCAD-generated electron density surface plots of G and 7-deazaG exhibited identical electrical 
potential maps, with strong hydrogen donor sites at the N1 and N2 positions and a moderate hydrogen 
accepting site at the 06  (Figure 6-3). However, as a result of the intramolecular hydrogen bonding, the 06 
was observed to possess diminished electronegative character comparably in the Q and 7-am-7-deazaG 
molecules. This suggests a compromise of their Watson-Crick type hydrogen bond accepting status. 
Additionally, the relative strength of the electronegativity at the traditional hydrogen donating sites of the 
N1 and N2 in both these nucleotides appears to be reduced.
The results of the structural and charge studies performed for these molecules indicate the 
importance of the interaction between the quaternary amine and the 06 in the two molecules with the 
aminomethyl side chains. It appears that this intramolecular hydrogen bond alters the hydrogen 
donating/accepting profile of the base. Whereas the G and 7-deazaG appear to have a traditional (Watson- 
Crick type) ADD hydrogen bonding pattern, Q and 7-am-7-deazaG are suggested to have a DD pattern 
which may even be weaker in strength than the imino form of an adenosine. Of course, in biochemical and 
chemical systems, interactions such as hydrogen bonding are freely reversible. Therefore, both guanosine­
like and adenosine-like interactions are likely to be possible with Q and 7-am-7-deazaG.
The quaternary amine of the aminomethyl side chain, existing in both Q and 7-am-7-deazaG, 
provides an electrostatic difference manifesting itself in hydrogen bonding potential differences between 
these two nucleosides and G or 7-deazaG. However, the aminomethyl side chain is not likely to have any 
steric effect on the codon-anticodon interaction, since the configuration of the nucleotide appears to 
position this extension away from the site for base-pair hydrogen bonding-confirming results seen in the 
original crystal structure o f the Q nucleotide (13). Thus, the a possible codon bias effect is suggested based 
on differential electrical potential of tRNAs for wobble bases with and without the aminomethyl sidechain.
Anticodon Stem/Loop Analysis
Transfer RNA anticodon stem/loop structures with modifications of the wobble residue were 
analyzed using molecular dynamics simulation to determine differential intramolecular associations caused 
by the 7-deazaG, 7-am-7-deazaG, and Q bases. Unfortunately, due to computational limitations the 
addition of counterions and solvation to the system was not possible. In addition, a reasonably long length 
of simulation (up to ms) was also not possible. However, these preliminary studies were performed based 
on a qualitative method developed by Nilsson and Karplus on very different software and hardware 
computer systems for the anticodon stem-loop of tRNAphe (97). The data generated was validated by the 
duplication of the original study and a favorable comparison between the original and duplicated results for 
tRNAphc and the present study of tRNA*sp.



















Figure 6-3. Electrical Potential Surface Studies o f Guanosine and its Analogues, Electron density surfaces were generated for each nucleotide in 
observed in (Figure 6-2). An electrical potential map for each was generated and is displayed on the surfaces with a red color representing the 
strongest positive charge proton donor capacity and purple indicating the strongest negative charge (proton acceptor capacity).
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Using molecular dynamics simulations, molecular rigidity was assessed to determine queuosine’s 
effects on the overall flexibility of the anticodon loop: a region critical for the tRNA’s function as an 
adaptor for the mRNA codon. At 10 ps into the temperature plateau the RMS fluctuations o f kinetic versus 
total energy were calculated for the three modified and the G-containing stem/loop structures and were 
determined to be less than 2%. This indicated a stable simulation for data collection and analysis. Transfer 
RNA“P anticodon stem/loop molecules mutated to contain 7-am-7-deazaG and 7-deazaG produced 
minimization and dynamics results that were essentially identical to that observed for the G-containing 
tRNA. However, residue mobility and molecular flexibility differences were observed in the loop region 
of these molecules as compared with the Q-modified RNA loop.
The stem of the tRNA molecule from residue 26 through 31 and 39 through 44 maintains its base- 
pairing and A-helix structure throughout the simulation. The radius of gyration remains fairly constant, 
fluctuating from 9.85 to 1020 A for G-containing, 7-deazaG-modified, and 7-am-7-deazaG-modified 
tRNAasp molecules and 9.70 to 10.10 A for Q-modified tRNA*sp during the 15 ps to 55 ps time frame over 
the course of the simulation plateau, as compared to 10.6 to 10.9 A for tRNA1** in the original study (97). 
The helix does appear to condense slightly over the length o f the run and corresponds well to Nilsson and 
Karplus’ tRNA1** anticodon stem/loop data. The RMS deviation from starting positions over the 
simulation was 0.54 to 0.70 A on average for all G-containing, 7-deazaG-modified, and 7-am-7-deazaG 
tRNA*sp stem atoms, while 0.64 to 0.75 A for all Q-modified tRNA“p stem atoms. This parameter could 
not be compared with Nilsson and Karplus’ data because of the differences in available reference structures 
(initial dynamics structures (97) versus X-ray crystal coordinates) due to the limitations of the number of 
programmable steps in the software utilized. Overall, the stem structures of the molecules were well 
maintained with the only significant structural deviation at the ends (residues 26 and 44, and to a limited 
degree 27 and 43). This “end-effect” artifact was brought about by the artificial termination of the 
structure and was described by Nilsson and Karplus in the original work with the tRNA1** anticodon 
stem/loop (97). This artifact is a necessary but unfortunate side-effect of the structural truncation required 
for minimizing the computation time required for these complex calculations.
The resulting RMS differences in atomic positions o f the G-containing, 7-deazaG-modified, and 
7-am-7-deazaG-modified tRNAup anticodon stem/loop structures closely mimic that of truncated tRNA1** 
model (97) in comparisons of data at 5, 10 and 40 ps timepoints (data not shown). However, in the 
calculations of the Q-modified tRNA“p, the resulting RMS difference values are dramatically different in 
the movement of specific loop residues (residues 32 through 37). The variance in these nucleoside 
positions are far lower in intensity than that observed in either the G-containing, 7-deazaG-modified, or 7- 
am-7-deazaG-modified tRNA“p or the tRNA1** anticodon stem/loop structures (97). This suggests possible 
structural and electrostatic influences on intramolecular mobility in the anticodon loop caused by the 
queuosine residue.
During the molecular dynamics simulation, it was observed that the greatest fluctuation of residue
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positions of all tRNAup anticodon stem/loop molecules exists at residues 34 and 35 (Graph 6-1). The great 
flexibility at the wobble position and that of the middle anticodon residue (position 35) are important for 
the association of the anticodon/codon triplet interaction. The movement of each o f the anticodon bases is 
known to be influenced through direct covalent linkages as well as base-stacking interactions. In addition, 
the slowly decreasing mobility of residues through the anticodon bases (34,35, & 36), as compared with 
those of residues 33 and 32 at the 5’ side o f the anticodon, corroborates the long-held assumption 
concerning the role of base-stacking interactions in the global motility of the 3’ side o f the anticodon loop. 
However, it was observed that distinct differences exist in the mobility of several Q-modiffed loop residues 
as compared with those in the G-containing, 7-deazaG, or 7-am-7-deazaG-modified loops.
The magnitude of RMS fluctuation of the residue at the wobble position (34) is greatest in the 
case of G-containing, 7-deazaG-modified, and 7-am~7-deazaG-modified loops, but in the Q-modified loop 
this falls to a level below that o f residue 35 (Graph 6-1). The extent of fluctuation for residue 35 appears to 
be unchanged between the two anticodon stem/loop molecules, however the decrease in RMS fluctuations 
over the anticodon bases is terminated much more quickly in the Q-modified loop, indicating a great 
decline in mobility after residue 36 and before the queuosine wobble residue. Additionally, the sharp 
decrease of RMS fluctuations on the 5’ side of the wobble base at residues 33 and 32 is more dramatic in 
Q-modified tRNA with virtual immobility of base 32. These observations of differences in residue 
fluctuations and mobility can be explained by intramolecular hydrogen bond associations observed during 
the molecular dynamics simulation.
Visual inspection of the anticodon loop residues over the molecular dynamics simulation suggests 
that several potential intramolecular hydrogen bonding interactions influence the traditional base-stacking 
interactions of the anticodon nucleotides. In both G-containing and Q-modified anticodon loops, a 
hydrogen bond was observed between the N3 position of the uridine residue at position 33 (U33) and the 
backbone phosphate of the cytidine residue at 36 (C36) during the molecular dynamics simulation (Figure
6-4). Confirmation of this cross-loop hydrogen bond in the anticodon loop of guanosine-containing 
tRNA*sp was published after the completion of this research in a solvated system with counterions, and for 
a simulation running roughly 10-fold longer than this simulation by Auffinger and Westhof (99). 
Interestingly, the number of timepoints exhibiting the cross-loop U33 to C36 hydrogen bond in the Q- 
containing loop was 68%, while its presence in G-containing-, 7-deazaG-modified, and 7-am-7-deazaG- 
modified loops was less than 36%. The increased frequency of intramolecular hydrogen bonding 
interaction between these residues in the Q-modified anticodon loop may explain the decreased mobility 
(decline in slope) of the 3’ side of the loop (residues 37 and 38), as well as the previously discussed 5' side 
of the loop (residues 33 and 32).
On closer examination of the Q-modified tRNA<sp anticodon loop, it was observed that the 
hydroxyl groups of the cyclopentenediol ring were maintained in close proximity to the 3*0 and 2’OH of 
the backbone ribose of U33, as well as the phosphate of the Q residue at 34 (Q34). Further analysis
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Graph 6-1. Fluctuations o f Anticodon Loop Residue Positions During the Molecular Dynamics Simulations. The root mean square (RMS) fluctuation of the 
position of each nucleotide in the anticodon stem loop structure was determined using a molecular dynamics simulation. A tRNA“p anticodon loop containing 
guanosine in position 34 is represented by the graph on the left. A queuosine modified loop (position 34) is represented in the graph on the right. The 
flexibility of the entire anticodon region is greater in the guanosine-containing model than in the queuosine-modified anlicodon model, with positions 32, 34, 

















Figure 6*4. Queuosine Induced Stabilization of Anticodon Flexibility Through Hydrogen Bonding Networks. Representation of ribbon backbones with ball and 
stick nucleoside bases for anticodon residues 34,33, and 36 as well as the backbones of residues 33 and 36, a) The structure on the left depicts the queuosine 
modified tRNAasp anticodon loop (green), Queuosine (green base and orange side-chain) engages in several stabilizing hydrogen bonded interactions between 
its cyclopentendio) hydroxyl groups and the phosphoribosyl backbone of U33 (indicated by solid yellow arrows), These interactions promote the stability of the 
additional cross loop U33 to C36 hydrogen bond interaction (indicated by yellow arrow outline), b) The structure on the right depicts the guanosine-containing 
tRNAasp anticodon loop (blue). In this anticodon loop, there is no additional hydrogen bonding network observed due to the lack of the wobble base's 
cyclopentenediol ring on the side-chain. As a result the U33 to C36 cross loop hydrogen bond is less frequently observed during the molecular dynamics 




revealed that allowable hydrogen bonding parameters exist between the hydroxyl groups of the queuosine 
cyclopentenediol ring to the 3’0  during approximately 55% of the 55 ps simulation run and to the 2’OH 
for approximately 35% of the simulation run. Though it was initially proposed that these hydroxyl groups 
could interact with the phosphate group (13), in these studies the 3’0/2’0H associations were observed 
even more frequently than interactions with the phosphate group. In several instances, two or three of 
these hydrogen bonding associations (networks) formed simultaneously which would increase the stability 
of each interaction. In one example, the one hydroxyl group o f the cyclopentenediol ring was close enough 
to interact with both the 3’0  and the O of the phosphate simultaneously, with the other hydroxyl group 
interacting with the 2’OH. The presence of this hydrogen bonding network would explain the decreases in 
RMS fluctuation for the residues from 32 to 36, as these intramolecular bonds would greatly restrict the 
movement of these nucleotides.
The full structure of the Q modification appears to have great intramolecular influence on the 
flexibility of the andcodon loop. The intraresidue hydrogen bond between the quaternary amine and the 
06 o f queuosine, in addition to the potential electrostatic influences on base-pairing ability, appears to 
position the cyclopentenediol ring near the backbone of the anticodon loop between Q34 and U33. The 
presence of the dihydroxyl groups of the cyclopentenediol ring appears to be the major cause of this 
restriction of anticodon loop flexibility. Neither the 7-am-7-deazaG nor 7-deazaG residues contain the 
cyclopentenediol moiety nor comparable hydroxyl groups, and the modified anticodon loop forms of these 
bases show RMS fluctuation profiles virtually identical to that o f G-containing tRNA. The two hydroxyl 
groups of Q’s cyclopentenediol ring are then able to interact with the 3’0  and 2’OH of the U33 residue, 
and the O of the backbone phosphate of residue Q34. This effectively locks the flexibility of the 5’ side of 
the anticodon loop which is suggested to position the U33 in a more favorable conformation for it’s 
association with the backbone phosphate of C36. Thus, a proposed hydrogen bonding network is 
suggested to be stabilized by the queuosine modification; initially forming on the 5’ side of the anticodon 
between Q34 and U33, and across the loop with the interaction between U33 and C36 on the 3’ side of the 
loop. This network would likely produce the decreases in overall anticodon loop flexibility seen in these 
molecular dynamics simulations.
Since the completion of this work a report has been published of a significantly longer molecular 
dynamics simulation of the flexibility of the anticodon stem-loop of tRNA*9  containing guanosine in 
position 34 of the anticodon (99). In addition, the system was solvated and contained sodium counterions 
for the charges present in the phosphodiester backbone. The calculations were performed using the 
CHARMM force field (98) on a different computer system with different simulation software. However, 
the anticodon stem-loop structures, flexibility, and predicted presence of the cross-loop hydrogen bond 
were virtually identical to those shown here. The necessary design weaknesses o f the computational 
methods used in this experimentation (namely the length of simulation and lack of solvent and counterions) 
are acknowledged, but the results obtained are validated by this published report.
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Macromolecular Complex Analysis: Interaction o f A- and P-site tRNAs (Codon Context)
In an initial study of macromolecular associations, a 5’-GACUUU-3’ transcript was modeled with 
either an A-site Q-modified tRNA“p anticodon stem/loop region of tRNA*5** and P-site tRNA1*6 or A-site 
tRNAphe and A-site Q-modified tRNA*9  anticodon stem/loop region of tRNA*9. This was performed to 
assess any possible steric or electrostatic interaction between the anticodon loops and stems of side-by-side 
tRNAs on a translating mRNA (codon context). These tRNAs were chosen because they contain two o f 
the largest RNA nucleosides currently known—queuosine (Q) in tRNA“p and wyebutine (Y) in tRNApbe 
(Figure 6-5).
Observation of the two complexes indicates that there is no interaction between the anticodon 
stems of either o f the two orientations of tRNAs. As for possible anticodon loop interaction, with Q- 
modified tRNAasp in the A-site and Y-tRNAphe in the P-site, the terminal methyl of the side-chain acetyl of 
wyebutine comes closest to the hydrogen of the N2 amine of queuosine at approximately 6.9 A (Figure 6- 
6). This is too great a distance to suggest that steric hindrance might be exerted between these two tRNAs. 
With a relatively uncharged methyl group being a participant in any possible interaction, 6.9 A is also too 
great a distance to support any electrostatic interaction. A recent cryoelectron microscopic model of the 
ribosome (110,111) suggests that the sites for the placement of the A- and P-site tRNAs are “buried” within 
a fairly tight cavern, this is likely to exclude a great deal of water for hydration of even charged atoms. 
Finally, with the tRNAs in reversed orientation, Y-modified tRNAphe in the A-site and Q-modified tRNA“p 
in the P-site, the modified nucleotides are on opposite sides of the complex (Figure 6-6). This 
conformational model suggests that there is no potential for anticodon loop interaction in this 
configuration. These findings effectively eliminate the possibility of sterically or electrostatically-based 
restrictive codon context in A- and P-site:Q-Y interacting anticodon loop pahs.
A caveat must be included here, however. That we did not see anticodon stem or loop interaction 
in this computational modeling study does not preclude the fact that the interactions may occur in the 
“real” world. Our study is based on the best three dimensional model known at this time and our findings 
appear to be correct based on the predicted “kink” in the mRNA between the A- and P-site codons. This 
was predicted by Fuller and Hodgson in 1969 (166) and has been recently confirmed by the cryoelectron 
microscopy studies of Agrawai et al. (111). The mechanism for predicted codon context effects may then 
be answered by the possibility o f interactions based on the proximity of aminoacyl acceptor ends, DHU 
loops, or even specific variable loops (167) o f A- and P-site tRNAs. Additionally, recent cross-linking 
studies with ribosomal components have suggested a strong potential for rRNA interactions to influence 
the stability of tRNA/mRNA complexes by direct interaction with the wobble base of A-site tRNA (168). 
Thus, the previous codon context observations may be explained by rRNA/tRNA interactions which were 
not under investigation in this study.
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Figure 6-5. Structures o f Hypermodified Nucleotidyl Bases: Queuosine and Wybutine. These two 
modified nucleosides are currently the largest ones that have been identified in any nucleic acid. The 
wybutine base (often designated Y) is found in all organisms next to the anticodon of tRNAphc in position 
37. The queuine base (Q) is found in the wobble position (34) of tRNA*” , tRNA*sp, tRNAh“, and tRNA1̂  
in all organisms except for yeast.



















Figure 6-5. Interaction Between Anlicodon Loops Complexed with mRNA on Ribosomes, a) Shows the ternary complex o f  queuosine-modified (Q34) tRNA*5'1 
(green) in the A-site adjacent to a wyebutine-modified (Y37) tRNAPhe (blue) in the P-site o f  a  ribosome complexed to apair o f  cognate codons in a hexameric 
mRNA (red), b) Shows the reverse orientation o f  wyebutine-modified (Y37) tRNAi*® (blue) in the A-site adjacent to a queuosine-modified (Q34) tRNA"P 
(green) in the P-site o f a ribosomal complex. The highly modified Q  and Y bases are drawn in yellow. The models are consistent with the structural parameters 
established by Easterwood and Harvey for tRNA-mRNA-ribosomal interactions. Results indicate that a bend occuring in the mRNA between the A- and P-sites 




Macromolecular Complex Analysis: Anticodon-Codon Association at the A-site (Codon Bias)
In an additional study of macromolecular associations, the G-containing and three modified 
anticodon stem/loops of tRNA“p were modeled onto the A-site o f either a 5’-GACUUU-3’ (GAC-mRNA) 
or 5’-GAUUUU-3’ (GAU-tnRNA) transcript to form eight possible tRNA/mRNA complexes. The 
strength of association of each o f these complexes was assessed by temperature-ramping molecular 
dynamics simulations to determine the effects o f the unmodified and modified wobble bases on anticodon- 
codon interactions. Visual and computational examinations o f G-containing, 7-deazaG-modified, 7-am- 
7deazaG- modified, and Q-modified tRNA"*’ complexes were performed.
Our results suggest that the G-tRNA/GAC-mRNA, 7-deazaG-tRNA/GAC-mRNA, and 7-am-7- 
deazaG-tRN A/GAC-mRNA complexes were tightly associated through all three anticodon-codon bases 
from 48 K through 323 K. Through a ramping protocol for increasing temperatures, the GAU-tnRNA 
complexes and both Q-tRNA/GAC-mRNA and Q-tRNA/GAU-mRNA complexes were observed to 
“retract’' the S’ end of their anticodon loops away from the codon beginning at the wobble (34) position. 
This indicated that G-, 7-deazaG-, and 7-am-7-deazaG-containing anticodon stem/loops associated in a 
more stable complex with the GAC- over that o f GAU-programmed mRNAs. In contrast, the Q-containing 
anticodon stem/loop did not appear to have a preference for association with either GAC- or GAU- 
programmed mRNAs.
Total, potential, and kinetic energies for each system were determined during the simulations 
(Graph 6-2). The total energy of each complex was observed to increase with the temperature ramp. 
However, there are distinct differences in the energetics patterns of complexes involving the G-containing, 
7-deazaG-modified, and 7-am-7-deazaG-modified tRNAs as compared with the Q-modified tRNA 
complexes. With the rise in temperature during the simulation, those complexes involving a G/C or 
modified-G/C interaction (traditional Watson-Crick base-pairing) at the wobble position exhibited a more 
gradual increase in kinetic and potential energies than that observed for queuosine-containing complexes. 
The rate of increase in total energy for the G-tRNA/GAC-mRNA, 7-deazaG-tRNA/GAC-mRNA, and 7- 
am-7-deazaG-tRNA/GAC-mRNA complexes was approximately half that of the G-tRNA/GAU-mRNA, 7- 
deazaG-tRNA/GAU-mRNA, 7-am-7-deazaG-tRNA/GAU-mRNA, and both Q-tRNA complexes with GAC 
or G AU-mRNAs. The slow rise of energy levels for the second grouping of complexes indicates that the 
initial geometry assumed for all complexes is less favorable for the non-traditional Watson-Crick pairing 
structures. Each tRNA associates with either o f it’s cognate codons by exploiting the flexibility of the 
anticodon region. In comparing the energy patterns for the four nucleosides studied, we suggest that the 
reason for the difference in kinetic, potential and total energy pattern of the queuosine-containing complex 
is not due to the replacement of the guanosine base’s N7 atom with a carbon atom, since the G-tRNA and
7-deazaG-tRNA complexes exhibit identical energetics patterns. The effects observed are also unlikely to 
be due to the charged aminomethyl side chain of the queuosine modification, since the 7-am-7-deazaG-
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Graph 6-2. Energetics Analysis o f Eight Complexes During Temperature Ramping Studies. The grey lines show the efficiency of the temperature steps during 
the molecular dynamics simulation. The red line ( • )  indicates the rise in kinetic energy, the blue line (O) represents the rise in potential energy and tlic purple 
line (+) indicates the rise in total energy during the simulations's increases in temperature (❖), These were calculated by a programmed algorithm within the 
Sybyl software (Advanced compulation module). Each temperature step was examined for equilibration time (generally within 10 fs) and the remaining data 
points for each of S fs intervals during the 100 fs step were averaged. Note the similarities in all lines for the complexes involving a guanosinc-, 7- 
dcazaguanosinc-, or 7-aminomethyl-7-dcazaguanosinc-containing tRNA and the traditional Watson-Crick partner for the rnRNA’s codon, cytosine. Also note 
the similarities in those complexes with the wobble pairing of the mRNA’s codon containing uridine with both queuosine-modiffed tRNA complexes involving 
cytosine or uridine in the third position.
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tRNA energetics patterns also duplicate that observed for G-tRNA and 7-deazaG-tRNA. Instead, the 
differences detected for complex stability of the G-, 7-deazaG-, and 7-am-7-deazaG-tRNAs versus the Q- 
tRNA systems are suggested to be caused by the presence of the cyclopentenediol ring moiety that exists 
only in the queuosine modification.
These results demonstrate that tRNA*sp/mRNA complexes containing the queuosine modification 
and all those with GAU-programmed codons exist in a higher energy state than those with the more 
traditional Watson-Crick type interaction. Additionally, we have shown that the modification of tRNA 
with Q greatly increases structural rigidity of the anticodon loop which is suggested to cause the observed 
destabilization of the anticodon/codon interaction. These computational modeling studies provide similar 
results to published experimental data (149,163,164) which indicate that the queuosine modification 
eliminates the G-containing tRNA’s strong codon bias for codons ending in cytidine over uridine. Thus, 
alterations in RNA structure, represented by these sequence variations, appear to have a significant impact 
on the ability o f the tRNA to efficiently associate with (decode) the sequence of the mRNA transcripts.
The results of this study provides evidence of differences in the hydrogen bonding potential o f the 
Q-modified versus G-containing anticodon triplet in addition to differential rigidity o f anticodon loops of 
Q-modified and G-containing forms of tRNAasp. Either or both effects of the queuosine modification are 
suggested to have the potential to restrict the “wobbling ability” o f the queuosine base and the anticodon 
when compared to the G-containing form.
Codon context effects by A- and P-site anticodon loop interactions do not appear to be a factor in 
systems containing queuosine-modified tRNA anticodon stem and loop structures due to the modeled 
“kink” in the mRNA between these two sites used in this study. The axes of A- and P-site tRNA molecules 
sharply angle away from each other which prevents even highly modified nucleosides on adjacent tRNAs, 
such as that seen for queuosine and wyebutine, from interacting.
Potential coding biases, however, do appear to exist between G-containing and Q-modified 
tRNA“p anticodon stem/loop structures for the cognate and pseudo-cognate codons. G-containing tRNA“p 
demonstrates a much more stable and energetically favored association with the traditional Watson-Crick 
type codon GAC, than with the wobble codon GAU. However, Q-modified tRNA*9  molecules exhibit no 
difference in complex stability with either of mRNA codons GAC or GAU. In addition, both Q-modified 
tRNA<sp complexes exhibit virtually identical structural and energetic associations as the G-containing 
tRNA“p/GALJ complex. The bias difference between guanosine- and queuosine-containing systems 
appears to be primarily due to the inflexibility o f the Q-modified anticodon loop and its inability to 
accommodate the proper positioning required o f tight Watson-Crick type associations. The presence of 
altered electrostatic potential surface (hydrogen bonding) characteristics of the wobble base appears to be 
subordinate to the strong differences observed in loop flexibility for realistic effects on overall function of 
Q-modified anticodon loops but may play a synergistic role in the overall function of queuosine-modified 
tRNA.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
113
In 1982, Yarus proposed an “extended anticodon hypothesis” whereby many of the nucleosides in 
the anticodon loop are likely to have influence over the structure and the function of the anticodon, 
particularly in regard to anticodon/codon interaction at the A-site of the ribosome (169). In the following 
years, his proposition has been verified and extended to the functions of modified nucleosides in stabilizing 
or destabilizing the anticodon loop dynamics o f tRNA (149). Thus, the efficiency and accuracy of 
translation is not solely limited to the participation o f the three anticodon nucleosides. Moreover, 
modifications o f nucleosides in and around the anticodon appear to be important factors effecting the 
coding potential and efficiency of tRNAs (170).
The results of this research suggest that the queuosine modification is involved with the regulation 
of gene expression rates in cells via a codon bias mechanism in tRNA-mRNA associations on the 
ribosome. The proposed mechanism is based on the decreased flexibility of the anticodon produced by the 
queuosine-induced extended intramolecular hydrogen bonding network of the anticodon loop. This 
appears to restrict the modified anticodon loop’s ability to accommodate proper positioning for tight 
Watson-Crick type associations with cognate codons, thereby limiting wobbling capabilities for queuosine- 
modified tRNA. In eukaryotic tRNA“p and tRNAlyr, the cyclopentenediol ring o f the queuosine 
modification is often modified with one or several mannose or galactose moieties, respectively (14,18,19). 
Individual oligosaccharides or chains of these glycosidic additions may have the potential to establish 
supplementary hydrogen bond interactions through the loop and up along the groove of the A-type RNA 
helix of the anticodon stem. If this proves to be true, it would undoubtedly further enhance the structural 
stabilization of the anticodon loop providing a significantly decreased bias in the coding potential of 
tRNA** and tRNAtyr molecules.
The cellular level of Q-modified tRNA appears to have strong implications with regard to 
translational control of gene expression for “biased” genes involved in cellular differentiation, stress 
response and neoplastic transformation. These events are tightly regulated by the production levels of 
specific growth control, differentiation inducing and stress response proteins. It is doubtful that the 
queuosine modification alone is responsible for the dramatic effects needed for phenotypic alterations of 
cells. However, it is likely that the costly and complex enzymatic formation of this modification has a 
measurable effect on global cellular physiology, particularly in collaboration with well known mechanisms 
for transcriptional regulation of specific growth control gene products.
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CHAPTER SEVEN 
THE EFFECT OF Q ON TERRAN LIFE-FORMS
The research discussed in this document has produced a description o f the mammalian queuosine 
modification system which has been largely based on that found in human cells. This system is 
dramatically different from the well understood prokaryotic version. For many years it has been assumed 
that the production of the queuosine modification m tRNA of all organisms was by the same or a similar 
mechanism.
Since 1973 the transglycosylase enzyme that incorporates the modified base into tRNA has been 
designated as tRNArguanine transglycosylase in both Escherichia coli and rabbit reticulocytes where it was 
first found to reversibly exchange a guanine-for-guanine in position 34 of asparagine*, aspartate-, histidine- 
and tyrosine-encoding tRNAs (60). The first indications that the eukaryotic and prokaryotic queuosine 
modification systems are different were published in 1976 with evidence of glycosylation o f the queuosine 
residues of tRNA19 and tRNA11* in rabbit reticulocyte lysates (14). In 1978 the substrate of the base-for- 
base exchange leading to the synthesis of queuosine in E  coli was determined to be pret^ and not Q (24), 
while in 1980 it became evident that mammals required the fully-formed Q base for incorporation (11,61).
A comprehensive description of the prokaryotic queuosine modification system has been 
published (23) and is explained in depth in the introduction o f Chapter 3 of this document It is a synthetic 
mechanism which uses readily available substrates within the cell to build the modification on intact tRNA. 
The mammalian system, discussed in Chapters 3 and 4 o f this treatise, is based on a utilization scheme 
which incorporates a specific transport mechanism for the queuine base, an incorporation enzyme that 
places it directly into position 34 o f the involved tRNAs, and a salvage mechanism which can recycle the 
queuine base from tRNA turnover products for reuse by the incorporation enzyme (Figure 7-1). Even the 
generalized structures of the incorporation enzymes, which may catalyze a similar reaction with the two 
different substrates, are dramatically different
Control of both the prokaryotic and eukaryotic queuosine modification systems is also dissimilar. 
The modulation of the prokaryotic system is based on transcriptional regulation of the operon which 
contains two of the four enzymes required for queuosine synthesis. The FIS (factor of inversion 
stimulation) serves to activate the gene expression for both the “queuine operon” and operons containing 
sequences for the four substrate tRNAs (114) The mammalian system is shown to be regulated by a post- 
translational phosphorylation-based mechanism in Chapter 4 of this document Two of the three 
components are activated by protein kinase C-catalyzed phosphorylation while deactivated by the action of 
a protein phosphatase. The kinase-phosphatase reciprocal scheme is a common paradigm observed for the 
control of important metabolic events in virtually all eukaryotic systems, with protein kinase C a key 
regulatory switch for cellular growth and differentiation mechanisms.

















Figure 7-1. The Cellular Design for the Eukaryotic Queuosine Modification System. This depiction of the eukaryotic system is based on the three step 
mechanism with modulation described in chapters three and four of this document; It involves an uptake step facilitated by a specific queuine transmcmbranc 
transporter (shown in blue) which is activated by the pohosphorylation of protein kinase C (PKC) (shown in green). Once inside the cell, tRNAiguaninc 
ribosyltransfcrasc (TGRasc) catalyzes the incorporation reaction of the queuine base (Q) into tRN A"", tRNA"1’, tRNA1"1, or lRNA,yr with concomitant release of 
guanine (G). The TGRasc enzyme is a hctcrodimcr made up of a larger regulatory subunit (shown in black) which is the target for phosphorylation by PKC, 
and a smaller catalytic subunit (shown in red). This enzyme is shown as being loosely associated with the membrane since the addition of detergents to the 
homogenization buffer during protein purification increases the yield of the isolate dramatically. The stoichiometry of phosphorylation and the functional slate 
of the enzyme (dimcrizcd or dissociated, associated with the membrane or soluble in the cytosol) is still in doubt. So a range of possibilities are shown here.
Finally, the last step of the queuosine modification system is a salvage step (catalyzed by an unknown mechanism represented in orange) which recycles free 
queuine base for the incorporation step from qucuosinc-S’-monophosphate. _
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Malfunctions o f various steps of the queuosine modification system have been found to correlate 
with drastic phenotypic changes in cellular appearance and behavior. These include the inability to survive 
environmental stresses and to undergo developmental differentiation. In addition, queuosine deficiencies 
have been strongly correlated with increased growth rate, retrograde differentiation, and neoplastic 
transformation and metastatic progression of mammalian cells. In Chapter 5 o f this document, two 
different human adenocarcinoma cell-Iines (colon and breast), both strongly deficient in queuosine levels, 
were determined to contain lesions of the incorporation and salvage steps, respectively. The in vivo 
methods developed in this research could be used to screen many other cell-lines and biopsies and 
determine sites of queuosine insufficiency in their queuosine modification systems. In addition, along with 
the in vitro assay methods, these techniques could be used to fully characterize a biopsy’s pathological 
phenotype for neoplastic grading as has been previously suggested (40-43).
Despite this new understanding of the queuosine modification system in eukaryotes and 
prokaryotes, a realistic physiochemical mechanism for queuosine’s effect on cellular metabolism has still 
not been developed in either set of organisms. In order to discover the purpose and biological function o f 
the queuosine modification of tRNA and explain queuosine’s connection to the control of cellular 
maintenance, differentiation and growth, it is important to determine the most logical place for the greatest 
influence of this molecule in the cell. There has been some discussion of the queuine base as an activator 
for tyrosine kinases(l5,171), however this has not been pursued as a significant function of the nucleotidyl 
base and would not account for the correlations o f queuosine level fluctuations with such a wide variety of 
phenotypic alterations that have been observed.
Transfer RNA molecules are involved in many minor cellular functions, including serving as 
cofactors in retroviral priming, RNA polymerase priming, ATP-dependent ubiquitin-directed proteolysis, 
sequestration of the glucocorticoid receptor, chloroplast synthesis ofS-aminolevuIinic acid and 
chlorophyll, synthesis of heme and vitamin BI2> and prokaryotic cell wall biosynthesis (172). However, in 
situ the tRNA molecule’s major role is in protein synthesis. Thus, the most logical site for the global effect 
of queuosine-modified tRNAs in areas as diverse as development, differentiation, stress-management, and 
neoplastic transformation is in the control o f the translation stage of gene expression.
There are a few defined reactions of the tRNA which might be influenced by the presence or 
absence of modified bases. Transfer RNAs are involved with both initiation and elongation phases of 
protein translation, however those molecules involved with the queuosine modification (asparaginyl-, 
aspartyl-, histidyl-, and tyrosyl-tRNAs) are only utilized during elongation. The tRNA is complexed with 
several macromolecules during the elongation phase of translation: the cognate aminoacyi synthetase; the 
transport-specific elongation factor; and the ribosomal complex which includes the mRNA, aminoacyi 
(A-) site, peptidyl (P-) site, and exit (E-) site tRNAs, rRNAs and rRNPs.
In translation, the first major reaction for tRNA is it’s association with a cognate tRNA synthetase. 
Several researchers have shown that a key identity determinant for proper association of the tRNA with it’s
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cognate aminoacyi synthetase is in the anticodon (173). However, many tRNAs are identified based on 
specialized base presence in the DHU or PFC loop and especially (even in the case of the aspartyl-tRNA) 
in the aminoacyi acceptor arm (174). Kinetics studies of guanosine-containing versus queuosine-modified 
tRNAs show no significant difference in aminoacylation rates by cognate aminoacyi synthetases (175).
Aminoacylated tRNAs are then required to associate with the ribosome, the site for the translation 
process. Movement through the ribosome is facilitated by translational elongation factors (EFs). 
Prokaryotic EF-Tu and eukaryotic EF-la appear to have the same function in cells. They transport all 
aminoacyl-tRNAs to the ribosome for association with the ribosomal complex. The EFs do not 
discriminate when binding to any tRNA family member or isoacceptor. Recently, EF-tRNA complexes 
have been crystallized and are shown to bind solely to the aminoacyi acceptor arm of the tRNA (176). 
Therefore, it can be inferred that the presence or absence of a modified base in the anticodon should not 
have an effect on the association or transport o f tRNAs by EFs.
The association o f the tRNA with the ribosome is currently a focus of a great amount o f  research. 
£  coli ribosomal complexes have been the predominant subject for cross-linkage, nuclease protection, and 
tRNA binding studies (168), with their global structure recently clarified by high resolution cryoelectron 
microscopy (111). tRNA association with the translation platform appears to be due to the interactions of 
the EF and aminoacyi acceptor stem of the tRNA with the 23S rRNA, and the tRNA-anticodon with the 
mRNA (177). Cross-linkage studies have strongly suggested the presence of a ternary interaction between 
the tRNA-anticodon, the mRNA-codon and the C1400 residue of the 16S rRNA at the wobble position, 
which may be a stabilizing influence on the complex (168). No evidence of direct rRNP-tRNA interactions 
have yet been reported.
After the association of the tRNA with the A-site of the ribosome, the formation of the peptide 
bond (transpeptidation) and translocation of the tRNA to the P-site and then to the E-site takes place at a 
relatively steady state rate (177). Transpeptidation appears to be catalyzed by the 23S rRNA in the 
aminoacyi acceptor stem region of the A- and P-site tRNAs, with the translocation of the mRNA and 
associated tRNAs caused by the shifting of the tRNA molecules causing the subsequent dragging of the 
entire ribosomal complex along the mRNA transcript (178). Therefore, it is suggested that the presence of 
the modified wobble base does not have an effect on the rate of transpeptidation or translocation.
Finally, the potential effect o f the wobble modification on translational rate is narrowed to either 
or both the interaction o f the incoming tRNA with the P-site tRNA and the association of a tRNA with the 
mRNA. These are described by well known theories of “codon context” and “codon bias”, respectively. 
Interaction between neighboring tRNAs in the A- and P-sites of the ribosome have been suggested to be 
due to the close proximity o f the successive codons on the mRNA and the extended nature of a couple of 
modified bases located near the margins of the anticodon loops: such as wyebutine located at position 37 
of tRNA1*® and queuosine in position 34 of tRNA“", tRNA*sp, tRNA1*, and tRNA'*'(4,112,179). However, 
in the case of tRNA1** and tRNA*55 with the currently accepted models of A-site tRNA/mRNA/P-site tRNA
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conformations, it is shown in Chapter 6 of this treatise that these two bases do not interact. A very recent 
report has been published indicating that the neither presence nor the absence of the queuosine- 
modification in tRNA** has a dramatic effect on translational frameshifting at the coraavirus frameshift 
signal (180). This supports the computational model which disputes the biological function o f queuosine 
in codon context effects for such events as ribosomal frameshifting.
Harvey’s group demonstrated that the anticodon loop of tRNAs are functionally and structurally 
separated from the rest o f the molecule by the extended anticodon stem (94). Differences in the strength 
and stability of the anticodon-codon interaction, caused by an alteration in the flexibility of the anticodon 
loop, could influence the speed of tRNA placement into the A-site of the ribosome (169). Thus, the 
flexibility of the anticodon loop may have an effect on the rate of translation in general. Since the wobble 
base is often modified in tRNA, a modified nucleoside could effect the rate of translation due to it’s ability 
to associate with the codon’s corresponding base.
Modified bases have been shown to greatly effect the flexibility of the tRNA molecule by 
influencing ribose puckering, base stacking, and intraloop hydrogen bonding networks (151-155,181). 
These factors have been shown to greatly increase the ability of the tRNA to efficiently decode their 
corresponding tRNAs (149,170,182). Results discussed in Chapter 6 of this document show that the 
presence of the queuosine modification in tRNAasp does alter both the structural flexibility of the anticodon 
loop and the complex stability of the anticodon with the mRNA. In the case of tRNA*9, the addition of the 
queuosine modification dramatically decreases the flexibility of the anticodon loop by establishment of an 
extended cross-loop hydrogen bonding network, thereby decreasing the stability of a tRNA complex with 
either the cognate or pseudo-cognate mRNA. In a ribosomally-based context, the modification of the 
tRNA*5’’ with queuosine decreases the strong bias of guanosine-containing tRNAs for the traditional 
Watson-Crick pairing (cognate) over the wobble pairing (pseudo-cognate) for association with the codon 
on the mRNA.
In a final study performed in this research, a preliminary analysis of codon usage for several 
oncodevelopmental control and housekeeping transcript sequences was made. This was attempted in order 
to assess possible effects of the presence or absence of the queuosine modification on protein synthesis of 
these important proteins. Over time, the identity of the tRNA wobble base (queuosine or guanosine) could 
have a global effect on the metabolism and, potentially, phenotypic alteration of a cell.
Queuosine-modified tRNAs (asparaginyl-, aspartyl-, histidyl-, and tyrosyl-) translate four specific 
codons ending in either the traditional Watson-Crick base cytosine (C) or wobble base uridine (U) (Table 
7-1). An analysis of the codon usage for these codons was performed for a sampling of several 
housekeeping and oncodevelopmental genes. The results are shown in Table 7-II. The percent usage of 
queuosine-involved from all transcript codons varies from 10 to 17 percent with no consistent trend based 
on housekeeping versus oncodevelopmental status. Although this does not seem to be a large percentage 
of residues, these four amino acids often play a major role in structural stabilization and function of
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Figure 7-2. The Genetic Code


























































GUU GCU GGU U
GUC GCC GGC C
G GUA GCA GAA GGA A"
GUG GCG GAG GGG G
Start and stop codons are indicated. Queuosine-related codons, darkly shaded, are encoded by the letters 
NAU or NAC (N indicates any nucleotide base). Tyrosine-encoding codons begin with uridine (U), 
histidine-encoding codons begin with cytosine (C), asparagine-encoding codons begin with adenosine (A), 
and aspartate-encoding codons begin with guanosine (G).
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proteins based on either their proton or electron transfer capabilities. An important observation of these 
codon patterns, however, is that the ratio of U (wobble base) to C (Watson-Crick base) in the wobble 
position of these codons differs between the housekeeping versus oncodevelopmental transcripts. In the 
overall nucleic acid sequence comparisons for the involved amino acid codons, the U to C wobble ratios 
demonstrate a large gap between the housekeeping transcripts (greater than 0.71) and the 
oncodevelopmental transcripts (less than 0.32) for those sequences examined. Thus, it is suggested that 
there may be a bias between these two classes of gene sequences which is able to be exploited by the 
guanosine-containing versus queuosine-modified tRNA translational machinery.
In developing a queuosine-associated codon bias hypothesis, normal and cancer cells would have 
different protein synthetic levels for specific proteins based on the codon usage o f each mRNA sequence 
and the levels of queuosine-modified tRNA levels within the cells. Cells exhibiting normal queuosine- 
modified tRNA levels would produce housekeeping proteins such as ornithine decarboxylase, 
phospholipase A* (3-gaIactosidase, a-actin, and a- and P-globin in similar quantities to oncodevelopmental 
protein assuming a comparable number o f transcript copies. This is suggested to occur due to the lack of 
preference of queuosine-modified tRNAs for either NAC or NALJ codon. In neoplastic cells, which 
contain elevated levels of guanosine-containing tRNAs, oncodevelopmental proteins such as c-fos, N-myc, 
c-Jun, and c-myc would be translated much more efficiently and rapidly than “usual” due to the more 
stable association o f guanosine-containing tRNA to NAC over NAU codons.
Current dogma accepts that transcriptional regulation of oncodevelopmental genes in normal ceils 
greatly reduces the quantity of these transcripts when compared to housekeeping mRNAs. Dual control of 
the expression of these growth control genes through both transcriptional and translational regulation could 
effectively modulate the levels of these important gene products. Thus, fully queuosine-modified normal 
cells would produce the housekeeping proteins in much larger quantities relative to the highly influential 
oncodevelopmental proteins which must be maintained at very low intracellular levels.
This document proposes a codon bias-directed hypothesis explaining the effect of the queuosine 
modification on cellular physiology. The organization of the queuosine modification system in 
prokaryotes and eukaryotes is now known. In addition, regulatory mechanisms for wiring the modification 
systems in with cellular metabolism have been identified. Thus, the cellular dynamics of the queuosine 
modification’s formation in tRNA, as well as the molecular dynamics o f queuosine’s effect in protein 
translation are regulated in a cellular physiological context This theory appears to propose a logical 
mechanism for how the loss of normal queuosine levels could cause the shift of the cellular life-cyde from 
stasis to retrograde-differentiation, and neoplastic transformation to tumor progression.
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Table 7-1. Wobble Base Bias o f Codons Decoded by tRNAam, tRNA**, tRNAhis and 
tRNA1°'r in Selected Human Gene Transcripts
Human Gene Transcript Total Number o f 
Codons




Ornithine Decarboxylase 461 73
(16%)
2.04






























All analyses were performed manually. The total number of codons, Q codons (those encoding for 
asparagine, aspartate, hisidine, and tyrosine), and those Q codons that ended in U or in C were determined 
based on visual inspection of the coding sequences for the gene transcripts. The percentage of total codons 
that involved Q and wobble U/C ratio was calculated based on these observations.
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APPENDIX 
SEPARATION OF QUEUOSINE-MODIFIED tRNA ISOACCEPTOR FAMILIES 
BY RPC-5 AND W-POREX C4 LIQUID CHROMATOGRAPHY
Introduction
An eariy method developed to directly measure levels o f  the queuosine modification in tRNA is 
based on reversed phase C-5 (RPC-5) medium pressure liquid chromatography. The protocol employs the 
use of an RPC-5 column matrix composed of 10 micron polychlorofluoroethylene particles coated with 
trialkyImethylammonium chloride-containing alkyl groups ranging in length from C, to Ct0- The RPC-5 
methodology has been applied to the separation of tRNA species from many sources (183,184), and is the 
standard technique applied to the chromatographic analysis of queuosine-modified tRNAs (21,91,185). 
Despite its successful application, the RPC-5 methodology presents some serious limitations and 
disadvantages. The RPC-5 matrix does not separate the different isoacceptor families with high efficiency. 
For example, it is possible to resolve the queuosine-modified from unmodified forms of aminoacylated 
tRNAs. However, the separation of tRNA"**, tRNA*” , tRNA1” , and tRNA'5'1 species is not possible. 
Furthermore, the RPC-5 matrix does not tolerate repeated pressurized applications with reproducible 
resolution. In addition, the use of organic solvents for optimizing separations on the RPC-5 column can 
lead to degradation of the matrix, where alkyl groups are gradually stripped away from the inert support 
The rate of this deterioration can be decreased by the addition o f a trace amount of trialkylammonium 
chloride (Adogen 264) to the running buffer (Farkas, pers. commun.). Ultimately, the matrix must be 
removed from the column to be regenerated. This takes time and compounds problems with 
reproducibility between reconditioned batches. Finally, and maybe most importantly, the RPC-5 matrix is 
no longer commercially available.
An alternative high pressure liquid chromatography (HPLC) column matrix has shown promise as 
a potential replacement for RPC-5 in analysis of queuosine modification levels in tRNA. The W-Porex C4 
HPLC column has been successfully applied to the separation o f bulk tRNAs isolated from bovine liver 
and wheat germ, as well as snRNA from L929 cells (35). The column matrix consists of an inert support 
of 5 micron porous silica particles with a uniform pore size o f 30 nm. A C4 carbon chain bound to the 
support provides the hydrophobic reversed phase for separation. The W-Porex C4 matrix has been 
demonstrated to significantly improve separation of bulk tRNAs over that of RPC-5 (35). This column 
matrix also has a high capacity for tRNA binding (1 to 20 mg), high durability, and excellent resolution 
over high pressure applications (60 to 90 BAR at a flow rate of 1 mL/min). In studies shown here, the W- 
Porex C4 column was tested for the ability to resolve the four families of the queuosine-containing tRNAs, 
and for the ability to separate individual queuosine-modified from unmodified tRNA isoacceptors.
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Materials and Methods
Transfer RNA from promyelocytic leukemia (HL-60), chronic lymphocytic leukemia (CLL), 
acute myelocytic leukemia (AML), and normal human foreskin fibroblast (HFF) cells were isolated using 
established methods (21,91).
In vivo labelling of queuosine-containing tRNA from HL-60 cells was performed by exposure of 
the cell cultures to a radiolabeled queuine analog (iQT3; specific activity 0.19 Ci/mmol, 0.1 pCi/mL). The 
cells were grown in a ISO cc culture flask to a density of 2 x 106 cells/mL, then exposed to 100 nM rQT3 
for 24 hours. Finally, the tRNA was isolated as mentioned above.
Enhancement of queuosine-deficient HL-60 tRNA was performed by treatment of cultures with 7- 
methyiguanine, an inhibitor of TGRase activity. Enhancement of queuosine-modified HL-60 tRNA 
populations was performed by the addition of excess queuine to the media. These tRNA populations were 
used to assess shifts in the levels o f queuosine-modified versus unmodified tRNA isoacceptors when 
compared to untreated HL-60 tRNA. All cells were grown in 500 mL cultures to a density of 2 x I06 
cells/mL and exposed to 10 pM 7-methylguanine or 0.10 units of queuine for 24 hours. Again, the 
tRNA was isolated as above.
In vitro aminoacylation o f tRNA with 3H-aspartic acid, 3H-histidine, and 3H-tyrosine or unlabeled 
amino acids was performed using isolates from 0.10 A360 queuine-treated and 10 pM 7-methylguanine- 
treated HL-60 cells. Mouse liver aminoacyl-tRNA synthetase, isolated by established methods, was 
utilized to catalyze the aminoacylation reaction. Enzyme isolation and aminoacylation reaction conditions 
were performed as previously described (21,91).
Unlabelled tRNA, rQT3-labeled tRNA, and 3H-aminoacyl tRNA were analyzed by W-Porex C4 
HPLC. Generation of tRNA profiles was accomplished using a 250 x 4.6 mm i.d. W-Porex C4 column 
purchased from Phenomenex (Rancho Palos Verdes, CA). A programmable LKB Ultrachrom GTi 
Bioseparation system was used to develop running conditions for the column. All buffers were filtered 
through 0.22 pm filter and degassed prior to column equilibration and sample analysis. The optimal 
conditions for separation and analysis of queuosine-containing tRNAs were developed at a flow rate of 1.0 
mL/min with a back pressure of 70 to 90 BAR based on elution conditions described by Dudock (35). A 
linear decreasing salt gradient was applied for separation of tRNAs consisting of 1.0 M to 0 M ammonium 
sulfate in 0.10 M potassium phosphate buffer (pH 7.0) modified with 0.75% isopropanol. The column was 
equilibrated in 1.0 M ammonium sulfate containing buffer at 1.0 mL/min for 10 minutes prior to analysis 
of tRNA samples. A linear descending salt gradient from 1.0 M ammonium sulfate to 0.20 M ammonium 
sulfate was applied for 80 minutes, then the salt concentration was reduced to 0 M over 20 minutes. The 
column was rinsed an additional 10 minutes with no salt buffer, brought back to 1.0 M salt over a one 
minute interval and re-equilibrated in 1.0 M ammonium sulfate containing buffer for ten minutes prior to 
the next analysis. On the final run o f the day, the column was left in no salt buffer and the flow rate was
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reduced to 0.1 mL/min and allowed to run continuously overnight. The rate of gradient change could be 
altered to enhance resolution of specific peaks either early or late in the chromatogram, but the simple 
linear gradient demonstrated adequate efficiency at separating the queuosine-containing tRNA 
isoacceptors.
The HPLC profiles of tRNA from rQT3-treated HL-60 cells were used to identify the retention 
times of the four rQT3-modified tRNAs. Isolated 0.10 A^o queuine-treated HL-60 tRNA samples were 
radiolabeled in an aminoacylation reaction and the retention times determined. The tRNA isolated from 7- 
methylguanine treated HL-60 cells was subjected to a radiolabeling aminoacylation reaction and analyzed. 
Comparisons between differentially 3H-aminoacyIated tRNA profiles of 0.10 A^o queuine-treated and 7- 
methylguanine-treated HL-60 tRNAs in order to determine the isoacceptor identity of each "peak” and the 
relative amounts o f queuosine-modified and unmodified tRNAs were determined based on the established 
retention times for HL-60 tRNA.
Results and Discussion
Transfer RNA, isolated from several human cultured cell-lines (HL-60, AML, CLL, and HFF), 
was subjected to HPLC using a W-Porex C4 column in order to determine the best running conditions for 
effective resolution of different populations of tRNA isoacceptors (Figure A-l). The ability of this column 
matrix to perform good separation o f bulk tRNA populations is a particular feature of this resin, and has 
been shown to be more proficient than the RPC-5 matrix (35). The optimal running conditions for the 
separation of the HL-60 tRNA isoacceptors was established at 1.0 mL/min which provided a back-pressure 
of 70 to 90 Bar for the HPLC system (36). The elution is controlled using a linear decreasing ammonium 
sulfate gradient from 1.0 M to 0.2 M in 0.10 M potassium phosphate buffer (pH 7.0) over 80 minutes, and 
finally to 0.0 M over an additional 20 minutes (37).
Parallel tRNA samples were isolated from HL-60 and CLL cultures that were either exposed to 
non-radiolabeled queuine or to a radiolabeled queuine analogue, rQT3, for 24 hours. The unlabeled control 
tRNA was aminoacylated in three reaction mixtures with one of the three available tritiated amino acids 
(3H-aspartate, 3H-histidine, or 3H-tyrosine). The tRNA containing the rQT3 label was aminoacylated with 
non-radioactive amino acids. Each reaction mixture was applied to the W-Porex C4 HPLC system. The 
profile overlays for tritiated aminoacylated (Figure A-2) or tritiated queuosine-containing tRNAs (Figure 
A-3) are shown with identifying labels. Four distinct regions of radioactivity for queuosine-containing 
tRNAs were detected at retention times of 6,21,55, and 70 minutes. This is suggested to be due to the 
separation of the four different possible queuosine-modified tRNA isoacceptors. RPC-5 medium pressure 
liquid chromatography does not have the ability to resolve tRNA isoacceptors, and can only differentiate 
glycosylated from non-glycosylated forms of queuosine-modified tRNAs (87).
To verify that the four peaks detected with the in vivo rQT3 labeling experiment were due to four 
distinct tRNA isoacceptors, another study was begun to detect both specific tRNA isoacceptors and
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Figure A-l. W-Porex C4 HPLC Profiles o f Transfer RNA Isolatedfrom Four Human Cell Cultures. 
Purified tRNA samples (0.5 mg) from chronic lymphocytic leukemia (CLL), acute myelocytic leukemia 
(AML), promyelocytic leukemia (HL-60), and normal human fibroblast (HFF) cells were separated by an 
80 minute decreasing salt gradient of 1.0 M to 0.2 M (NH^SC^ in 0.10 M potassium phospate buffer (pH 
7.0) modified with 0.75% isopropanol. The running buffer was then held at 0.2 M (NH^SO* for 20 
minutes. The samples were eluted on a 250 x 4.6 mm Phenomenex W-Porex C4 column at 1 mL/min and 
monitored by an on-line UV detector which measured the absorbance of the flow at 254 nm.
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Figure A-2. Aminoacylated Transfer RNAs from Chronic Lymphocytic and Promyelocytic Leukemia Cells. 
Purified transfer RNAs from CLL and HL-60 cells exposed in vivo to 0.10 Am units of queuine were each 
aminoacylated, in three separate reactions, with 3H-aspartate, 3H-tyrosine, or H-histidine. In each reaction 
SO fig of tRNA was charged with 3H-amino acid (0.S pCi) in the presence of semi-purified mouse liver 
aminoacyl-tKNA synthetase in a total volume of ISO pL. Each sample was separated by W-Porex C4 
HPLC by a decreasing salt gradient of 1.0 M to 0.2 M (NH4)2S04  over 80 minutes, then held at 0.2 M 
(NH4)2S0 4 for 20 minutes at a flow rate of 1 mL/min. Elution fiactions were collected at 0.S minute 
intervals and analyzed by scintillation. This figure represents an overlay of the three chromatograms (one 
for each }H-amino acid) for tRNA isolated derived from CLL and HL-60 cells, respectively. Backgrounds 
were subtracted to normalize the baselines relative to each other.












Figure A-3. Queuosine-Containing Transfer RNAs from Chronic Lymphocytic and Promyeiocytic 
Leukemia Cells. Transfer RNA from CLL and HL-60 cells exposed to 100 nM rQT3 in culture was isolated 
and a sample (0.5 mg) was added to a reaction mixture for aminoacylation with non-radiolabeled amino 
acids. The reaction mixture was separated by a decreasing salt gradient of 1.0 M to 0.2 M (NH^SO., over 
80 minutes, then held at 0.2 M (NH^SO* for 20 minutes at a flow rate of 1 mL/min. Eluent fractions were 
collected at 0.5 minute intervals and analyzed by liquid scintillation. The figure shows four major 
radioactive peaks returned from each cell-type corresponding to the four queuosine-containing tRNA 
species. The peaks were assigned identities by comparison to the elution patterns of ̂ -aminoacylated 
tRNAs seen in Figure A-2. *The tRNA“" peaks were assigned by process of elimination, since no 3H- 
asparagine was available at the time of these studies.
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visualize each queuosine-modified and deficient forms. The HL-60 cell-line is known to be naturally 60 to 
80% queuosine-deficient, so the cells were exposed in culture to two effectors o f the queuosine 
modification system in order to exaggerate the queuosine-modified and queuosine-deficient populations of 
tRNA. Parallel cultures of HL-60 cells were treated for 24 hours with either an additional 0.10 A ^  
queuine to induce saturation o f the queuosine-modified tRNA isoacceptors, or 10 pM 7-methylguanine 
which is a competitive inhibitor (used at 10 times the Kj) of the queuine incorporation enzyme. The tRNA 
fractions of these cultures were isolated and in vitro aminoacylation reactions were performed with each of 
three specific radiolabeled amino acid substrates (3H-histidine, 3H-tyrosine, and ^-aspartate).
Radiolabeled asparagine, the remaining queuosine-related isoacceptor, was not commercially available at 
the time of this study. Overlays of each amino acid's chromatographic profiles for both queuine-treated 
and 7-methylguanine-treated tRNA samples are shown in Figure A-4.
The 3H-histidyl tRNA profiles o f queuine-saturated and queuine-deficient both exhibit three peaks 
of identical retention times. The 6 minute peak is likely to be the flow-through of excess radiolabeled 
amino acid remaining from the aminoacylation reaction. The peaks at 37 and 67 minutes correspond to 
tRNA1"  isoacceptors. Integration of the two peaks indicates that the 0.10 A260 queuine-treated sample 
contains a 62 to 38% ratio o f area from the first to the second peak, while the 7-methylguanine-treated 
sample has a ratio of 48 to 52% area. Therefore, the 37 minute peak corresponds to the queuosine- 
modified tRNA1"  isoacceptor, with the unmodified tRNA1"  eluting at 67 minutes. The incomplete 
saturation of the modification as seen in these percentages of shift was not unexpected given unpublished 
observations in this laboratory. However, the limited extent of the shift is somewhat disconcerting, since 
these conditions have been published as being effective concentrations of effectors o f the queuosine 
modification system and utilized in many cell culture studies (116).
The 3H-tyrosyl tRNA profiles of queuine-saturated and queuine-deficient samples both exhibit 
three peaks of identical retention times. The 7 minute peak is the flow through o f excess radiolabeled 
amino acid remaining from the aminoacylation reaction. The peaks at 18 and 25 minutes correspond to 
tRNA1̂  isoacceptors. Integration of the two peaks indicates that the 0.10 A^o queuine-treated sample 
contains a 82 to 18% ratio of area from the first to the second peak, while the 7-methylguanine-treated 
sample has a ratio o f 47 to 33% area. It is concluded that the 18 minute peak corresponds to the queuosine- 
modified tRNA1̂  isoacceptor, with the unmodified tRNA1*1 eluting at 25 minutes. As seen with the histidyl 
tRNA profiles, incomplete saturation and inhibition of the queuosine modification system is in evidence 
with this aminoacyl tRNA also, although not quite to the same extent as with tRNA1" .
The 3H-aspartyl tRNA profiles of queuine-saturated and queuine-deficient samples both exhibit 
two peaks of identical retention times. The 5 minute peak may be due to either the flow through of excess 
radiolabeled amino acid remaining from the aminoacylation reaction, or it may also be a significant peak 
with a second peak eluting at a retention time of 8 minutes. Assuming (for sake of argument) that the first 
peak is due entirely to one form of tRNA*sp isoacceptor, integration of the two peaks indicates that the 0.10
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queuine-treated sample contains a 99 to 1% ratio of area from the first to the second peak, while the 7- 
methylguanine-treated sample has a very similar ratio of 98 to 2% area. This suggests that the 5 minute 
peak corresponds to the queuosine-modified tRNA*5’’ isoacceptor, with the unmodified tRNA“p eluting at 8 
minutes. As seen with both the histidyl and tyrosyl tRNA profiles, incomplete inhibition of the queuosine 
modification system is in evidence with this isoacceptor. Therefore, years o f unpublished observations in 
this laboratory and elsewhere (29) regarding a non-uniform and preferential loss of the queuosine 
modification by certain isoacceptors are corroborated by the lack of complete inhibition of the queuine 
incorporation enzyme expected at these published concentrations for 7-methylguanine (76). In addition, 
the inhibition o f queuosine modification for aminoacyl tRNA isoacceptors is not a global effect but occurs 
in a specific order with the tRNA“p and tRNA'5'1 isoacceptors exhibiting the greatest resistance to queuosine 
decreases.
A final comparison of all three profiles and table o f values (Table A-I) suggests that one combined 
aminoacylation reaction (3H-histidyl, 3H-tyrosyl, and 3H-aspartyl labeled tRNA) mixture run on the W- 
Porex C4 HPLC system can separate both the tRNA isoacceptors and the queuosine-modified from 
unmodified forms. An experiment reacting the rQT3 labeled tRNA population with individually labeled 
amino acids and a mixed reaction of all four amino acids is currendy underway. However, the results of 
this preliminary study also suggests that, were radiolabeled asparagine available, a combined reaction assay 
of all four aminoacyl tRNAs would resolve all four possible isoacceptors and their queuosine-modified and 
unmodified forms. This contention is based on the resolution of four distinct regions of rQT3 incorporated 
tRNAs from in vivo studies. The results of the W-Porex C4 HPLC method is in direct contrast with 
chromatographs from established RPC-5 protocols which separate queuosine-modified from unmodified 
forms but do show acceptable resolution between isoacceptors. The RPC-5 methodology can, however, 
identify glycosylated from unglycosylated queuosine-containing tRNAs, while the W-Porex C4 HPLC 
system does not appear to be able to do this.
The W-Porex C4 HPLC method is, therefore, a very effective method for the separation and 
quantification of queuosine-modified tRNAs. Although it does not resolve glycosylated from 
unglycosylated modifications, it does have the advantage over RPC-5 medium pressure liquid 
chromatography of the ability to simultaneously detect the four tRNA isoacceptors and each queuosine- 
modified from unmodified form. This is important due to the current limitations of the RPC-5 
methodology which is no longer commercially available and has several other drawbacks including rapid 
deterioration of the matrix by both solvent exposure and pressurized running conditions. Both liquid 
chromatographic procedures require rather large amounts of sample to analyze. Although the 
chromatographs shown in this chapter were run on the W-Porex C4 column with sample sizes of as little as 
23 |ig tRNA, most protocols would require > to 10 mg tRNA for efficient resolution. Therefore, it is 
important to note that this suggested sample size can limit the type of applications that could utilize this 
technology.
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Figure A-4. Aminoacylated Transfer RNAs from Queuosine-Modified and Queuosine-Deficient 
Promyelocytic Leukemia Cells. The shift o f 3H-aminoacyIated tRNA peaks was analyzed for tRNA 
isolated from HL-60 cells exposed to 0.10 A26o units of unlabeled queuine to help produce a fully 
queuosine-modified compliment of tRNAs (solid lines) and those who were pre-exposed for 24 hours to 10 
pM 7-methylguanine, a competitive inhibitor for the queuine incorporation enzyme (dashed lines). HL-60 
tRNA samples (50 pg) were placed in aminoacylation reactions with partially-purified mouse liver 
aminoacyl-tRNA synthetase in three separate reactions with either 3H-aspartate, 3H-tyrosine, or 3H- 
histidine (0.5 pCi each). The samples were seperated by W-Porex C-4 HPLC by a decreasing salt gradient 
of 1.0 M to 0.2 M (NH4)2S04 over 80 minutes, then held at 0.2 M (NH^SO., for 20 minutes at a flow rate 
of 1.0 mL/min. Elution fractions were collected at 0.5 minute intervals and analyzed by liquid scintillation. 
Backgrounds were subtracted to normalize the baselines relative to each other.
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The retention times (RJ for each of the three aminoacylated HL-60 tRNA isoacceptor pairs were based on 
the results depicted in Figures A-3 and A-4. The first peak suggested to contain queuosine-modified tRNA 
and the second the unmodified guanosine-containing form. The tRNA populations were purified samples 
from parallel HL-60 cultures, that had been exposed for 24 hours ro either 0.10 A260 units of exogenous 
queuine (to attempt to fully saturate the tRNA) or 10 pM 7-methylguanine (a strong competitive inhibitor 
for the queuine incorporation enzyme responsible for the formation o f queuosine). Percent composition 
was ascertained from integration of the chromatographic profile shown in Figure A-4. Despite the 
assumption that the queuine-saturated and 7-methylguanine-treated cells should contain homogenous 
populations of queuosine-modified or queuosine-deficient tRNAs, this was not observed. A shift in the 
peak areas, however, was determined and exhibited the expected trend.
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